propranolol has been researched along with atenolol in 951 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 475 (49.95) | 18.7374 |
1990's | 174 (18.30) | 18.2507 |
2000's | 147 (15.46) | 29.6817 |
2010's | 122 (12.83) | 24.3611 |
2020's | 33 (3.47) | 2.80 |
Authors | Studies |
---|---|
Easson, PA; Lap, BV; Letts, GL; Lim, CH; Temple, DM; Williams, LR | 1 |
Baldwin, JJ; Christy, ME; Denny, GH; Freedman, MB; Gross, DM; Habecker, CN; Lyle, PA; Ponticello, GS; Sweet, CS; Varga, SL | 1 |
Alexander, J; Cargill, R; Michelson, SR; Schwam, H | 1 |
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Baldwin, JJ; Denny, GH; Freedman, MB; Gross, DM; Hirschmann, R; Ponticello, GS; Sweet, CS | 1 |
Gubernator, K; Kansy, M; Senner, F | 1 |
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL | 1 |
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Baker, JG | 1 |
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
Caron, G; Ermondi, G | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Faier, A; Gabinet, Y; Gilon, C; Halbfinger, E; Haskell-Luevano, C; Hess, S; Hoffman, A; Lapidot, T; Linde, Y; Ovadia, O; Portillo, FP; Safrai, E; Shalev, DE; Swed, A; Winkler, I; Xiang, Z; Yarden, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bartkowski, DM; Bertolini, T; Dragovich, PS; Gobbi, A; Kamran, R; Kirkovsky, L; Lardy, M; Lebrun, LA; Li, LS; Murphy, DE; Nolan, TG; Norris, DA; Okamoto, E; Patel, R; Sergeeva, MV; Shah, AM; Stankovic, N; Sun, Z; Tsan, M; Webber, SE; Zhao, J; Zhou, Y | 1 |
Ayida, B; Bartkowski, DM; Bertolini, T; Brooks, J; Dragovich, PS; Kamran, R; Kirkovsky, L; Kissinger, CR; Lebrun, LA; Li, LS; Murphy, DE; Nolan, TG; Norris, DA; Patel, R; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Stankovic, N; Sun, Z; Tran, CV; Tsan, M; Webber, SE; Zhao, J; Zhao, Q; Zhou, Y | 1 |
Bartkowski, DM; Dragovich, PS; Han, Q; Kamran, R; Kim, SH; Kirkovsky, L; Kissinger, CR; Lardy, M; Lebrun, LA; Li, LS; Murphy, DE; Nolan, TG; Norris, DA; Patel, R; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Tran, CV; Tran, MT; Tsan, M; Webber, SE; Zhao, J; Zhou, Y | 1 |
Ayida, B; Bartkowski, DM; Blazel, J; Ellis, D; Gobbi, A; Han, Q; Kim, SH; Kirkovsky, L; Kissinger, CR; LeBrun, LA; McGuire, H; Murphy, DE; Nolan, TG; Norris, DA; Patel, R; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Tran, CV; Tran, MT; Tsan, M; Webber, SE; Xiang, AX; Zhao, Q; Zhou, Y | 1 |
Bartkowski, DM; Blazel, JK; Dragovich, PS; Ellis, DA; Han, Q; Kamran, R; Kirkovsky, L; Kissinger, CR; Lardy, M; LeBrun, LA; Li, LS; McGuire, HM; Nolan, TG; Norris, DA; Patel, R; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Sun, Z; Tran, CV; Tsan, M; Webber, SE; Xiang, AX; Zhao, J; Zhou, Y | 1 |
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
Ayida, BK; Bartkowski, DM; Kamran, R; Kirkovsky, L; Kissinger, CR; Lebrun, LA; Nolan, TG; Norris, DA; Patel, R; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Sun, Z; Tsan, M; Webber, SE; Zhao, Q; Zhou, Y | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Blazel, JK; Dragovich, PS; Ellis, DA; Han, Q; Kamran, R; Kirkovsky, L; Kissinger, CR; LeBrun, LA; Li, LS; Murphy, DE; Noble, M; Patel, RA; Ruebsam, F; Sergeeva, MV; Shah, AM; Showalter, RE; Tran, CV; Tsan, M; Webber, SE; Zhou, Y | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Arnér, ES; Austin, CP; Chakrapani, H; Inglese, J; Jadhav, A; Keefer, L; Lea, WA; Leister, W; Luecke, HF; Maloney, DJ; Prast-Nielsen, S; Rai, G; Sayed, AA; Shen, M; Simeonov, A; Thomas, CJ; Williams, DL | 1 |
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
Barber, JR; Chen, J; Liu, G; Ng, SC; Reddy, PS; Yoon, IS; Zhang, B; Zhang, M; Zhou, Y | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barasoain, I; Chen, H; Chu, JW; Diaz, JF; Fang, WS; Li, Y; Lu, P; Sharom, FJ; Sheng, L; Trigili, C; Wu, J; Xiao, X; Zhao, Y | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Covarrubias, C; Hernández-Luis, F; Navarrete-Vázquez, G; Sánchez-Díaz, R; Vilchis-Reyes, MA; Yépez-Mulia, L | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, L; Conda-Sheridan, M; Cushman, M; Kondratyuk, TP; Morrell, A; Park, EJ; Pezzuto, JM; Reddy, PV; van Breemen, RB | 1 |
Adler, M; Aubele, DL; Franzini, M; Garofalo, AW; Gauby, S; Goldbach, E; Probst, GD; Quinn, KP; Ren, Z; Santiago, P; Sham, HL; Tam, D; Truong, A; Ye, XM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Brownell, AL; Choi, JK; Huang, XP; Kang, HJ; Kil, KE; Poutiainen, P; Roth, BL; Zhang, Z | 1 |
Bloomer, WD; Chatelain, E; Ioset, JR; Kaiser, M; O'Shea, IP; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR | 1 |
Bloomer, WD; Kaiser, M; O'Shea, IP; Papadopoulou, MV; Rosenzweig, HS; Wilkinson, SR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bassetto, M; Brancale, A; Ferla, S; Kandil, S; McGuigan, C; Pertusati, F; Westwell, AD | 1 |
Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
Hao, Y; Liu, Y; Shi, C; Xia, G; Yu, J; Zhang, J; Zhang, L; Zhao, F | 1 |
Bagnyukova, D; Forsberg, MM; Ihalainen, J; Krasavin, M; Lehtonen, M; Lukin, A; Moore, D; Rautio, J; Tikhonova, IG; Zahanich, I; Zhurilo, N; Zozulya, S | 1 |
Fu, L; Jiang, F; Lam, C; Li, J; Liu, W; Qiao, Y; Xia, Y; Xie, D; Xie, F; Yang, F; Zhang, Y | 1 |
Albrecht, W; Bauer, SM; Laufer, SA; Unger, A | 1 |
Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
Andring, JT; Bua, S; Carta, F; Ceruso, M; Filippi, L; Gratteri, P; Lanzi, C; Lomelino, CL; Masini, E; Matucci, R; McKenna, R; Nocentini, A; Pecori, R; Selleri, S; Sgambellone, S; Supuran, CT | 1 |
Barouch-Bentov, R; Brannan, JM; De Jonghe, S; Dye, JM; Einav, S; Herdewijn, P; O'Brien, CM; Prugar, LI; Pu, SY; Rozenski, J; Schor, S; Wouters, R | 1 |
Cini, E; De Santis, R; Giannini, G; Manera, F; Manetti, F; Milazzo, FM; Pace, S; Petricci, E; Stasi, MA; Tallarico, C; Vesci, L | 1 |
Botta, M; D'Agostino, I; De Luca, F; Del Prete, R; Deodato, D; Docquier, JD; Ferraro, T; Guglielmi, MB; Mancini, A; Pasero, C; Sannio, F; Truglio, GI; Visaggio, D; Visca, P; Zamperini, C | 1 |
Bavari, S; Besch, R; Duplantier, AJ; Jay, WB; Kota, KP; Kuehl, K; Lazić, M; Mudhasani, R; Panchal, RG; Pavić, A; Retterer, C; Sean, VA; Selaković, Ž; Šolaja, BA; Soloveva, V; Tran, JP; Vasiljević, B; Verbić, T | 1 |
Chowdhury, SR; Fu, L; Jiang, F; Li, L; Liang, Y; Liu, W; Qi, Y; Xia, Y; Xie, D; Xie, F; Yang, F | 1 |
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
Bae, MA; Choi, J; Choi, JH; Kim, MJ; Kim, YC; Lee, D; Lee, KR; Lee, S; Park, CJ; Seo, J; Shin, DS; Song, YK | 1 |
Bischoff-Kont, I; Chaikuad, A; Faudone, G; Fürst, R; Heering, J; Kaiser, A; Knapp, S; Merk, D; Rachor, L; Willems, S; Zhubi, R | 1 |
Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
Hu, J; Hu, Q; Kong, X; Liu, J; Luo, G; Shen, H; Wang, C; Wu, T; Wu, X; Xiang, Q; Xu, Y; Zhang, C; Zhang, Y; Zhuang, X; Zou, L | 1 |
Hu, J; Hu, Q; Liu, J; Luo, G; Wang, C; Wu, S; Wu, T; Xiang, Q; Xu, H; Xu, J; Xu, Y; Zhang, C; Zhang, M; Zhang, Y; Zhuang, X | 1 |
Bandopadhyay, P; Das, N; Dastidar, UG; Ganguly, D; Pal, S; Rahaman, O; Roy, S; Sinha, BP; Talukdar, A | 1 |
Pandolfi, M; Wettrell, K | 1 |
Bilski, A; Dawes, PM; Wale, J | 1 |
Barritt, DW; Marshall, AJ; Roberts, CJ | 1 |
Barnett, D; Deacon, SP | 1 |
Barritt, DW; Marshall, A; Roberts, CJ | 1 |
Becker, HJ; Grobecker, H; Lutz, E; Petersen, P; Planz, G; Simrock, R; Wiethold, G | 1 |
Amery, A; De Plaen, JF; Fagard, R; Linjen, P; Reybrouck, T | 1 |
Harry, JD; Knapp, MF; Linden, RJ; Newcombe, CP; Stoker, JB | 1 |
Harris, EA; Nisbet, HE; Singh, BN; Whitlock, RM | 1 |
Cullen, PM; Macdonald, MJ; Phillips, CI | 1 |
Brown, HC; Carruthers, SG; McDevitt, DG; Shanks, RG | 1 |
Wettrell, K | 1 |
Gooren, L; Harms, HH; Hesse, C; Spoelstra, AJ; Verschoor, L | 1 |
Schürmann, W; Turner, P | 2 |
Erdmann, E; Krawietz, W; Pruchniewski, M; Weinsteiger, M | 1 |
Dickerson, DD; Fulmor, IE; Goldberg, ME; Lee, RJ | 1 |
Wilcox, RG | 2 |
Day, MD; Roach, AG | 1 |
Bühler, FR; Burkart, F; Marbet, G; Patel, U | 1 |
Kiechel, JR; Meier, J | 1 |
Hugues, FC; Julien, D; Marche, J; Munera, Y | 1 |
Berdeaux, A; Giudicelli, JF | 1 |
Aubert, P; Chaignon, M; Guédon, J; Lucsko, M | 1 |
Dietz, R; Lüth, JB; Mann, JF; Rascher, W; Schömig, A | 1 |
Bennett, T; Gardiner, SM | 1 |
Bliddal, J; Hartling, O; Lysbo Svendsen, T; McNair, A; Trap-Jensen, J | 1 |
Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
Hugues, FC; Julien, D; Marche, J | 1 |
Carlsson, E; Herrmann, I; Lundgren, B | 1 |
Brown, B; Buckley, M; Darragh, A; Fitzgerald, D; Foley, JE; O'Kelly, D; Tormey, W; Vukovich, RA; Willard, DA | 1 |
Bell, C; McLachlan, EM | 1 |
Boger, WP | 1 |
Harry, JD; Knapp, MF; Linden, RJ; Newcombe, C; Stoker, JB | 1 |
Hartling, O; Svendsen, TL; Trap-Jensen, J | 1 |
Dollery, CT; Ferrara, A; Hamilton, CA; Maling, TJ; Mucklow, JC; Reid, JL | 1 |
Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J | 1 |
Kristensen, BO | 1 |
Harry, JD; Jackson, G; Jewitt, DE; Kitson, D; Robinson, C | 1 |
Landauer, AA; Pocock, DA; Prott, FW | 1 |
Carlsen, JE; Christensen, NJ; Svendsen, TL; Trap-Jensen, J | 2 |
Dornan, TL; Gokal, R; Ledingham, JG | 1 |
Richardson, PD; Withrington, PG | 1 |
Anderson, R; van Rensburg, AJ | 1 |
Davidson, C; Myint, S; singleton, W; Taylor, SH; Thadani, U | 1 |
Beil, M; Ulmer, WT | 1 |
Cowen, KJ; Zacharias, FJ | 1 |
Simpson, WT | 1 |
Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A | 3 |
Barnett, D; Deacon, SP; Karunanayake, A | 1 |
Deacon, SP | 1 |
Epstein, SE; LUbbe, WF | 1 |
McDevitt, DG; Nelson, JK | 1 |
Breithardt, G; Jochum, E; Kuhn, H; Seipel, L | 1 |
Henningsen, NC; Mattiasson, I | 1 |
Banks, DC; Edwards, B; Fentem, PH; Hampton, JR; Roland, JM; Wilcox, RG | 1 |
Distler, A | 1 |
Giese, J; Ibsen, H; Leth, A; McNair, A | 1 |
Betts, TA; Clayton, AB; Harvey, PG | 1 |
Allsopp, D; Bailey, PJ; Higgins, TJ | 1 |
Wilkinson, R | 1 |
Pearson, DV; Yen, TT | 1 |
Bune, A; Dargie, HJ; Dollery, CT; Watkins, J | 1 |
Almqvist, S; Kågedal, B; Karlberg, BE; Nilsson, OR; Tegler, L | 1 |
Boer, P; Dorhout Mees, EJ; Geyskes, GG; van Rooijen, GJ | 1 |
Jefferson, D; Jenner, P; Marsden, CD | 1 |
Bachmann, M; Burckhardt, D; Kappenberger, L; Münch, U; Nager, F; Raeber, E; Schwytzer, F | 1 |
Gamio-Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Pérez-Medina, T | 1 |
Breithardt, G; Döhring, HP; Seipel, L | 1 |
Hayduk, K; Hepp, A; Maisch, B; Raff, U | 1 |
Adams, L; Ead, H; Hamer, J; Hayward, R; Spurrell, R; Stephens, J | 1 |
Barber, HE; Hawksworth, GM; Kitteringham, NR; Petersen, J; Petrie, JC; Swann, JM | 1 |
Niedermayer, W; Seiler, KU; Wassermann, O | 1 |
Day, JL; Metcalfe, J; Page, RL; Simpson, N | 1 |
Aberg, H; Hansson, L; Karlberg, BE; Westerlund, A | 1 |
Amery, A; De Plaen, JF; Reybrouck, T | 1 |
Amery, A; Fagard, R; Lijnen, P; Reybrouck, T | 1 |
Chiueh, CC; Grobecker, H; Kopin, IJ; McCarty, R; Saavedra, JM | 1 |
Barrett, AM | 2 |
Aström, H; Vallin, H | 1 |
Conway, FJ; Fitzgerald, JD; McAinsh, J; Rowlands, DJ; Simpson, WT | 1 |
Aberg, H; Hedstrand, H; Ross, SB; Wetterberg, L | 1 |
Grau Real, F; Rodrigo Baeza, F | 1 |
Aström, H | 1 |
Daly, S; Fremming, BD; Hodgson, BJ | 1 |
Bischoff, KO; Diesch, J; Geigenmüller, L; Hübner, H; Meesmann, W; Stephan, K | 1 |
Ead, H; Hamer, J; Hayward, R; Stephens, J | 1 |
Dahlöf, C; Nederfors, T | 1 |
Blatteis, CM; Quan, N; Ungar, AL; Xin, L | 1 |
Burnham, WR; Day, S; McIntyre, AS; Thompson, DG; Walker, ER | 1 |
Lang, CH | 2 |
Bousser, MG; Massiou, H | 1 |
Goldberg, SR; Schindler, CW; Tella, SR | 1 |
Allen, RP; Bezold, HJ; Hienz, RD; Turkkan, JS | 1 |
Cruikshank, JM; McAinsh, J | 1 |
Demopoulos, CA; Kapoulas, VM; Tsangaris, GT; Tsoukatos, DC | 1 |
Levenson, J; Pithois-Merli, I; Simon, A; Valensi, P | 1 |
Jancinová, V; Nosál, R; Petríková, M | 1 |
Hienz, RD; Turkkan, JS | 1 |
Bassan, MM; Rogel, S | 1 |
Law, B; Weir, S | 1 |
Beckwith, LJ; Benn, JJ; Brown, PM; Farebrother, M; Sönksen, PH | 1 |
Mooij, JM; Schiffers, PM; van Baak, MA | 1 |
Cooper, RC; Ekwuru, M; Fletcher, S; Gilbody, J; Husseyin, TS; Ishaque, M; Jagathesan, R; Reddy, G; Smith, SE; Thomas, SH | 1 |
Crea, F; Gaspardone, A; Kaski, JC; Maseri, A | 1 |
Carlen, PL; Jahromi, SS; Niesen, C | 1 |
Hara, A; Hori, Y; Koga, Y; Takamoto, T; Toshima, H; Yokoyama, MM | 1 |
Berney, CE; Derksen, FJ; Robinson, NE; Scott, JS | 1 |
Fletcher, BJ; Fletcher, GF; Sweeney, ME | 3 |
Garson, A; Perry, JC | 1 |
Celle, G; Dagnino, F; Grasso, A; Gris, A; Marenco, S; Nobili, F; Risso, D; Rodriguez, G; Rosadini, G; Testa, R | 1 |
Allavena, A; Brambilla, G; Gazzaniga, GM; Martelli, A; Mazzei, M; Robbiano, L | 1 |
Feldt-Rasmussen, U; Hansen, JE; Hegedüs, L; Kayser, L; Perrild, H; Skovsted, L | 1 |
Mills, RG; Roberts, MS; Shen, JJ; Wanwimolruk, S | 1 |
Jancinová, V; Nosál', R; Petríková, M | 1 |
Gitter, S; Gordon, I; Rehavi, M; Speiser, Z | 1 |
Malik, KU; Schwartz, DD | 1 |
Andreasen, M; Lambert, JD | 1 |
Birkeland, K; Gullestad, L; Kjekshus, J; Larsen, S; Nordby, G | 1 |
Biediger, AM; Keeton, TK | 1 |
Bedi, GS | 1 |
Faergeman, O; Jensen, HK; Sørensen, EV | 1 |
Freedman, AM; Kramer, JH; Mak, IT; Weglicki, WB | 1 |
Holzer, BC; Kostis, JB; Rosen, RC; Seltzer, LG; Taska, LS | 1 |
Nyarko-Adomfeh, C | 1 |
Takuma, T | 1 |
de Meis, L | 1 |
Haunsø, S; Sejrsen, P; Svendsen, JH | 1 |
Brime, J; Costales, M; Díaz, F; Lopez-Sela, P; Marín, B; Vijande, M | 1 |
Elliott, HL; McNally, C; Meredith, PA; Reid, JL | 1 |
Cunha, FQ; Ferreira, SH; Lorenzetti, BB; Poole, S | 1 |
Lithell, HO | 1 |
Bowdle, TA; Kharasch, ED | 1 |
Chan, WL; Gilligan, DM; Oakley, CM; Stewart, R | 1 |
Bilić, A; Ljubicić, N | 1 |
Cobo, C; De Crée, J; Geukens, H; Verhaegen, H | 1 |
Hansen, O; Johansson, BW; Nilsson-Ehle, P | 1 |
Balasubramaniam, S; Chang, S; Hickie, JB; Simons, LA | 1 |
Dimenäs, E; Kerr, D; Macdonald, I | 1 |
Heller, SR; Kerr, D; MacDonald, IA; Tattersall, RB | 1 |
Bessho, H; Kitada, Y; Narimatsu, A; Suzuki, J; Tobe, A | 1 |
Abdelrahman, A; Nguyen, H; Pang, CC | 1 |
Borgers, M; Flameng, W; Lu, HR; Vandeplassche, G; Wouters, L | 1 |
Davidson, JM; Maurice, J; Richardson, R; Smith, ER; Walter, T | 1 |
Chee, KY; Sachdev, P | 1 |
Pang, CC; Tabrizchi, R | 1 |
Enquist, M; Hermansson, J | 1 |
Fiocchi, G; Fogari, R; Poletti, L; Rizzardi, G; Tettamanti, F; Zoppi, A | 1 |
Burgherr, J; Bürgi, U; Bürgi-Saville, ME; Clément, M; Lauber, K | 1 |
Husayni, TS; Novak, J; Quinones, JA; Thilenius, OG | 1 |
Kingwell, BA; Korner, PI; McPherson, GA | 1 |
Bessho, H; Kitada, Y; Narimatsu, A; Satoh, N; Suzuki, J; Tobe, A | 1 |
Bowman, CE; Rogers, TK | 1 |
Jansen, H | 1 |
Sakata, S; Shimamoto, H; Shimamoto, Y | 1 |
al Kattan, AH; Noble, AR; Parker, JC | 1 |
Funck-Brentano, C; Roden, DM; Silberstein, DJ; Wood, AJ; Woosley, RL | 1 |
Dunn, AJ; Yang, XM | 1 |
Avezzano, ES; Seefe, LB | 1 |
Friedhoff, AJ; Santo, JP; Steiner, SS; Wecker, JR; Wilson, BL | 1 |
Bennett, T; Rahman, MA | 1 |
Cleophas, TJ; Stapper, GJ | 1 |
Allberry, RA; Drake, HF | 1 |
Gross, CR; O'Connell, MB | 1 |
Belpaire, FM; Bogaert, MG; Chauvelot-Moachon, L; de Smet, F; Rosseel, MT; Vermeulen, AM; Vynckier, LJ | 1 |
Demitrack, MA; Lewy, AJ; Reus, VI | 1 |
Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
Abe, Y; Narimatsu, A; Tobe, A | 1 |
Bouscarel, B; Cortinovis, C; Mayer, D; Murat, JC; Paris, H | 1 |
Braga, G; Mazzocchi, C; Mazzoleni, G; Presta, M; Ragnotti, G; Riboni, L; Ziliani, S | 1 |
Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A | 1 |
Grebow, P; Khandwala, A; Pruss, TP; Wolf, PS; Wong, L | 1 |
Vaughan Williams, EM | 1 |
Botana, LM; Eleno, N; Espinosa, J | 1 |
Belz, GG; Palm, D; Wellstein, A | 1 |
Belz, GG; Bühring, KU; Leopold, G; Pabst, J; Palm, D; Wellstein, A | 1 |
Beil, ME; Cabot, CF; Coram, WM; Olson, RW; Weiss, GB | 1 |
De Cree, J; Janssen, PA; Janssens, W; Reneman, RS; Van de Water, A; Van Neuten, J; Verhaegen, H; Xhonneux, R | 1 |
Cook, LL; Edens, FW; Tilson, HA | 1 |
Kirkegaard, P; Magid, E; Nexø, E; Poulsen, SS; Rasmussen, T; Skov Olsen, P | 1 |
Daniell, HB; Gaffney, TE; Oatis, JE; Walle, T; Webb, JG | 1 |
Conant, J; Engler, R; Gilpin, E; Janowsky, D; LeWinter, M; Maisel, A | 1 |
Baggen, MG; Birkenhäger, JC; Jansen, H; Lammers, R | 1 |
Patterson, JF | 1 |
Burnham, WR; Day, SJ; O'Brien, JD; Thompson, DG; Walker, E | 1 |
Grobecker, H; Schrader, E | 1 |
Colombo, M; de Franchis, R; Dioguardi, N; Sangiovanni, A; Tommasini, M | 1 |
Chin, SK; Giacomini, KM; Hui, AC | 1 |
Anselmi, E; Candenas, ML | 1 |
Jancinová, V; Nosál, R | 1 |
Abraham, S; Beatch, GN; Paletta, MJ; Walker, MJ | 1 |
Colombo, M; de Franchis, R; Sangiovanni, A; Tommasini, M | 1 |
Bowden, CR; Marchione, CS | 1 |
Hansen, O; Johansson, BW | 1 |
Hansen, JM; Jørgensen, B; Kayser, L; Perrild, H; Poulsen, HE; Skovsted, L | 1 |
Coutie, WJ; Lipworth, BJ; McDevitt, DG; McFarlane, LC | 1 |
Mehvar, R | 1 |
Negita, S; Tsuru, H | 1 |
From, RP; Mehta, MP; Pathak, D | 1 |
Fukanoki, S; Hyon, SH; Ikada, Y; Morimoto, K; Morisaka, K | 1 |
Berger, C; Jost, S; Lichtlen, P; Rafflenbeul, W | 1 |
Fogh-Andersen, N; Jørgensen, B; Kayser, L; Mølholm Hansen, JE; Perrild, H | 1 |
Mimura, G; Murakami, K; Nagamine, F; Sakanashi, M | 1 |
Baird, AR; Henry, JA; Minton, NA | 1 |
Thörne, A; Wahren, J | 1 |
Feese, G; Freund, BJ; Jilka, SM; Joyner, MJ; Kalis, J; Nittolo, JM; Peters, H; Taylor, JA; Wilmore, JH | 1 |
Friedman, DB; Musch, TI; Ordway, GA; Williams, RS | 1 |
Leenen, FH; Reeves, RA | 1 |
Frohman, EM; Gupta, S; van den Noort, S; Vayuvegula, B | 1 |
Ebihara, A; Fujimura, A | 1 |
Frcka, G; Lader, M | 1 |
Berkin, KE; Thomson, NC; Walker, G | 1 |
Pringle, TH; Riddell, JG; Shanks, RG | 1 |
Cole, S; Dahlbert, T; Knaster, HB; Weinstein, RS | 1 |
Groszmann, RJ; Kroeger, RJ | 1 |
Knopes, KD; McLeod, AA; Shand, DG; Williams, RS | 1 |
Cilliers, JF; Gordon, NF; Kielblock, AJ; Krüger, PE; Van der Linde, A; Van Rensburg, JP | 1 |
McGourty, JC; Silas, JH; Solomon, SA | 1 |
Rothwell, NJ; Stock, MJ; Sudera, DK | 1 |
Belz, GG; Palm, D; Pitschner, HF; Wellstein, A | 1 |
Birmingham, AT; Patrick, JM; Wharrad, HJ; Wilson, CG | 1 |
Jackson, PR; Lewis, RV; Ramsay, LE | 2 |
Barney, CC; Katovich, MJ | 1 |
Carlsen, JE; McNair, A; Svendsen, TL; Trap-Jensen, J | 1 |
Fletcher, GF | 1 |
Opie, LH | 1 |
Floras, JS; Hassan, MO; Jones, JV; Sleight, P | 3 |
Chiba, S; Kobayashi, M; Shimotori, M | 1 |
Barrett, JA; Pruss, TP; Smith, RD; Wolf, PS | 1 |
Goshima, Y; Kubo, T; Misu, Y | 1 |
Kawecka-Jaszcz, K; Skoczeń, M | 1 |
Fink, M; Lemmer, B; Ohm, T; Winkler, H | 1 |
Riddell, JG; Shanks, RG | 1 |
Cruickshank, JM; Neil-Dwyer, G | 1 |
McDevitt, DG | 1 |
Betts, TA; Blake, A; Crowe, A; Harvey, P; Knight, R; Mortiboy, D | 1 |
Alford, C; Betts, TA | 1 |
Westerlund, A | 1 |
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 1 |
Balgavý, P; Jakubovský, J; Jancinová, V; Nosál, R; Ondrias, K | 1 |
Brownlee, WC; Durrington, PN; Large, DM | 1 |
Arendt, RM; Greenblatt, DJ; Mutschler, E; Ochs, HR; Schäfer-Korting, M | 1 |
Hawksworth, GM; Petrie, JC; Rigby, JW; Scott, AK | 1 |
Bruschi, C; Cerveri, I; Karitinos, P; Pamparana, F; Rossi, A; Zanon, P | 1 |
Cruickshank, J; Neil-Dwyer, G; Stratton, C | 1 |
de Boo, T; Lemmens, WA; Lenders, JW; Salemans, J; Thien, T; van't Laar, A | 1 |
Finch, MB; McNeill, AJ; O'Connor, PC; Pringle, TH; Riddell, JG; Shanks, RG | 1 |
Fagher, B; Liedholm, H; Monti, M; Moritz, U | 1 |
Fishbein, L; Jackson, CD | 1 |
Ewy, GA; Freund, BJ; Hetrick, GA; Jilka, SM; Joyner, MJ; Martinez, E; Wilmore, JH | 1 |
Katano, Y; Kishi, H; Kitazawa, T; Kondo, H; Ohta, T; Temma, K | 1 |
Charyev, KhE; Iurenev, AP; Shkhvatsabaia, IK | 1 |
Epstein, M; Oster, JR | 1 |
Barberis, S; Galietti, F; Giorgis, GE; Massaglia, GM; Miravalle, C; Onoscuri, E | 1 |
Lennard, MS; Silas, JH; Tucker, GT; Woods, HF | 1 |
Abila, B; Marshall, RW; Richens, A; Wilson, JF | 1 |
Belpaire, FM; Bogaert, MG; Mugabo, P; Rosseel, MT | 1 |
Ji, LL; Kochan, RG; Lardy, HA; Lennon, DL; Nagle, FJ | 1 |
Fukuzaki, H; Sakamoto, S; Yokoyama, M | 1 |
Barrett, JE; Durel, LA; Krantz, DS | 1 |
Bühring, KU; Leopold, G; Pabst, J; Simane, Z; Ungethüm, W; Wiemann, H | 1 |
DiMicco, JA; Hatfield, SM; Petersen, BH | 1 |
Bühring, KU; Garbe, A | 1 |
Burris, JF; Goldstein, J; Plachetka, JR; Sirgo, MA; Sutton, JM; Zager, PG | 1 |
Ngatidjan, D; Rand, MJ | 1 |
Blizzard, RM; Mauras, N; Rogol, AD; Thorner, MO | 1 |
Edwards, E; Whitaker-Azmitia, PM | 1 |
Lew, MJ; Ludbrook, J; Pavia, JM; Quail, AW; Rutter, PC | 1 |
Brotzu, G; Palmina, P; Roberto, M; Susanna, F | 1 |
Brismar, K; Mogensen, L; Wetterberg, L | 1 |
Bertolotti, G; Galdangelo, F; Mazzuero, G; Tavazzi, L; Zotti, AM | 1 |
Deighton, N; Howie, CA; Jones, CR; Reid, JL; Sumner, DJ; Whyte, K | 1 |
Hicks, RW; Jilka, SM; Joyner, MJ; Kalis, JK; Lohman, TG; Nittolo, J; Taylor, JA; Wilmore, JH | 1 |
Croughwell, N; de Bruijn, N; Knopes, K; Reves, JG | 1 |
Adebayo, GI; Mabadeje, AF; Oyenuga, AB | 1 |
Yuwiler, A | 1 |
Morrison, JF; Pearson, SB; Simpson, FG | 1 |
Pandhi, P; Sharma, PL | 1 |
Adler, L; Angrist, B; Corwin, J; Reiter, S; Rotrosen, J | 1 |
Schauer, I; Schauer, UJ | 1 |
Berkenboom, G; Degre, S; Desmet, JM; Fontaine, J | 1 |
Harvengt, C; Heller, FR; Martiat, P; Van Nieuwenhuyze, Y | 1 |
Gwirtz, PA; Mass, H | 1 |
Chockalingam, A; Drover, A; Fifield, F; Fodor, JG; Pauls, CJ | 1 |
Norris, RJ | 1 |
Brooks, B; Danielsen, U; Hansen, JE; Jørgensen, B; Kayser, L; Perrild, H | 1 |
Banerjee, AK; De Boer, HJ; Dhasmana, KM; Saxena, PR | 1 |
Altomare, GF; Gandossi, E; Pigatto, PD; Polenghi, MM | 1 |
DeNatale, RW; Leach, SD; Stern, H; Tilson, MD; Toole, AL | 1 |
Clerici, C; Harf, A; Macquin-Mavier, I | 1 |
Blumenthal, JA; Ekelund, LG; Madden, DJ | 1 |
Belz, GG; Butzer, R; Palm, D; Pett, B; Polsak, R; Wellstein, A | 1 |
Proegler, M; Schneider, H | 1 |
Bonsignore, MR; Culver, PL; Dodek, PM; Jerome, EH; Staub, NC | 1 |
Hoitsma, AJ; Huysmans, FT; Koene, RA; van Heusden, FH; Wetzels, JF | 1 |
Jekelis, AW; Kostis, JB; Rosen, RC | 1 |
Ambudkar, IS; Baum, BJ; Horn, VJ | 1 |
Leenen, FH; Nguyen, PV; Smith, DL | 1 |
Anschütz, S; Wessler, I | 1 |
Kato, T; Nagamine, F; Nakasone, J; Noguchi, K; Sakanashi, M | 1 |
Frishman, WH; Soberman, JE | 1 |
Lamon, KD | 1 |
Currie, D; Lewis, RV; McDevitt, DG; Nicholson, AN; Wright, NA | 1 |
Currie, D; McDevitt, DG; Nicholson, AN; Wright, NA; Zetlein, MB | 1 |
Harada, Y; Kashiwabara, T; Nakayama, K; Yamada, S; Yamazawa, T | 1 |
Viinikka, L; Ylikorkala, O | 1 |
Jones, DL | 1 |
King, KA; Pang, CC; Tabrizchi, R | 1 |
Lavanchy, N; Martin, J; Rossi, A | 1 |
Inoue, T; Mohri, M; Nakamura, M; Tomoike, H | 1 |
Badylak, SF; Geddes, LA; Gray, M; Janas, W; Stevens, L; Voorhees, WD | 1 |
Ebihara, A; Hosoda, S; Kumagai, Y; Nakashima, H; Ohashi, K; Shitou, T; Tateishi, T | 1 |
Drake-Holland, AJ; Noble, MI; Wanless, RB | 1 |
Brotzu, G; Carboni, MG; Falchi, S; Montisci, R; Petruzzo, P | 1 |
Frisk-Holmberg, M; Juhlin-Dannfelt, A; Kaijser, L; Kaiser, P; Tesch, PA | 1 |
Brown, JE; McLeod, AA; Shand, DG | 2 |
Haeusler, G; Harting, J; Schliep, HJ; Schulze, E | 1 |
Arnold, JM; McDevitt, DG | 2 |
Chakravarti, S; Kulkarni, SK; Parale, MP | 1 |
Beld, AJ; Hermanussen, MW; Lammers, JW; Rodrigues de Miranda, JF; van Ginneken, CA; van Koppen, CJ; Verrijp, KN | 1 |
Boomsma, F; Man in 't Veld, AJ; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ | 1 |
Blumenthal, JA; Ekelund, LG; Krantz, DS; Light, KC; Madden, DJ; McKee, DC | 1 |
Barer, DH; Cruickshank, JM; Ebrahim, SB; Mitchell, JR | 1 |
Deering, AH; Harron, DW; Riddell, JG; Shanks, RG | 1 |
Ciancio, SG | 1 |
Nye, PC; Paterson, DJ | 1 |
Trap-Jensen, J | 1 |
Barer, DH; Ebrahim, SB; Mitchell, JR | 1 |
Fox, KM | 1 |
Brismar, K; Eliasson, K; Hylander, B; Rössner, S; Wetterberg, L | 1 |
Parry, BL; Rosenthal, NE; Tamarkin, L; Wehr, TA | 1 |
Chatterji, T; Gattani, RK; Mahajan, V; Puri, R | 1 |
Lovell, HG; Petrie, JC; Robb, OJ; Webster, J; Witte, K | 1 |
Blumenthal, JA; Ekelund, LG; Krantz, DS; Light, KC; Madden, DJ; McKee, DC; Simon, J | 1 |
Freund, BJ; Jilka, SM; Joyner, MJ; Kalis, JK; Nittolo, J; Wilmore, JH | 1 |
Kato, T; Nagamine, F; Noguchi, K; Sakanashi, M; Sunagawa, R | 1 |
Bouchier, IA; Connacher, AA; Hamilton, I | 1 |
Freund, BJ; Jackson, JC; Moriguchi, S; Watson, RR; Werner, L; Wilmore, JH | 1 |
Cournot, A; Desche, P; Duchier, J; Guery, O; Prost, JF | 1 |
Agnew, JE; Bateman, JR; Clarke, SW; Lennard-Jones, AM; Pavia, D | 1 |
Maltbaek, N; Rehling, M; Svendsen, TL; Tangø, M; Trap-Jensen, J | 2 |
Leenen, FH; Reeves, RA; Smith, DL | 1 |
Ali, S; Peet, M | 1 |
Kochar, MS; Thachil, J; Zeller, JR | 1 |
Baldassarre, G; Gadaleta, CD; Ventrella, F | 1 |
Berry, DA; Finley, D; Holtzman, JL; Johnson, B; Sirgo, MA | 1 |
Fagher, B; Liedholm, H; Monti, M | 1 |
DeLoach, G; Satumtira, N; Yorio, T | 1 |
Kawecka-Jaszcz, K; Kocemba, J; Wojciechowska, M | 1 |
Bright, PS; Gaffney, TE; Street, JA; Webb, JG | 1 |
Guidobono, F; Netti, C; Olgiati, VR; Pecile, A; Sibilia, V | 1 |
Calder, AA; Forbes, CD; Greer, IA; Walker, JJ | 1 |
Hengeveld, WL; Schouten, JA; Westerman, RF | 1 |
ten Berge, BS; van der Veur, E; Wesseling, H; Wouda, AA | 1 |
Gordon, EP; Harrison, DC; Haskell, WL; Hewitt, BF; Kaplan, SM; Savin, WM | 1 |
Ewy, GA; Faris, WE; Freund, BJ; Hartzell, AA; Hetrick, GA; Joyner, MJ; Strother, RT; Wilmore, JH | 1 |
Ewy, GA; Freund, BJ; Hartzell, AA; Jilka, SM; Joyner, MJ; Kinzer, SM; Pepin, EB; Todd, CA; Wilmore, JH | 1 |
Anderson, RL; Ewy, GA; Freund, BJ; Hartzell, AA; Joyner, MJ; Todd, CA; Wilmore, JH | 1 |
Gordon, NF | 1 |
Eliasson, K; Hylander, B; Kaijser, L; Kaiser, P | 1 |
Jutrin, I; Lang, R; Ravid, M | 1 |
Decourt, S; Flouvat, B; Lebrec, D; Leneveu, A; Rocher, I; Rosier, SP | 1 |
Fagerström, KO; Hugdahl, K; Lundström, N | 1 |
Aviram, M; Berkovitch, Y; Brook, JG; Marmur, A | 1 |
Vidt, DG | 1 |
Dutton, RE; Gonsalves, SF; Nolan, WF; Smith, EJ | 1 |
Campbell, DG; Heyma, P; Larkins, RG | 1 |
Jounela, AJ; Juustila, H; Lilja, M; Mattila, MJ | 1 |
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
Letts, LG; Temple, DM; Williams, LR | 1 |
Coenen, CH; Leenen, FH; Maas, AH; Zonderland, M | 1 |
Iijima, T; Philippu, A | 1 |
Innemee, HC; Ros, FE; van Zwieten, PA | 1 |
Ohrström, A; Pandolfi, M | 1 |
Bush, LR; Haack, DW; Lucchesi, BR; Shlafer, M | 2 |
Abiko, Y; Hattori, Y; Izumi, T; Kanno, M; Nakaya, H; Nishimura, T; Sakai, K | 1 |
Anker, E; Bergrem, H; Dahle, K; Jervell, J; Leivestad, T; Myrseth, L; Pape, J; Thaulow, E; Urving, H; vd Lippe, A | 1 |
Frishman, WH; Koch-Weser, J | 1 |
Kirch, W; Köhler, H; Mutschler, E; Spahn, H | 1 |
Himori, N; Honma, S; Ishimori, T; Izumi, A | 1 |
Carroll, JD; Jefferson, D; Taylor, EA; Turner, P | 1 |
Hampton, JR | 1 |
Kudo, Y; Sokabe, H; Zehr, JE | 1 |
Dalal, JJ; Dart, AM; Griffith, TM; Henderson, AH; Penny, WJ | 1 |
Burmeister, WE; Lee, RJ; Reynolds, RD | 1 |
Botting, JH; Crook, P | 1 |
McLeod, AA; Shand, DG | 1 |
Presta, M; Ragnotti, G; Riboni, L | 1 |
Kaiser, P; Karlsson, J; Rössner, S | 1 |
Forsgren, A; Hallengren, B; Melander, A | 1 |
Kaiser, P | 2 |
Day, JL; Metcalfe, J; Simpson, CN | 1 |
Ohrström, A | 1 |
Hjalmarson, A | 1 |
Henderson, A; Lewis, M; Ross, J; Sheridan, D | 1 |
Fuerst, M | 1 |
Al-Khader, A; Hernandez, J; Prichard, BN; Walden, RJ; Yu, Y | 1 |
Lohmöller, G; Stocker, K | 1 |
Alpers, JH; Crockett, AJ; Latimer, KM; McIntyre, EL; Ruffin, RE; Ward, HE | 1 |
Ahmad, D; Carruthers, SG; Hamilton, JT; Twum-Barima, Y | 1 |
Patel, L; Turner, P; Weerasuriya, K | 1 |
Adam, WR; Barter, CE; Meagher, EJ | 1 |
Iskandrian, AS; Kotler, MN; Segal, BL | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Bai, TR; Hamilton, M; Webb, D | 1 |
Houben, H; Thien, T; Van't Laar, A; Wijnands, G | 1 |
Higginson, LM; Opie, LH; Thandroyen, FT; Worthington, MG | 1 |
Hatori, Y; Horii, M; Nakamura, Y; Nemoto, E; Otsuka, K; Sakai, T; Tsukiyama, H; Yamamoto, Y; Yamato, T; Yoshii, Y | 1 |
Fellenius, E | 1 |
Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L | 1 |
Earl, DC; Halliday, SE; Smith, HJ; Stribling, D | 1 |
Himori, N; Ishimori, T; Iwamura, M; Izumi, A; Makino, M; Yasuda, K | 1 |
Jaramillo, J | 1 |
Ermakova, VN | 1 |
Kaiser, P; Karlsson, J; Kjessel, T | 1 |
Charyev, KhE; Erina, EV | 1 |
Desiatnichenko, VM; Romakov, AIu; Sagirov, AM; Sobol', IuS; Sumarokov, AB | 1 |
Cummings, JR; Grimes, D; Stern, M; Wojdan, A | 1 |
Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A | 1 |
Briscoe, MG; Halliday, SE; Smith, HJ; Snow, HM | 1 |
Kawashima, K; Kudo, Y; Sokabe, H | 1 |
Brown, JE; Kitchell, BB; Kuhn, C; McLeod, AA; Sedor, FA; Shand, DG; Williams, RS | 2 |
Buylaert, W; Derom, E; Elinck, W; van der Straeten, M | 1 |
Teräväinen, H | 1 |
Jackson, EA; Sullman, SA | 1 |
Fyhrquist, F; Groop, L; Groop, PH; Kala, R; Tolppanen, EM; Tötterman, K | 1 |
Lucchesi, BR; Patterson, E | 1 |
Bralet, J; Didier, JP; Moreau, D; Opie, LH; Rochette, L | 1 |
Crankshaw, DJ; Ruzycky, AL | 1 |
Amlie, JP; Refsum, H | 1 |
Johns, VJ | 1 |
Fitzgerald, DE; Harry, JD | 1 |
Ahokas, JT; Davies, C; Ravenscroft, PJ | 1 |
Bellens, R; Degre, S; Degreve, M; Fitzsimons, TJ; Gangji, D; Herchuelz, A; Juvent, M; Niset, G; Poortmans, J; Wathieu, M | 1 |
Fitzsimons, TJ; Holt, D; Johnston, A; Warrington, SJ | 1 |
Kirch, W; Mutschler, E; Spahn, H | 2 |
Betts, T; Crowe, A; Hawksworth, G; Knight, R; Nyemitei-Addo, I; Parry, K; Parsons, A; Petrie, JC; Raffle, A | 1 |
Bax, ND; Lennard, MS; Malia, RG; Porter, NR; Preston, FE; Tucker, GT; Woods, HF | 2 |
Deanfield, J; Fox, K; Krikler, S; Ribeiro, P; Wright, C | 2 |
Cherenshchikova, EA; Filippov, AK; Iuzhakov, SD; Mashkovskiĭ, MD; Porotikov, VI | 1 |
Beaulieu, G; Grimes, D; Muirhead, C; Oshiro, G | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 1 |
Peele, ME; Shulkin, BL; Utiger, RD | 1 |
DeWitt, DF; Sparks, HV; Wangler, RD | 1 |
McGoon, MD; Vlietstra, RE | 1 |
Hülsmann, WC; Jansen, H; Schoonderwoerd, K | 1 |
Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
Lillywhite, KJ; Miners, JO; Smith, KJ; Wing, LM | 1 |
Anderson, S; Brater, DC; Kaplan, NM; Ram, CV | 1 |
Ooshima, A; Tarazi, RC; Yamori, Y | 1 |
Asking, B; Emmelin, N; Gjörstrup, P | 1 |
Hughes, JM; Seale, JP; Temple, DM | 1 |
Dennis, P; Vaughan Williams, EM | 1 |
O'Donnell, SR; Wanstall, JC | 1 |
Andersson, RG; Karlberg, BE; Nilsson, OR | 1 |
DiBona, GF; Osborn, JL; Thames, MD | 1 |
Perucca, E; Pickles, H; Richens, A | 1 |
Kaiho, M; Kubo, T; Misu, Y | 1 |
Lubbe, WF; McFadyen, EL; Muller, CA; Opie, LH; Worthington, M | 1 |
Hardy, P; Hugues, FC; Julien, D; Marche, J | 1 |
Goldie, RG; Paterson, JW; Wale, JL | 2 |
Cabrera, R; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Toruncha, A | 1 |
Kudo, Y; Sokabe, H | 1 |
Hilakivi, I | 1 |
Andreu, L; Arrizabalaga, P; López Pedret, J; Martinez Vea, A; Montoliu, J; Revert, L | 1 |
Goshima, Y; Kubo, T; Misu, Y; Ueda, H | 1 |
Christensen, NJ; Lauridsen, UB; Lyngsøe, J | 1 |
DiBona, GF; Holdaas, H; Osborn, JL; Thames, MD | 1 |
Carter, DC; Farah, DA; Lorimer, AR; Mills, PR; Rae, AP; Russell, RI | 1 |
Kraus, WE; McLeod, AA; Williams, RS | 1 |
Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG | 1 |
Desiatnichenko, VM | 1 |
Elvander-Ståhl, E; Melander, A; Wåhlin-Boll, E | 1 |
Alcázar, JM; Arribas, F; García-Robles, R; Mancheño, E; Miranda, B; Nieto, J; Rodicio, JL; Ruilope, L; Sancho, J | 1 |
Hawksworth, GM; McLean, I; Petrie, JC; Webster, J | 1 |
Drazen, JM; Lacouture, PG; Miller, MJ | 1 |
Oppenheim, G | 1 |
Brandt, R; Nowak, J; Seppälä, E; Vapaatalo, H | 1 |
Koivula, T; Laustiola, K; Nikkari, T; Seppälä, E; Sovijärvi, A; Uusitalo, A; Vapaatalo, H | 1 |
Monma, Y; Tanabe, T; Yamazaki, N | 1 |
Guevara, F | 1 |
Brown, JE; Kitchell, BB; Kuhn, DC; McLeod, AA; Sedor, FA; Shand, DG; Williams, RS | 1 |
Crutcher, EC; Quinn, PJ | 1 |
Bogaert, MG; Lefebvre, RA; Rosseel, MT | 1 |
Bianchi, M; Sora, S | 1 |
Adamska-Dyniewska, H; Pruszczyński, J; Trela, R | 1 |
Cannella, G; Cesura, AM; Giambelli, A; Maiorca, R; Picotti, GB; Scolari, F; Tosoni, S | 1 |
Fong Chi, S; Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A | 1 |
Harrison, RN; Hutchinson, PF | 1 |
McGibney, D; Silke, B; Singleton, W; Taylor, SH | 1 |
Ismailov, ShI; Iuzhakov, SD; Mashkovskiĭ, MD; Medvedev, OS; Val'dman, AV | 1 |
Hintze, TH; Vatner, SF | 2 |
Clapp, RJ; Frewin, DB; Leonello, PP; Penhall, RK | 1 |
Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Wilcox, RG | 1 |
Sjaastad, O; Stensrud, P | 2 |
Harry, JD; Hawkins, T; Kerr, DN; Pickering, M; Robson, V; Stevens, IM; Wilkinson, R | 1 |
Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N | 1 |
Jeffers, TA; Petrie, JC; Robb, OJ; Scott, AK; Webster, J | 1 |
Haghfelt, T; Pindborg, T; Thayssen, P | 1 |
England, JD | 1 |
DeMets, DL; Friedman, LM; Furberg, C; May, GS; Passamani, E | 1 |
Chatterjee, SS; Cruickshank, JM; Ellis, ME; Ellis, SH; Sahay, JN | 1 |
Benatar, SR; Keeton, GR; Ranchod, A | 1 |
Chadha, DR; Houtzagers, JJ | 1 |
Hallengren, B; Karlberg, BE; Melander, A; Nilsson, OR; Tegler, L; Wåhlin-Boll, E | 1 |
Lemmer, B; Ried, W; Winkler, H | 1 |
Daneshmend, TK; Roberts, CJ | 1 |
Chin, WP; Imai, S; Nakagawa, Y; Takeda, K | 1 |
Dock, DS; McNeil, GN; Shaw, PK | 1 |
Calne, DB; Larsen, TA; Teräväinen, H | 1 |
Baumgart, P; Boerlin, HJ; Greminger, P; Havelka, J; Lüscher, T; Siegenthaler, W; Vetter, H; Vetter, W; Walger, P | 1 |
Kirch, W; Köhler, H; Mutschler, E; Ohnhaus, EE; Spahn, H | 1 |
Andrejak, M; Coevoet, B; Decourt, S; Fournier, A; Guéris, J; Makdassi, R; Morinière, P; Sebert, JL | 1 |
Weisser, P; Wink, K | 1 |
Nishi, K; Sakanashi, M | 1 |
Grundy, R; Loveday, B; Taylor, DC | 1 |
Harrison, DC; Jackson, G; Kates, RE; Schwartz, J | 1 |
Halawa, B; Mazurek, W | 1 |
Taylor, EA; Turner, P | 1 |
Sanchez-Cascos, A | 1 |
Andrejak, M; Coevoet, B; de Fremont, JF; Decourcelle, PH; Fournier, A; Gheerbrand, JD; Kassouf, J; Makdassi, R; Moriniere, P; Roussel, A | 1 |
Clausen, JP; Hartling, OJ; Noer, I; Svendsen, TL; Trap-Jensen, J | 1 |
Charrier, A; Lemmer, B | 1 |
Cameron, MM; Cruickshank, JM; McAinsh, J; Neil-Dwyer, G | 1 |
Dahlöf, C; Nederfors, T; Twetman, S | 1 |
Nosál, R | 1 |
Barnes, PJ; Belvisi, MG; Miura, M; Rabe, KF; Verleden, GM | 1 |
Dehaye, JP; Turner, RJ; Valdez, IH | 1 |
Kigoshi, S; Muramatsu, I; Oda, Y; Takita, M | 1 |
Kiowski, W; Lindner, W; Stoschitzky, K | 1 |
Donnerer, J; Kahr, S; Klein, W; Lindner, W; Luha, O; Maier, R; Schumacher, M; Stoschitzky, K | 1 |
Beebe, HG; Messina, LM; Moursi, MM; Stanley, JC; Welling, TH | 1 |
Liu, YL; Stock, MJ | 1 |
Aston-Jones, G; Harris, GC | 2 |
Cailmail, S; Gaudin, C; Komeichi, H; Lebrec, D; Moreau, R | 1 |
Derman, WE; Dunbar, F; Haus, M; Lambert, M; Noakes, TD | 1 |
Kanno, M; Matsumoto, S; Nakaya, H; Shida, S | 1 |
Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
Ameri, L; Arias, E; Girotti, P; Mazzoleni, G; Presta, M; Radaelli, G; Ragnotti, G; Zavanella, T | 1 |
el Batran, S; Gaafar, K; Salama, S | 1 |
Kabeyama, A; Nishio, A; Obi, T | 1 |
Engelhardt, N; Greenblatt, DJ; Harmatz, JS; Scavone, JM; Shader, RI | 1 |
Kaila, T; Marttila, R | 1 |
Kastelova, A; Stoytchev, T | 1 |
Matsumoto, K; Ohta, H; Shimizu, M; Watanabe, H | 1 |
Matsumoto, K; Ohta, H; Watanabe, H | 1 |
Dutz, S; Jakobs, KH; Mewes, T; Ravens, U | 1 |
Arad, M; Atsmon, J; Rabinowitz, B; Roth, A; Solomon, A | 1 |
Heimberg, RG | 1 |
Dahlöf, C; Ericsson, T; Nederfors, T; Twetman, S | 1 |
Akgün, G; Gürel, T; Pamĭr, G; Salbaş, K | 1 |
Couch, SJ; Pals, DT | 1 |
Ebihara, A; Fujimura, A; Ohashi, K; Shiga, T; Tateishi, T | 1 |
Mooij, JM; van Baak, MA; Wijnen, JA | 1 |
Ostman-Smith, I | 1 |
Kerns, W; Kline, J; Ransom, M; Raymond, R; Tomaszewski, C | 1 |
Buckley, NA; Dawson, AH; Epid, D; Reith, DM; Sayer, GP; Whyte, IM | 1 |
Kaila, T; Kantola, I; Ruskoaho, H; Scheinin, M; Tarssanen, L; Viinamäki, O | 1 |
Calders, P; Kint, J; Matthys, D; Pannier, JL | 1 |
Nederfors, T | 1 |
Kemp, GJ; Odoom, JE; Radda, GK | 1 |
Clark, JT; Davidson, JM; Hoffman, BB; Kacker, SR; Raskin, A; Smith, ER; Yun, PT | 1 |
Hattori, K; Hosohata, Y; Maruyama, K; Nagatomo, T; Ohnuki, T; Sasaki, K; Suzuki, J; Watanabe, K | 1 |
Neubert, RH; Rüttinger, HH; Schwarz, MA | 1 |
Harris, GC; Hedaya, MA; Kalivas, P; Pan, WJ | 1 |
Brennan, FX; Cobb, CL; Maier, SF; Silbert, LH; Watkins, LR | 1 |
Burrello, N; Calogero, AE; D'Agata, R; Ossino, AM; Weber, RF | 1 |
Finck, A; Golan, R; Headley, SA; Kendrick, ZV; Moser, CD; Paolone, AM | 1 |
Anson, O; Neumann, L; Paran, E | 1 |
Berthault, F; Kintz, P; Mangin, P | 1 |
Alexander, SP; Hernández, F; Kendall, DA; Neil, KE | 1 |
Finkelhor, RS; Kalhan, SC; Lamont, LS; Romito, RA | 1 |
Fujimoto, S; Itoh, T | 1 |
McGaugh, JL; Quirarte, GL; Roozendaal, B | 1 |
Hucks, D; Priest, RM; Ward, JP | 1 |
Guy, S; Riddell, JG; Silke, B | 1 |
Kobayashi, M; Ohno, M; Shibata, S; Watanabe, S; Yamamoto, T | 1 |
Fukushima, T; Homma, H; Imai, K; Santa, T; Yang, X | 1 |
Alpert, JS | 1 |
el-Komy, AA; el-Sayed, MG; el-Sayed, MT; Elazab Abd el, S; Hafeiz, MH; Hassan, E | 1 |
Grahn, A; Hermansson, I; Hermansson, J | 1 |
Bahr, R; Børsheim, E; Høstmark, AT; Knardahl, S | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Mulleners, WM; Steiner, TJ; Whitmarsh, TE | 1 |
Lastra, CF; Mariño, EL; Modamio, P | 1 |
Fernandes, AC; Filipe, PM; Manso, CF; Silva, JM | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Humphreys, WG; Morrison, RA; Obermeier, MT | 1 |
Hattori, K; Hosohata, Y; Kaneko, H; Nagatomo, T; Ohnuki, T; Okuyama, M; Shen, Y; Suzuki, J | 1 |
Inoue, H; Nozawa, T | 1 |
Doggrell, SA; Henderson, CJ | 1 |
Beilin, LJ; Croft, KD; Dimmitt, SB; Williams, PD | 1 |
Chung, YB; Han, K; Lee, VH; Nishiura, A | 1 |
García Alvarez-Coque, MC; Rapado Martínez, I; Villanueva Camañas, RM | 1 |
Humphrey, SJ | 1 |
Degan, M; Delva, P; Lechi, A; Pastori, C | 1 |
Chen, X; Floras, JS; Hassan, MO; Jones, JV; Sleight, P | 1 |
Corradi, L; Fogari, R; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
Lercher, P; Liebmann, P; Lindner, W; Maier, R; Sakotnik, A; Stoschitzky, K; Zweiker, R | 1 |
Cardani, R; Radaelli, G; Ragnotti, G; Zavanella, T | 1 |
Hakko, H; Räsänen, P; Tiihonen, J | 1 |
Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV | 1 |
Alov, P; Kastelova, A; Koleva, M | 1 |
Christensen, JD; Frederiksen, C; Hansen, EW; Moesby, L; Mølris, M | 1 |
Barsh, GS; Catania, A; Furukawa, S; Ichiyama, T; Lipton, JM; Sakai, T | 1 |
Akerman, S; Järvinen, K; Karhu, M; Paronen, P; Savolainen, J; Svarfvar, B; Tarvainen, T | 1 |
Lewis, SJ; Whalen, EJ | 1 |
al-Deeb, OA; al-Majed, AA; Belal, F; Gad-Kariem, EA | 1 |
Cherian, A; Mustafa, SM; Oriowo, MA; Yousif, M | 1 |
Belhassen, B; Dorostkar, PC; Eldar, M; Scheinman, MM | 1 |
Andrews, ML; Benhorin, J; Crampton, RS; Hall, WJ; Locati, EH; Medina, A; Moss, AJ; Napolitano, C; Priori, SG; Robinson, JL; Schwartz, PJ; Timothy, K; Towbin, JA; Vincent, GM; Zareba, W; Zhang, L | 1 |
Daneryd, P; Hyltander, A; Körner, U; Lundholm, K; Sandström, R | 1 |
Braza, AJ; Mariño, EL; Modamio, P | 1 |
Ikeda, U; Kurosaki, K; Maeda, Y; Shimada, K | 1 |
Chapman, D; Dhalla, NS; Dyck, C; Elimban, V; Netticadan, T; Temsah, RM | 1 |
Arieli, Y; Marder, J; Ophir, E; Raber, P | 1 |
Palmer, ME; Tetler, LW; Wilson, ID | 1 |
Beal, AM | 2 |
Drozdzik, M; Gawronska-Szklarz, B; Kostyrka, R; Kozlowski, K; Pawlik, A; Sterna, R; Wójcicki, J; Wójcicki, M; Wojciechowski, G | 1 |
Chidlow, G; Melena, J; Osborne, NN | 1 |
Chagneau, C; Heller, J; Lebrec, D; Moreau, R; Pateron, D; Philippe, M; Poirel, O; Sogni, P; Tazi, KA | 1 |
Hanratty, CG; Riddell, JG; Silke, B; Veres, SM | 1 |
Damle, SV; Patil, PN; Salunkhe, MM | 1 |
Fernhall, B; Gorman, PA; Kamimori, GH; Kessler, CM; Szymanski, LM | 1 |
Crespi, CL; Fox, L; Hu, M; Steimel, DT; Stocker, P | 1 |
Lind, L; Millgård, J; von zur Můhlen, B | 1 |
Ghosh, B; Khanam, J; Kulkarni, RV; Reddy, LH | 1 |
Gindorf, C; Haltner, E; Ruoff, J; Schmitz, S | 1 |
Capuzzo, A; Fabbri, E; Moon, TW; Selva, C | 1 |
Gottlieb, SS; McCarter, RJ | 1 |
D'Agostino, B; Falciani, M; Fici, F; Filippelli, A; Gallelli, L; Mangrella, M; Rossi, F | 1 |
Aizawa, Y; Chinushi, M; Furushima, H; Washizuka, T | 1 |
Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
Carek, PJ; Dickerson, LM | 1 |
Enzminger, H; Lemmer, B; Witte, K | 1 |
Kalodimos, PJ; Ventura, S | 1 |
Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR | 1 |
Chelimsky, G; Chelimsky, T | 1 |
Bourreau, JP; Chan, FL; Chan, HY; Huang, Y; Tsang, SY; Yao, X | 1 |
Asakawa, N; Ishihama, Y; Murata, K; Yamamoto, E | 1 |
Ghosh, B; Reddy, LH | 1 |
De Sarro, A; De Sarro, G; Di Paola, ED; Ferreri, G; Fischer, W | 1 |
Delgado, M; Fernández-Alfonso, MS; Fuentes, A | 1 |
Ball, P; Baymiller, SP; Buchanan, RW; McMahon, RP | 1 |
Doskina, EV | 1 |
Ebzeeva, EIu; Kirichenko, AA | 1 |
Cruickshank, JM | 1 |
Borda, E; García, G; Joensen, L; Kohout, T; Perry, S; Sterin-Borda, L | 1 |
Droździk, M; Gawrońska-Szklarz, B; Jaroszynska, M; Pawlik, A; Sterna, R; Wójcicki, J | 1 |
Arora, M; Bhushan, R | 1 |
Alegria, JR; Gersh, BJ; Hammill, SC; Hodge, DO; Scott, CG; Shen, WK | 1 |
Abou-Sekkina, MM; El-Ries, MA; Hassan, SS; Wassel, A | 1 |
Joshi, R; Langguth, P; Merkle, HP; Werdenberg, D; Wolffram, S | 1 |
Chang, P; Hung, DY; Roberts, MS; Siebert, GA | 1 |
Akimoto, Y; Horinouchi, T; Koike, K; Tanaka, Y | 1 |
Höcht, C; Opezzo, JA; Taira, CA | 1 |
Telatyńska-Smieszek, B | 1 |
Gintautas, J; Polena, S; Sanghvi, K; Shikara, MM; Solinas, A | 1 |
Chi, CS; Chiu, YT; Fu, YC; Hsu, SL; Hwang, B; Yin, SC | 1 |
Grishko, VI; Oliveira, D; Tran, CD | 1 |
Anesini, C; Borda, E; Coussio, J; Ferraro, G; Turner, S | 1 |
Andersson, KK; Barra, AL; Engalytcheff, A; Kolberg, M; Tilquin, B | 1 |
Droździk, M; Gawrońska-Szklarz, B; Sterna, R; Sulzyc-Bielicka, V; Telatyńska-Smieszek, B; Wójcicki, J | 1 |
Amidon, GL; Barends, DM; Junginger, HE; Midha, KK; Möller, H; Olling, M; Shah, VP; Vogelpoel, H; Welink, J | 1 |
Djahanguiri, B; Haidari, H; Jafari, MR; Zarrindast, MR | 1 |
Jung, S; Jung, Y; Kang, S; Lee, S; Park, H | 1 |
Aungst, B; Dobson, G; Hidalgo, I; Letendre, L; Scott, M | 1 |
de Quervain, DJ; Hahn, EL; McGaugh, JL; Nathan, SV; Roozendaal, B | 1 |
Goadsby, PJ; Shields, KG | 1 |
Bublak, P; Mottweiler, E; Müller, U | 1 |
Cleuvers, M | 1 |
Asadpour-Zeynali, K; Jouyban, A; Majidi, MR | 1 |
Balaraman, R; Bansal, SK; Bhardwaj, SH; Bodhankar, SL; Coumar, MS; Jindal, DP; Nandakumar, K; Singh, R | 1 |
Bornemeier, RA; McCrindle, BW; Yetman, AT | 1 |
Bagatin, J; Lukin, A; Marković, V; Polić, S; Punda, A; Rumboldt, Z | 1 |
Fabryova, V; Jancinova, V; Majekova, M; Nosal, R; Petrikova, M | 1 |
Almeida, VK; Larive, CK | 1 |
Antunes, E; Arantes, EC; Baracat, JS; De Nucci, G; Teixeira, CE | 1 |
Gajewska, M; Glass, G; Kostelecki, J | 1 |
Ho, PC; Jozwiak, K; Moaddel, R; Patel, S; Wainer, IW; Yamaguchi, R | 1 |
Beyan, C; Ifran, A; Kaptan, K | 1 |
Angier, MK; Canfield, DV; Chaturvedi, AK; Lewis, RJ | 1 |
Matthijs, N; Vander Heyden, Y | 1 |
Dupuis, C; Feuerstein, M; Gaulier, JM; Lachâtre, G; Léonetti, G; Marquet, P; Pélissier-Alicot, AL | 1 |
Dainese, F; Maggioni, F; Mainardi, F; Ruffatti, S; Zanchin, G | 1 |
Johnson, RD; Lewis, RJ | 1 |
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
Deftereos, D; Norton, G; Osadchii, O; Woodiwiss, A | 1 |
Fonarow, GC | 1 |
Hayashi, N; Kataoka, M; Kido, J; Nagata, T; Shinohara, Y | 1 |
Abdulkerimova, NZ; Alipov, NN; Bobrova, NA; Kuznetsova, TE; Sergeeva, OV | 1 |
Allemandi, DA; Manzo, RH; Rigo, MV | 1 |
Macleod, SL; McClure, EL; Nikolai, LN; Wong, CS | 1 |
Adriaensen, J; Augustijns, P; Brewster, ME; Mackie, C; Melis, A; Mensch, J; Noppe, M | 1 |
Krzek, J; Kwiecień, A; Zylewski, M | 1 |
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
Croft, SL; Mansor, SM; Nair, NK; Navaratnam, V; Ramanathan, S; Sattar, MA; Venkatesh, G | 1 |
Bramaz, N; Escher, BI; Lienert, J; Richter, M | 1 |
Horinouchi, T; Koike, K; Michikawa, H; Tanaka, Y; Yamashita, Y | 1 |
Funakami, Y; Hata, T; Itano, S; Itoh, E | 1 |
Khan, MA; Mansor, SM; Nair, NK; Navaratnam, V; Ramanathan, S; Sattar, MA; Venkatesh, G | 1 |
Alder, AC; Escher, BI; Maurer, M; Richle, P; Schaffner, C | 1 |
Liu, QT; Williams, HE | 1 |
Bansal, J; Bhatt, LK; Bodhankar, SL; Nandakumar, K; Piplani, P | 1 |
Abzalov, NI; Abzalov, RR; Ziyatdinova, AI | 1 |
Hitchcock, K; Saseen, J; Sontheimer, D | 1 |
Yu, L; Zeng, S | 1 |
Haynes, JM | 1 |
Horinouchi, T; Koike, K; Miwa, S; Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Tanaka, Y | 1 |
Bangalore, S; Grossman, E; Messerli, FH; Parkar, S | 1 |
Bansal, T; Jaggi, M; Khar, RK; Mishra, G; Mukherjee, R; Singh, M; Talegaonkar, S | 1 |
Baeyens, WR; De Beer, T; Dilinuer, M; Fei, GT; Ouyang, J; Wang, Y; Zhou, S | 1 |
Bhushan, R; Tanwar, S | 2 |
Goubaeva, F; Lee, HT; Mikami, M; Song, JH; Yang, J | 1 |
Fateev, MM; Fedorov, VN; Grigor'eva, MV; Sal'nikov, EV; Sidorov, AV | 1 |
Da Silva, A; Mendonca, D; Paravastu, SC | 1 |
Bansal, J; Bodhankar, SL; Nikam, AP; Piplani, P; Thakurdesai, PA | 1 |
Arnell, R; Fornstedt, T; Forssén, P; Kaspereit, M; Seidel-Morgenstern, A | 1 |
Chow, MS; Wang, Y; Zuo, Z | 1 |
Hu, X; Hu, Y; Li, G; Pan, J | 1 |
Alipov, NN; Sergeeva, OV; Smirnov, VM | 1 |
Bompart, M; De Wilde, Y; Gheber, LA; Haupt, K | 1 |
Auler, JO; Carmona, MJ; Malbouisson, LM; Pereira, VA; Santos, SR | 1 |
Cumming, RI; Liu, QT; Sharpe, AD | 1 |
Sal'nikov, EV | 1 |
Chabre, O; Chaffanjon, P; Martinie, M; Mazzuco, TL; Sturm, N | 1 |
Augustijns, P; Jorissen, M; Mallants, R; Vlaeminck, V | 1 |
Fontaine, F; Goh, LA; Khlentzos, AM; Liu, X; Nikolovski, J; Roberts, MS; Wang, JY | 1 |
Barceló, D; Caminal, G; Marco-Urrea, E; Petrović, M; Radjenović, J; Vicent, T | 1 |
Barta, J; Dhalla, KS; Dhalla, NS; Machackova, J; Sanganalmath, SK | 1 |
Dhalla, NS; Elimban, V; Machackova, J; Sanganalmath, SK | 1 |
Goodacre, R; Jarvis, RM; Wharfe, ES; Winder, CL | 1 |
Friedman, GD; Habel, LA; Udaltsova, N | 1 |
Oturan, MA; Oturan, N; Sirés, I | 1 |
Huang, X; Ma, L; Wu, Q; Xu, W; Yang, XW | 1 |
Fatibello-Filho, O; Medeiros, RA; Rocha-Filho, RC; Sartori, ER | 1 |
Amidon, GL; Tsume, Y | 1 |
Mizogami, M; Takakura, K; Tsuchiya, H | 1 |
Del Giaccio, A; Eblen-Zajjur, A | 1 |
Fukui, H; Iwachido, T; Miwa, E; Suyama, Y | 1 |
Massarsky, A; Moon, TW; Trudeau, VL | 1 |
Gammie, SC; Lee, G; Scotti, MA | 1 |
Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
Cole, SW; Ganz, PA | 1 |
Barron, TI; Bennett, K; Connolly, RM; Sharp, L; Visvanathan, K | 1 |
Arias, C; Brillas, E; Cabot, PL; Centellas, F; Garrido, JA; Isarain-Chávez, E; Rodríguez, RM | 1 |
Breugem, CC; Breur, JMPJ; de Graaf, M; Pasmans, SGMA; Raphaël, MF | 1 |
Cui, XG; Guo, YP; Huang, Y; Li, JB; Li, WZ; Liu, Y; Qi, HP; Xie, J; Yue, ZY | 1 |
Cooks, RG; Huang, G; Li, G | 1 |
Devost, D; Goupil, E; Hébert, TE; Iorio-Morin, C; Laporte, SA; Pétrin, D; Wrzal, PK; Zingg, HH | 1 |
Dixit, P; Dumbwani, J; Jain, DK | 1 |
Mains, J; Tan, LE; Urquhart, A; Wilson, C | 1 |
Furutani, K; Inanobe, A; Kurachi, Y; Ohno, Y; Yamakawa, Y | 1 |
Cela, R; Quintana, JB; Rodil, R | 1 |
Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q | 1 |
Ayora, C; Barbieri, M; Carrera, J; Licha, T; Nödler, K; Sanchez-Vila, X | 1 |
Brum, PC; Castellano, LR; de Cuba, MB; de Oliveira Loss, I; de Oliveira, LF; Dias da Silva, VJ; Junior, VR; Machado, JR; Machado, MP; Montano, N; Nascentes, GA; Paiva, LH; Prado, MA; Prado, VF; Ramirez, LE; Rocha, AM; Savino, W; Silva, EL; Silva, MV | 1 |
Chen, CY; Chuan, TY; Kuo, TB; Lai, CT; Tsai, SC; Wu, WY; Yang, CC | 1 |
Morante-Zarcero, S; Sierra, I | 1 |
Figueroa, JJ; Fischer, PR; Gehrking, JA; Iodice, V; Kimpinski, K; Low, PA; Opfer-Gehrking, TL; Sandroni, P; Singer, W; Sletten, DM | 1 |
Chmilenko, F; Gurtova, O; Ye, L | 1 |
Chantasart, D; Hao, J; Li, SK | 1 |
Chen, CA; Chiu, HH; Chiu, SN; Hu, FC; Lin, MT; Lu, CW; Wang, JK; Wu, MH | 1 |
Altamura, AC; Bareggi, S; Maffini, M; Mauri, MC; Moliterno, D; Paletta, S | 1 |
Jasper, JT; Sedlak, DL | 1 |
Kümmerer, K; Mahmoud, WM; Martins, AF; Wilde, ML | 1 |
Barceló, D; Kasprzyk-Hordern, B; López-Serna, R; Petrović, M | 1 |
Gao, H; Lin, Q; Wang, F; Yang, R; Zhang, P; Zheng, X | 1 |
Battistini, FD; Manzo, RH; Olivera, ME | 1 |
Furubayashi, T; Higaki, K; Higashi, Y; Inoue, D; Katsumi, H; Kimura, S; Kimura, T; Ogawara, K; Sakane, T; Shingaki, T; Tanaka, A; Yamamoto, A | 1 |
Breugem, CC; Breur, JM; Bruijnzeel-Koomen, CA; de Graaf, M; Knol, MJ; Kon, M; Pasmans, SG; Raphael, MF | 1 |
Da Silva, A; Mendonca, DA; Paravastu, SC | 1 |
Cardwell, CR; Hicks, BM; Hughes, CM; Murray, LJ; Powe, DG | 1 |
Elliott, M; Etherson, K; Halbert, G | 2 |
Ábarzúa-Araya, A; Heusser, F; Navarrete-Dechent, CP; Retamal, J; Zegpi-Trueba, MS | 1 |
Bednarski, M; Filipek, B; Marona, H; Rapacz, A; Sapa, J; Szkaradek, N | 1 |
Korotaeva, YV; Nozdrachev, AD; Tsirkin, VI | 1 |
Annaert, P; Augustijns, P; Stappaerts, J; Tack, J; Wuyts, B | 1 |
Akimova, IA; Alipov, NN; Antonov, IS; Kuznetsova, TE; Luzina, LS; Sergeeva, OV | 1 |
Bekhite, MM; Saliu, F; Sauer, H; Sharifpanah, F; Wartenberg, M | 1 |
Stawowy, P | 1 |
Abu-Zeitone, A; McNitt, S; Moss, AJ; Peterson, DR; Polonsky, B | 1 |
Ayala, C; Brunetto, Mdel R; Cerdà, V; Clavijo, S; Delgado, Y; Gallignani, M; Orozco, W | 1 |
Choi, S; Jun, JY; Kim, MY; Kim, YD; Lee, J; Park, CG; Park, IK; Park, JS; Shin, DH; So, I; Wu, MJ | 1 |
Coelho, M; Correia, G; Medeiros, R; Moz, M; Ribeiro, L; Teixeira, A | 1 |
Bonifácio, MJ; Fernandes-Lopes, C; Igreja, B; Loureiro, AI; Pires, N; Soares-da-Silva, P; Wright, LC | 1 |
Cela, R; Quintana, JB; Rodil, R; Rodríguez-Álvarez, T | 1 |
Bayart, CB; Brandling-Bennett, HA | 1 |
Cheng, CC; Chin, CC; Huang, YC; Kuo, YH; Lai, HC; Lee, KF; Li, JM; Shi, CS; Wang, KC | 1 |
Arvidsson, T; Hedeland, M; Jasper, JT; Pettersson, CE; Sedlak, DL; Svan, A | 1 |
Khalit, WN; Tay, KS | 1 |
Fruge, JH; Massengale, WT; Rouhana, HF | 1 |
Wang, FR; Wu, S; Xu, W; Yang, XW | 1 |
Li, Q; Shen, Y; Tan, X; Yang, J; Yang, Q | 1 |
Conviser, JM; Ng, AV; Rockey, SS; Thomas, DP | 1 |
Bhan, A; Chakrabarti, A; Sood, BR | 1 |
Alwera, S; Bhushan, R | 1 |
Baron, MG; Hetheridge, MJ; Jackson, SK; Jha, AN; Mintram, KS; Moody, AJ; Owen, SF; Purcell, WM | 1 |
Chen, W; Duan, L; Lee, MS; Ng, A; Nguyen, J; Shen, AY; Spencer, HT | 1 |
Bayart, CB; Golden, AB; Tamburro, JE; Vidimos, AT; Wang, L | 1 |
Andrén, PE; Goodwin, RJA; Hayes, MA; Hilgendorf, C; Nilsson, A; Peric, A; Strimfors, M | 1 |
Jiang, X; Sun, N; Xi, Y; Zhang, Y | 1 |
Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
Cafferkey, A; McMahon, C | 1 |
Casali, KR; Dartora, DR; Dias, LD; Eibel, B; Irigoyen, MC; Kalil, RAK; Kristochek, M; Lehnen, AM; Markoski, MM; Peres, TR | 1 |
Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
de Moura Leão, MF; de Oliveira, LFS; Duarte, JA; Machado, MM; Piccoli, JDCE; Sauzen, PD | 1 |
Chen, W; Duan, L; Lee, MS; Ng, A; Spencer, HT | 1 |
Alder, AC; Sun, H; Xu, J; Zhang, Y | 1 |
Chen, S; Ji, Y; Wang, Q; Xiang, B | 1 |
Alexopoulos, A; Dakoutrou, M; Georgiadou, E; Kakourou, T; Kanaka-Gantenbein, C; Miligkos, M | 1 |
Gumina, ME; Yan, AC | 1 |
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
Abraham, G; Abs, V; Bonicelli, J; Kacza, J; Zizzadoro, C | 1 |
Goto, S; Hayashi, K; Ishizuka, K; Kondo, H; Miyazawa, K; Muramatsu, R; Sato, T; Sekiya, T; Takeguchi, A; Togari, A; Uchibori, S | 1 |
Pourahmad, J; Seydi, E; Tabbati, Y | 1 |
Ashidate, K; Fujita, Y; Ito, T; Kikuchi, K; Kikuchi, T; Kikuchi, Y; Komano, H; Liu, J; Maeda, T; Niibori, S; Nishikata, D; Shen, X; Terakawa, T; Zou, K | 1 |
Cao, C; Ji, Q; Liu, J; Ma, Q; Yuan, Z; Zhang, H; Zhang, W; Zhang, Y | 1 |
Feng, X; Yao, S; Yohannes, A | 1 |
Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
Ghiamati, E; Goharjoo, M; Khodaei, K; Tabani, H; Zeraatkar Moghaddam, A | 1 |
Asmar, S; Bible, L; Castanon, L; Chehab, M; Ditillo, M; Douglas, M; Joseph, B; Khurrum, M; Tang, A | 1 |
Liu, C; Shao, L; Wang, QZ; Wu, HW; Zhang, WB; Zhao, ZL; Zheng, JW | 1 |
Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
Chen, S; Dai, S; Ji, Y; Jiang, X; Kong, F; Li, L; Lu, G; Qiu, L; Qiu, T; Xiang, B; Yang, K; Zhang, X; Zhang, Y; Zhou, J | 1 |
Chang, H; Chen, C; Du, H; Guan, C; Li, C; Qiu, L; Wang, S; Wang, T; Wu, Y; Zhang, L; Zhang, S; Zhou, H | 1 |
Bischoff, J; Fontaine, F; Francois, M; Graus, MS; Huang, L; Karnezis, T; McCann, A; Meunier, F; Mulliken, JB; Seebauer, CT; Staffa, SJ; Wylie-Sears, J; Zurakowski, D | 1 |
Chen, MKY; Der Sarkissian, S; Ge, L; Sebaratnam, DF; Sun, HY | 1 |
Alam, SD; Ali, I; Aljuwayid, AM; Jain, AK; Raja, R; Shirsath, V; Sillanpää, M; Yusuf, K | 1 |
Du, Y; Kan, Z; Ma, M; Zhang, J; Zhang, X | 1 |
Carroll, W; Chen, T; Clemmens, C; Gudipudi, R; Nguyen, SA | 1 |
Breugem, CC; Breur, JMPJ; De Graaf, M; De Laat, PCJ; De Wildt, SN; Hermans, MM; Jonge Poerink, E; Langeveld, HR; Mendels, EJ; Pasmans, SGMA; Ragamin, A; Raphael, MF; Rietman, AB; Schappin, R | 1 |
Du, Y; Feng, Z; Gan, J; Li, X; Ma, M; Miao, P; Zhang, J; Zhang, L | 1 |
Sun, H; Wang, Y; Xu, J; Zhang, W | 1 |
Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A | 1 |
Caputi, M; Cerasoli, G; Cerretani, E; Corradini, E; Falco, A; Frati, C; Gherli, A; Gnetti, L; Graiani, G; Lagrasta, C; Lorusso, B; Madeddu, D; Nogara, A; Pilato, FP; Quaini, F; Roti, G | 1 |
Appelt-Menzel, A; Brachner, A; Dehne, EM; Faust, D; Flötke, T; Gerhartl, A; Koenig, L; Marx, U; Mayer, M; Metzger, M; Neuhaus, W; Ramme, AP | 1 |
Li, D; Lou, J; Lu, H; Yi, M; Yu, P; Zhu, W | 1 |
Breugem, CC; Breur, JMPJ; de Graaf, M; de Laat, PCJ; de Wildt, SN; Hermans, MM; Langeveld, HR; Mendels, EJ; Pasmans, SGMA; Raphael, MF; Rietman, AB; Schappin, R | 1 |
Li, L; Ma, L; Wei, L; Yu, L | 1 |
46 review(s) available for propranolol and atenolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[The sympathetic nervous system and essential hypertension].
Topics: Atenolol; Catecholamines; Clonidine; Guanethidine; Humans; Hypertension; Methyldopa; Norepinephrine; Propranolol; Renin; Reserpine; Sympathetic Nervous System; Vanilmandelic Acid | 1979 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Beta blockers and quality of life.
Topics: Adrenergic beta-Antagonists; Atenolol; Calcium; Cholinesterase Inhibitors; Humans; Hypertension; Propranolol; Quality of Life | 1992 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Propranolol; Recurrence | 1990 |
Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Atenolol; Bronchi; Celiprolol; Heart; Propanolamines; Propranolol; Vasodilation | 1986 |
Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Atenolol; Blood Glucose; Fatty Acids, Nonesterified; Humans; Lipids; Liver; Liver Glycogen; Muscles; Myocardium; Physical Exertion; Potassium; Propranolol; Renin | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Oxprenolol; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta blockers and renal function: a reappraisal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dogs; Glomerular Filtration Rate; Heart; Humans; Hypertension; Kidney; Labetalol; Metoprolol; Nadolol; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1985 |
Celiprolol in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as Topic; Double-Blind Method; Humans; Placebos; Propanolamines; Propranolol; Random Allocation; Vasodilator Agents | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1988 |
Effects of smoking on the heart and peripheral circulation.
Topics: Atenolol; Blood Pressure; Coronary Circulation; Heart Rate; Humans; Hypertension; Propranolol; Regional Blood Flow; Smoking | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine; Propranolol; Smoking | 1988 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Practolol; Propranolol; Prospective Studies; Random Allocation; Timolol | 1982 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Serotonin Antagonists; Timolol; Vasomotor System | 1982 |
Muscle fatigue and beta-blockers--a review.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Fatigue; Fatty Acids, Nonesterified; Hemodynamics; Humans; Lactates; Metoprolol; Muscles; Perception; Physical Exertion; Pindolol; Propranolol; Rats; Tissue Distribution | 1983 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Dogs; Heart Rate; Humans; Hypertension; Labetalol; Myocardial Infarction; Propranolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone | 1981 |
Specific issues in the cognitive-behavioral treatment of social phobia.
Topics: Atenolol; Behavior Therapy; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Follow-Up Studies; Humans; Implosive Therapy; Phobic Disorders; Propranolol; Research Design; Social Behavior | 1993 |
[Treatment with beta-blockers in patients with acute coronary syndrome].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Atenolol; Clinical Trials as Topic; Coronary Disease; Humans; Metoprolol; Myocardial Infarction; Practice Guidelines as Topic; Propranolol; Syndrome | 1998 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Metoprolol; Myocardial Infarction; Prognosis; Propranolol | 2002 |
Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations.
Topics: Adrenergic beta-Antagonists; Algorithms; Atenolol; Carbazoles; Carvedilol; Humans; Myocardial Infarction; Practice Guidelines as Topic; Propanolamines; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention; Timolol | 2006 |
Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Family Practice; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Propranolol; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Timolol; Treatment Outcome | 2007 |
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Humans; Hypertension; Propranolol; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment | 2007 |
Beta blockers for peripheral arterial disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vascular Diseases; Pindolol; Propranolol; Randomized Controlled Trials as Topic | 2008 |
β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Endocrine Disruptors; Fishes; Gluconeogenesis; Glucose; Glycogenolysis; Insulin; Insulin Secretion; Lipolysis; Metoprolol; Molecular Structure; Mollusca; Muscle Contraction; Nadolol; Propranolol; Species Specificity; Water Pollutants, Chemical | 2011 |
Understanding the pharmacokinetics of anxiolytic drugs.
Topics: Adrenergic beta-Antagonists; Amines; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Atenolol; Benzodiazepines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Histamine Antagonists; Humans; Hydroxyzine; Pregabalin; Propranolol; Sleep Initiation and Maintenance Disorders | 2013 |
Beta blockers for peripheral arterial disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Intermittent Claudication; Metoprolol; Peripheral Vascular Diseases; Pindolol; Propranolol; Randomized Controlled Trials as Topic; Regional Blood Flow; Walking | 2013 |
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Preschool; Facial Neoplasms; Humans; Infant; Neoplastic Syndromes, Hereditary; Neurocutaneous Syndromes; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome; Vascular Neoplasms | 2015 |
Beta blocker treatment for infantile hemangiomas.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome | 2015 |
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Atenolol; Coronary Disease; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Incidence; Metoprolol; Network Meta-Analysis; Oxprenolol; Propranolol; Stroke; Treatment Outcome | 2017 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Atenolol; Hemangioma; Humans; Infant; Propranolol | 2019 |
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
Chiral separation of β-blockers by supercritical fluid chromatography using Chiralpak-IG and Chiralpak IBN-5 columns.
Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Chromatography, Supercritical Fluid; Propranolol; Stereoisomerism | 2022 |
Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Drug-Related Side Effects and Adverse Reactions; Hemangioma; Hemangioma, Capillary; Humans; Infant; Propranolol; Treatment Outcome | 2023 |
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity; Heart Failure; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 2022 |
247 trial(s) available for propranolol and atenolol
Article | Year |
---|---|
Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Clinical Trials as Topic; Depression, Chemical; Heart Rate; Humans; Hypoglycemia; Insulin; Male; Placebos; Propanolamines; Propranolol; Pulse; Sweating; Time Factors | 1976 |
A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings].
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Rate; Humans; Oxprenolol; Physical Exertion; Practolol; Propranolol; Sympathomimetics | 1975 |
Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Propanolamines; Propranolol; Pulse; Time Factors | 1976 |
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
[Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Bronchial Spasm; Female; Forced Expiratory Volume; Humans; Male; Pindolol; Practolol; Propranolol; Respiration; Vital Capacity | 1978 |
Acute hemodynamic effects of five beta-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol; Sympathomimetics | 1979 |
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Evaluation; Heart Rate; Humans; Kinetics; Male; Middle Aged; Oxprenolol; Physical Exertion; Pindolol; Propanolamines; Propranolol; Time Factors; Timolol | 1979 |
Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Depression, Chemical; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Practolol; Propranolol | 1979 |
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prazosin; Propranolol; Quinazolines | 1977 |
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Humans; Injections, Intravenous; Lidocaine; Myocardial Infarction; Oxprenolol; Propranolol; Ventricular Fibrillation | 1979 |
Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Topics: Adult; Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Propanolamines; Propranolol; Random Allocation | 1978 |
Effects of atenolol and propranolol on human performance and subjective feelings.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Cognition; Double-Blind Method; Emotions; Flicker Fusion; Heart Rate; Humans; Male; Motor Skills; Placebos; Propanolamines; Propranolol; Reaction Time; Vision, Ocular | 1979 |
Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Female; Forearm; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol; Regional Blood Flow; Smoking | 1979 |
[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
Topics: Adult; Aged; Airway Resistance; Atenolol; Blood Pressure; Bronchi; Chronic Disease; Clinical Trials as Topic; Female; Heart; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Organ Specificity; Propanolamines; Propranolol; Pulse | 1977 |
Comparison of propranolol and atenolol in hypertension.
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1977 |
Nature and incidence of unwanted effects with atenolol.
Topics: Atenolol; Clinical Trials as Topic; Cold Temperature; Double-Blind Method; Extremities; Fatigue; Humans; Kidney Function Tests; Liver Function Tests; Propanolamines; Propranolol | 1977 |
Antihypertensive effect of atenolol--a Swedish multicentre study.
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1977 |
Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.
Topics: Acebutolol; Adolescent; Adult; Atenolol; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diet, Diabetic; Double-Blind Method; Female; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Propanolamines; Propranolol | 1977 |
The effects of atenolol and propranolol upon lipolysis.
Topics: Adult; Atenolol; Blood Glucose; Clinical Trials as Topic; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Humans; Insulin; Male; Placebos; Propanolamines; Propranolol | 1978 |
Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Double-Blind Method; Humans; Hypertension; Middle Aged; Propanolamines; Propranolol; Pulse; Renin | 1977 |
Comparative trial of atenolol and propranolol in hyperthyroidism.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hyperthyroidism; Male; Middle Aged; Placebos; Propanolamines; Propranolol | 1978 |
[The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Disopyramide; Humans; Myocardial Contraction; Propiophenones; Propranolol; Quinidine; Systole; Time Factors | 1978 |
Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
Topics: Adult; Aged; Alprenolol; Atenolol; Central Nervous System; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Propranolol; Time Factors | 1979 |
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction.
Topics: Arrhythmias, Cardiac; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Propranolol | 1979 |
The effects of four antihypertensive agents on the Stroop colour-word test in normal male volunteer subjects.
Topics: Adolescent; Adult; Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Color Perception; Double-Blind Method; Humans; Male; Methyldopa; Personality; Personality Tests; Propranolol; Reading; Reserpine; Speech | 1977 |
Beta-blockers, blood sugar control, and renal function.
Topics: Atenolol; Creatinine; Humans; Hypertension; Propanolamines; Propranolol | 1979 |
Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.
Topics: Adolescent; Adult; Atenolol; Drug Evaluation; Female; Humans; Hyperthyroidism; Male; Middle Aged; Propanolamines; Propranolol; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse | 1979 |
Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Double-Blind Method; Evaluation Studies as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Propranolol; Renin | 1979 |
beta-Adrenoreceptor antagonists in essential tremor.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Propanolamines; Propranolol; Pulse; Sotalol; Tremor | 1979 |
[Atenolol in the treatment of angina pectoris].
Topics: Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol | 1979 |
Comparison of the effects of atenolol and propranolol in labile hypertension.
Topics: Adult; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Propanolamines; Propranolol | 1979 |
[Effects of Atenolol and Propranolol on sinus node and intracardiac conduction in man (author's transl)].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atenolol; Bundle of His; Electrocardiography; Female; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol; Sinoatrial Node; Syndrome; Time Factors | 1977 |
Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
Topics: Adult; Atenolol; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hypertension; Insulin; Male; Middle Aged; Propanolamines; Propranolol; Triglycerides | 1979 |
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Propanolamines; Propranolol | 1976 |
[Clinical testing of a new beta blocking agent--atenolol--in hypertension].
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Middle Aged; Placebos; Propanolamines; Propranolol | 1976 |
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
Topics: Adult; Atenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Isoproterenol; Male; Middle Aged; Physical Exertion; Placebos; Propanolamines; Propranolol; Rest; Tachycardia | 1976 |
Clinical evaluation of atenolol in hypertension.
Topics: Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Lung Diseases, Obstructive; Propanolamines; Propranolol | 1976 |
Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
Topics: Angina Pectoris; Atenolol; Hemodynamics; Humans; Hypertension; Physical Exertion; Propanolamines; Propranolol | 1977 |
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition.
Topics: Adult; Amylases; Atenolol; Calcium; Chlorides; Double-Blind Method; Hexosamines; Humans; Magnesium; Male; Phosphates; Placebos; Propranolol; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sialic Acids; Sodium | 1992 |
Modulation of human upper intestinal nutrient transit by a beta adrenoreceptor mediated pathway.
Topics: Adult; Albuterol; Atenolol; Depression, Chemical; Gastrointestinal Transit; Humans; Isoproterenol; Propranolol; Receptors, Adrenergic, beta; Single-Blind Method; Stimulation, Chemical | 1992 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
Topics: Administration, Cutaneous; Aged; Angina Pectoris; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise Test; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Propranolol | 1992 |
Effects of beta 2-adrenoceptor stimulation on exercise-induced myocardial ischemia.
Topics: Adult; Aged; Albuterol; Angina Pectoris; Atenolol; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Propranolol; Receptors, Adrenergic, beta; Single-Blind Method | 1991 |
Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Exercise Test; Humans; Magnesium; Male; Potassium; Propranolol; Random Allocation; Reference Values; Time Factors | 1991 |
Effects of beta-adrenoreceptor antagonists on cerebral blood flow of cirrhotic patients with portal hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Cerebral Cortex; Cerebrovascular Circulation; Female; Heart Rate; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Propranolol | 1991 |
The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Male; Metoprolol; Propranolol; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1991 |
Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; Blood Pressure; Double-Blind Method; Exercise Test; Fatigue; Heart Rate; Humans; Lactates; Male; Physical Fitness; Potassium; Propanolamines; Propranolol; Random Allocation; Terbutaline | 1991 |
Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
Topics: Adrenergic beta-Agonists; Adult; Atenolol; Blood Pressure; Calcium; Exercise Test; Fatigue; Heart Rate; Humans; Male; Physical Endurance; Potassium; Propanolamines; Propranolol; Xamoterol | 1991 |
Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
Topics: Adrenergic beta-Antagonists; Atenolol; Cerebral Cortex; Double-Blind Method; Electrocardiography; Electroencephalography; Exercise Test; Heart Rate; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Propranolol; Sleep Stages | 1991 |
Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiac Output; Double-Blind Method; Exercise; Exercise Test; Female; Heart; Heart Rate; Humans; Male; Myocardial Contraction; Oxygen Consumption; Propranolol; Receptors, Adrenergic, beta | 1991 |
The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
Topics: Adult; Atenolol; Blood Pressure; Drug Interactions; Exercise; Heart Rate; Humans; Kidney; Liver; Male; Nisoldipine; Propranolol; Reference Values; Regional Blood Flow | 1991 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
Hypokalemia before induction of anesthesia and prevention by beta 2 adrenoceptor antagonism.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anesthesia; Atenolol; Humans; Hypokalemia; Intraoperative Period; Middle Aged; Potassium; Propranolol; Receptors, Adrenergic, beta; Surgical Procedures, Operative; Time Factors | 1991 |
The effects of selective and non-selective adrenoceptor blockade on the portal blood flow in patients with liver cirrhosis.
Topics: Adult; Analysis of Variance; Atenolol; Blood Flow Velocity; Female; Humans; Labetalol; Liver Cirrhosis; Male; Middle Aged; Portal System; Propranolol; Sympatholytics; Ultrasonography | 1991 |
Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzopyrans; Blood Pressure; Ethanolamines; Heart Rate; Hemodynamics; Humans; Middle Aged; Nebivolol; Pindolol; Propranolol; Stroke Volume; Systole | 1990 |
Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Calcium; Diastole; Epinephrine; Fatty Acids, Nonesterified; Glucose; Heart Rate; Humans; Magnesium; Male; Phosphates; Potassium; Propanolamines; Propranolol; Systole | 1990 |
Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Central Nervous System; Delayed-Action Preparations; Double-Blind Method; Exercise; Female; Heart Rate; Humans; Male; Metoprolol; Propranolol; Randomized Controlled Trials as Topic; Tablets | 1990 |
Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cognition; Double-Blind Method; Female; Heart Rate; Humans; Hypoglycemia; Insulin; Male; Pancreatic Polypeptide; Potassium; Propranolol; Psychomotor Performance; Randomized Controlled Trials as Topic; Reaction Time; Tremor | 1990 |
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Forced Expiratory Volume; Humans; Hypertension; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Oxprenolol; Propanolamines; Propranolol | 1990 |
Influences of propranolol and atenolol on the circadian rhythm of heart rate in elderly patients with essential hypertension.
Topics: Aged; Aged, 80 and over; Atenolol; Blood Pressure; Circadian Rhythm; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Propranolol; Time Factors | 1990 |
A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Sotalol; Stereoisomerism | 1990 |
Prevention of recurrent variceal hemorrhage: to block or not to block?
Topics: Atenolol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Propranolol; Recurrence | 1990 |
Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Captopril; Cognition; Double-Blind Method; Enalapril; Humans; Hypertension; Male; Middle Aged; Propranolol; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Sexual Behavior; Sleep; Surveys and Questionnaires | 1990 |
The effects of propranolol or atenolol on the cardiovascular responses to central hypovolaemia in Europeans and Bengalees.
Topics: Adult; Atenolol; Blood Pressure; Blood Volume; Double-Blind Method; Electrocardiography; Ethnicity; Europe; Heart Rate; Hemodynamics; Humans; India; Male; Propranolol; Regional Blood Flow; Vascular Resistance | 1990 |
Effects of exercise testing, training and beta blockade on serum potassium in normal subjects.
Topics: Adult; Atenolol; Double-Blind Method; Exercise; Exercise Test; Female; Humans; Male; Oxygen Consumption; Potassium; Propranolol; Random Allocation | 1990 |
Preoperative beta-blockade for patients undergoing craniotomy: a comparison between propranolol and atenolol.
Topics: Adolescent; Adult; Aged; Anesthesia, Intravenous; Atenolol; Blood Pressure; Craniotomy; Electrocardiography; Female; Heart Rate; Humans; Intubation, Intratracheal; Laryngoscopy; Male; Middle Aged; Premedication; Pressoreceptors; Propranolol; Random Allocation | 1990 |
The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Humans; Hypertension; Male; Metoprolol; Middle Aged; Phenylpropanolamine; Propranolol; Random Allocation | 1990 |
Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Celiprolol; Forced Expiratory Volume; Humans; Hypertension; Isoproterenol; Propanolamines; Propranolol | 1986 |
Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility.
Topics: Adult; Affect; Aged; Atenolol; Central Nervous System Diseases; Humans; Lipids; Male; Middle Aged; Motivation; Propranolol; Solubility; Task Performance and Analysis | 1989 |
Perturbation of upper gastrointestinal transit and antroduodenal motility by experimentally applied stress: the role of beta-adrenoreceptor mediated pathways.
Topics: Adolescent; Adult; Atenolol; Cold Temperature; Duodenum; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Middle Aged; Propranolol; Receptors, Adrenergic, beta; Stomach; Stress, Physiological | 1989 |
Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Atenolol; Clinical Trials as Topic; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Propranolol; Random Allocation; Recurrence | 1989 |
Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Multicenter Studies as Topic; Propranolol; Randomized Controlled Trials as Topic; Survival Analysis | 1989 |
Exercise testing and training with beta-adrenergic blockade: role of the drug washout period in "unmasking" a training effect.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Male; Oxygen Consumption; Physical Education and Training; Propranolol; Respiration; Time Factors | 1989 |
S-Mg does not change inversely to S-FFA during acute stress situations.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Atenolol; Epinephrine; Fatty Acids, Nonesterified; Female; Hemodynamics; Humans; Magnesium; Male; Propanolamines; Propranolol; Stress, Physiological; Time Factors | 1989 |
Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance.
Topics: Adrenergic beta-Antagonists; Adult; Antipyrine; Atenolol; Humans; Male; Metoprolol; Phenytoin; Propranolol | 1989 |
Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Albuterol; Atenolol; Blood Glucose; Humans; Male; Potassium; Propranolol | 1989 |
[Effect of calcium antagonists and beta receptor blockers on coronary vessel diameter].
Topics: Angina Pectoris; Atenolol; Coronary Angiography; Coronary Circulation; Coronary Disease; Gallopamil; Humans; Propranolol; Vascular Resistance; Vasodilation | 1989 |
Changes in serum phosphate during beta-blockade in healthy men are not due to changes in the renal handling of phosphate.
Topics: Adult; Atenolol; Clinical Trials as Topic; Humans; Kidney; Male; Metoprolol; Parathyroid Hormone; Phosphates; Propranolol; Random Allocation | 1989 |
Thermoregulation during prolonged exercise in heat: alterations with beta-adrenergic blockade.
Topics: Adult; Arm; Atenolol; Body Temperature; Body Temperature Regulation; Cardiac Output; Cardiovascular Physiological Phenomena; Cardiovascular System; Heart Rate; Hot Temperature; Humans; Male; Muscles; Oxygen Consumption; Physical Exertion; Placebos; Propranolol; Receptors, Adrenergic, beta; Regional Blood Flow; Stroke Volume; Vascular Resistance | 1987 |
Beta-receptor-mediated increase in venous return in humans.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Epinephrine; Female; Heart; Heart Ventricles; Humans; Hydralazine; Isoproterenol; Male; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Terbutaline; Veins; Ventricular Function | 1987 |
Psychotropic effects of repeated doses of enalapril, propranolol and atenolol in normal subjects.
Topics: Adult; Affect; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Female; Humans; Male; Memory, Short-Term; Propranolol; Psychotropic Drugs; Reaction Time | 1988 |
Evidence for a dual effect by beta-adrenoceptor antagonists on post-exercise airway calibre.
Topics: Adult; Airway Resistance; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Lung Volume Measurements; Physical Exertion; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1988 |
Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
Topics: Adult; Atenolol; Blood Pressure; Drug Interactions; Fingers; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Physical Exertion; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Regional Blood Flow; Tremor; Vascular Resistance | 1988 |
Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Dose-Response Relationship, Drug; Female; Humans; Lactates; Lactic Acid; Male; Oxygen Consumption; Physical Exertion; Propranolol; Pulmonary Gas Exchange; Receptors, Adrenergic, beta | 1985 |
Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Body Temperature Regulation; Double-Blind Method; Heart Rate; Hot Temperature; Humans; Humidity; Male; Physical Exertion; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Respiration; Skin Temperature; Sweating; Time Factors | 1985 |
The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1985 |
Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bicycling; Blood Pressure; Female; Humans; Hypertension; Isometric Contraction; Male; Mathematics; Metoprolol; Middle Aged; Pindolol; Propranolol; Random Allocation; Reaction Time; Thinking | 1985 |
Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Blood Pressure; Heart Rate; Humans; Isoproterenol; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vascular Resistance | 1985 |
Beta-blockers and psychometric performance: studies in normal volunteers.
Topics: Adrenergic beta-Antagonists; Atenolol; Diazepam; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Nadolol; Oxazepam; Propanolamines; Propranolol; Psychometrics; Psychomotor Performance; Random Allocation; Reaction Time; Reference Values; Solubility; Time Factors | 1985 |
Beta-blockers and sleep: a controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Female; Humans; Lipid Metabolism; Memory; Metoprolol; Pindolol; Propranolol; Random Allocation; Sleep; Sleep, REM; Solubility | 1985 |
Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Central Nervous System; Double-Blind Method; Dreams; Female; Hallucinations; Heart Rate; Humans; Lipids; Male; Metoprolol; Middle Aged; Propranolol; Solubility; Water | 1985 |
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Heart Rate; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, VLDL; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Sotalol; Triglycerides | 1985 |
Acute effect of indenolol on human airways.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Indenes; Male; Maximal Expiratory Flow Rate; Middle Aged; Oxygen Consumption; Physical Exertion; Propanolamines; Propranolol; Respiration | 1985 |
Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhage.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Female; Humans; Isoenzymes; Male; Middle Aged; Placebos; Prognosis; Propranolol; Random Allocation; Subarachnoid Hemorrhage | 1986 |
The influence of intrinsic sympathomimetic activity and beta-1 receptor selectivity on the recovery of finger skin temperature after finger cooling in normotensive subjects.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Drug Evaluation; Female; Fingers; Forearm; Heart Rate; Humans; Male; Pindolol; Propranolol; Random Allocation; Skin Temperature | 1986 |
Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzeneacetamides; Blood Glucose; Blood Pressure; Double-Blind Method; Exercise Test; Forearm; Heart Rate; Hemodynamics; Humans; Insulin; Isoproterenol; Male; Potassium; Propanolamines; Propranolol; Regional Blood Flow; Tremor | 1986 |
Thermogenesis in human skeletal muscle as measured by direct microcalorimetry and muscle contractile performance during beta-adrenoceptor blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Body Temperature Regulation; Calorimetry; Double-Blind Method; Heart Rate; Humans; Male; Muscle Contraction; Muscles; Pindolol; Propranolol | 1986 |
Effects of beta-blockade on exercise capacity of trained and untrained men: a hemodynamic comparison.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiac Output; Heart Rate; Hemodynamics; Humans; Male; Oxygen Consumption; Physical Education and Training; Physical Exertion; Propranolol; Receptors, Adrenergic, beta; Stroke Volume | 1986 |
Intravenous beta-blockade during acute myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Humans; Injections, Intravenous; Metoprolol; Myocardial Infarction; Propranolol; Random Allocation; Ventricular Fibrillation | 1986 |
Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Hand; Heart Rate; Humans; Male; Physical Exertion; Propranolol; Receptors, Adrenergic, beta; Sotalol; Tremor | 1986 |
Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1986 |
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propranolol | 1986 |
Effects of propranolol, atenolol, and chlordesmethyldiazepam on response to mental stress in patients with recent myocardial infarction.
Topics: Adult; Aged; Anti-Anxiety Agents; Atenolol; Benzodiazepines; Diazepam; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nordazepam; Propranolol; Psychophysiology; Stress, Psychological | 1987 |
Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Hemodynamics; Humans; Lymphocytes; Oxprenolol; Potassium; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1987 |
Beta-blockade reduces tidal volume during heavy exercise in trained and untrained men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbon Dioxide; Humans; Male; Oxygen; Physical Endurance; Physical Exertion; Propranolol; Pulmonary Gas Exchange; Respiration; Tidal Volume | 1987 |
The effects of beta-adrenoceptor blockade on breathing during progressive exercise in normal man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Humans; Male; Physical Exertion; Propranolol; Respiration | 1987 |
Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Heart Rate; Humans; Isometric Contraction; Labetalol; Male; Prazosin; Propranolol; Random Allocation; Stress, Physiological | 1987 |
Atenolol and propranolol in neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Atenolol; Female; Humans; Male; Middle Aged; Propranolol; Psychomotor Agitation | 1987 |
Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Propanolamines; Propranolol | 1988 |
Three-week beta-adrenergic blockade does not impair or improve general intellectual function in young healthy males.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Attention; Clinical Trials as Topic; Humans; Intelligence; Learning; Male; Memory; Metoprolol; Propranolol; Random Allocation; Time Factors; Verbal Learning | 1988 |
Effects of beta-blockade and exercise on cardiovascular and cognitive functioning.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Diastole; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Memory; Middle Aged; Oxygen Consumption; Physical Exertion; Propranolol; Systole | 1988 |
Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bisoprolol; Double-Blind Method; Exercise Test; Heart Rate; Humans; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia | 1987 |
Beta-blocker effects on sexual function in normal males.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Libido; Male; Metoprolol; Penile Erection; Pindolol; Propranolol; Random Allocation; Testosterone | 1988 |
Acute volume loading, atrial natriuretic peptide release and cardiac function in healthy men. Effects of beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Blood; Blood Pressure; Cardiac Volume; Heart; Hematocrit; Humans; Male; Osmolar Concentration; Plasma Volume; Propranolol; Saline Solution, Hypertonic; Sodium; Stroke Volume | 1988 |
Celiprolol in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Celiprolol; Clinical Trials as Topic; Double-Blind Method; Humans; Placebos; Propanolamines; Propranolol; Random Allocation; Vasodilator Agents | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propanolamines; Propranolol | 1988 |
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Attention; Double-Blind Method; Electroencephalography; Emotions; Flicker Fusion; Heart Rate; Humans; Male; Memory, Short-Term; Oxazepam; Propranolol; Psychomotor Performance; Random Allocation; Reaction Time | 1988 |
Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
Topics: Adrenergic beta-Antagonists; Atenolol; Electroencephalography; Humans; Oxazepam; Postural Balance; Propranolol | 1988 |
Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Pressoreceptors; Propranolol; Reflex | 1988 |
Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Topics: Adult; Atenolol; Blood Pressure; Diltiazem; Half-Life; Heart Rate; Humans; Male; Metoprolol; Propranolol | 1989 |
Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism.
Topics: Adenosine Triphosphate; Adult; Atenolol; Double-Blind Method; Glucose; Glucose-6-Phosphate; Glucosephosphates; Heart Rate; Humans; Lactates; Lactic Acid; Male; Muscles; Oxygen Consumption; Phosphocreatine; Physical Endurance; Physical Exertion; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1986 |
In support of cardiac chronotropic beta 2 adrenoceptors.
Topics: Adult; Atenolol; Double-Blind Method; Heart; Heart Rate; Humans; Isoproterenol; Male; Physical Exertion; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1986 |
Memory performance by mild hypertensives following beta-adrenergic blockade.
Topics: Adult; Atenolol; Heart Rate; Humans; Hypertension; Male; Memory Disorders; Middle Aged; Propranolol; Psychomotor Disorders; Random Allocation; Reaction Time | 1986 |
Low dose beta blockade in acute stroke ("BEST" trial): an evaluation.
Topics: Activities of Daily Living; Aged; Atenolol; Brain; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Hemodynamics; Humans; Length of Stay; Male; Outcome and Process Assessment, Health Care; Prognosis; Propranolol; Random Allocation; Research Design | 1988 |
Effect of acute administration of propranolol and atenolol on baroreflex function in normal man.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Double-Blind Method; Humans; Infusions, Intravenous; Male; Nitroglycerin; Phenylephrine; Placebos; Pressoreceptors; Propranolol; Random Allocation | 1988 |
The pragmatic approach to stroke trial design: stroke register, pilot trial, assessment of neurological then functional outcome.
Topics: Aged; Atenolol; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Outcome and Process Assessment, Health Care; Pilot Projects; Propranolol; Registries | 1988 |
Smoking, catecholamines, and the ischemic myocardium.
Topics: Angina Pectoris; Atenolol; Catecholamines; Coronary Disease; Female; Heart; Humans; Male; Nifedipine; Propranolol; Smoking | 1988 |
Melatonin secretion related to side-effects of beta-blockers from the central nervous system.
Topics: Adult; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Melatonin; Propranolol; Prospective Studies; Random Allocation; Sleep Wake Disorders | 1988 |
Treatment of a patient with seasonal premenstrual syndrome.
Topics: Adult; Atenolol; Clinical Trials as Topic; Female; Hospitalization; Humans; Melatonin; Phototherapy; Premenstrual Syndrome; Propranolol; Seasons | 1987 |
A randomised double blind cross over trial of atenolol and propranolol in mild to moderate hypertension.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Random Allocation | 1987 |
Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
Topics: Aged; Aldosterone; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Propranolol; Random Allocation; Renin | 1987 |
Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension.
Topics: Adult; Atenolol; Behavior; Blood Pressure; Emotions; Humans; Hypertension; Male; Memory; Middle Aged; Propranolol; Psychological Tests; Psychomotor Performance; Random Allocation | 1988 |
Effect of beta-blockade on the drift in O2 consumption during prolonged exercise.
Topics: Adult; Atenolol; Double-Blind Method; Exercise Test; Humans; Male; Oxygen Consumption; Physical Exertion; Propranolol; Random Allocation | 1988 |
Modification of cellular immune functions in humans by endurance exercise training during beta-adrenergic blockade with atenolol or propranolol.
Topics: Adolescent; Adult; Atenolol; Double-Blind Method; Heart Rate; Humans; Leukocyte Count; Male; Oxygen Consumption; Physical Exertion; Propranolol; Random Allocation; T-Lymphocytes | 1986 |
Prolonged beta blockade due to tertatolol: a comparative study with propranolol and atenolol.
Topics: Adult; Atenolol; Cross-Sectional Studies; Double-Blind Method; Heart Rate; Humans; Male; Propanolamines; Propranolol; Thiophenes | 1987 |
Effect of selective and non-selective beta blockade on pulmonary function and tracheobronchial mucociliary clearance in healthy subjects.
Topics: Adult; Atenolol; Blood Pressure; Bronchi; Cilia; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung; Male; Mucus; Propranolol; Pulse; Trachea | 1986 |
Haemodynamic effects of atenolol, pindolol and propranolol during adrenaline infusion in man.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Forearm; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Propranolol; Regional Blood Flow; Stroke Volume; Vascular Resistance | 1986 |
Hemodynamic interaction of nonselective vs. beta-1-selective beta-blockade with hydralazine in normal humans.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Catecholamines; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Myocardial Contraction; Propranolol; Random Allocation; Renin | 1987 |
Propranolol and atenolol in the treatment of anxiety.
Topics: Adult; Anxiety Disorders; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Propranolol; Random Allocation | 1986 |
The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
Topics: Aged; Atenolol; Cardiac Output; Cardiovascular System; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Propranolol; Vascular Resistance | 1986 |
Short-term effects of beta-adrenoceptor blocking drugs on plasma lipoproteins in normal men: is there a case?
Topics: Atenolol; Cholesterol, HDL; Humans; Male; Propranolol | 1986 |
[Comparison of hypotensive effectiveness of propranolol and atenolol in combined treatment of primary hypertension].
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol | 1985 |
Prazosin once or twice daily?
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Posture; Prazosin; Propranolol; Quinazolines | 1985 |
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
Topics: Adolescent; Adult; Atenolol; Blood Circulation; Ethanolamines; Female; Fingers; Humans; Hypertension; Labetalol; Male; Middle Aged; Plethysmography; Propranolol; Regional Blood Flow | 1985 |
Exercise training during long-term beta-blockade treatment in healthy subjects.
Topics: Adult; Atenolol; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Propranolol; Random Allocation; Respiration | 1985 |
Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise Test; Heart Rate; Hemodynamics; Humans; Male; Oxygen Consumption; Physical Exertion; Propranolol; Random Allocation; Stroke Volume | 1985 |
Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Double-Blind Method; Exercise Test; Heart Rate; Hemodynamics; Humans; Male; Oxygen Consumption; Physical Exertion; Propranolol; Random Allocation; Respiration; Stroke Volume | 1985 |
Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners.
Topics: Adult; Atenolol; Exercise Test; Heart Rate; Humans; Oxygen Consumption; Propranolol; Pulmonary Gas Exchange; Respiration; Running | 1985 |
Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat.
Topics: Adult; Atenolol; Blood Glucose; Body Temperature; Body Temperature Regulation; Double-Blind Method; Electrolytes; Energy Metabolism; Hot Temperature; Humans; Lactates; Male; Physical Exertion; Potassium; Propranolol; Random Allocation; Sweating | 1985 |
Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise Test; Heart Rate; Humans; Hypertension; Lactates; Male; Middle Aged; Propranolol; Random Allocation | 1985 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Physical Exertion; Propranolol; Prospective Studies; Pulse | 1985 |
Effect of beta-receptor blockade on anxiety with reference to the three-systems model of phobic behavior.
Topics: Adult; Anxiety; Atenolol; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Rate; Humans; Middle Aged; Models, Biological; Models, Psychological; Phobic Disorders; Propranolol; Skin Temperature; Systole | 1985 |
[Smoking and beta adrenergic receptor blockade].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Male; Placebos; Propanolamines; Propranolol; Smoking | 1980 |
Interaction of clonidine and beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Blood Pressure; Clinical Trials as Topic; Clonidine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Rabbits; Sotalol | 1980 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Beta-blockers in immediate treatment of myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol | 1980 |
Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Double-Blind Method; Drug Interactions; Epinephrine; Female; Hemodynamics; Humans; Intraocular Pressure; Male; Propranolol; Pupil; Timolol | 1980 |
Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Heart Rate; Humans; Hypoglycemia; Insulin; Male; Metoprolol; Propranolol; Pulse | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Pyridines | 1981 |
Effects of beta-adrenergic blockade on endurance and short-time performance in respect to individual muscle fiber composition.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Muscle Contraction; Muscles; Physical Endurance; Physical Exertion; Propranolol | 1981 |
Running performance as a function of the dose-response relationship to beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Male; Perception; Physical Endurance; Physical Exertion; Propranolol; Running; Sports Medicine | 1982 |
Adrenergic mechanisms in control of plasma lipid concentrations.
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Fatty Acids, Nonesterified; Female; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Metoprolol; Oxprenolol; Propranolol; Random Allocation; Triglycerides | 1982 |
Adrenergic beta-receptor blockers, adrenalin and intraocular pressure.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Drug Combinations; Epinephrine; Female; Humans; Intraocular Pressure; Male; Middle Aged; Propranolol; Pupil; Random Allocation; Timolol | 1982 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Practolol; Propranolol; Prospective Studies; Random Allocation; Timolol | 1982 |
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Propranolol | 1982 |
Assessment of beta-adrenoceptor antagonists in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Female; Forced Expiratory Volume; Humans; Male; Physical Exertion; Pindolol; Propranolol; Time Factors; Tremor | 1982 |
Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbon Dioxide; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Metoprolol; Pindolol; Propranolol; Random Allocation; Respiration | 1982 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Propranolol; Serotonin Antagonists; Timolol; Vasomotor System | 1982 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Lung Volume Measurements; Metoprolol; Middle Aged; Propranolol | 1982 |
Effects of cold exposure on blood pressure, heart rate and forearm blood flow in normotensives during selective and non-selective beta-adrenoceptor blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Female; Forearm; Heart Rate; Humans; Male; Metoprolol; Propranolol; Regional Blood Flow | 1982 |
Alpine skiing and acute beta-blockade.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Lactates; Middle Aged; Physical Endurance; Physical Exertion; Propranolol; Skiing; Time Factors | 1983 |
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; Labetalol; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
Adrenergic beta-receptorblockade: haemodynamic relevance of beta-1-selectivity and ISA during adrenaline infusion.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Interactions; Epinephrine; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Propranolol; Receptors, Adrenergic, beta; Sympathetic Nervous System; Vascular Resistance | 1983 |
Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Epinephrine; Fatty Acids, Nonesterified; Glycogen; Hemodynamics; Humans; Male; Norepinephrine; Physical Exertion; Prazosin; Propranolol | 1984 |
Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; C-Peptide; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Humans; Hypertension; Insulin; Islets of Langerhans; Male; Middle Aged; Propranolol; Random Allocation | 1984 |
Diazepam/beta-adrenoceptor antagonist interactions.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Diazepam; Drug Interactions; Emotions; Humans; In Vitro Techniques; Kinetics; Male; Metoprolol; Microsomes, Liver; Nordazepam; Propranolol; Psychomotor Performance; Rats; Rats, Inbred Strains; Reaction Time; Visual Acuity | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Physical performance and muscle metabolism during beta-adrenergic blockade in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Energy Metabolism; Heart Rate; Humans; Hypertension; Lactates; Male; Metoprolol; Muscle Contraction; Muscles; Oxygen Consumption; Physical Endurance; Physical Exertion; Propranolol; Time Factors | 1984 |
Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
Topics: Adult; Atenolol; Blood Pressure; Heart Rate; Humans; Male; Metoprolol; Physical Exertion; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tachycardia; Tremor | 1981 |
Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Exercise Test; Hemodynamics; Humans; Lactates; Male; Metabolism; Norepinephrine; Propanolamines; Propranolol; Random Allocation; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin | 1983 |
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Portal Vein; Prazosin; Propranolol; Quinazolines | 1984 |
Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine.
Topics: Angina Pectoris; Atenolol; Clinical Trials as Topic; Exercise Test; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Nifedipine; Propranolol; Random Allocation; Smoking | 1984 |
Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Lactates; Male; Middle Aged; Physical Education and Training; Physical Endurance; Propranolol | 1984 |
Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol.
Topics: Atenolol; Blood Pressure; Female; Fingers; Humans; Male; Middle Aged; Physical Exertion; Posture; Propranolol; Pulse; Rest; Substance Withdrawal Syndrome; Tremor | 1984 |
Hemodynamic and metabolic responses to exercise after alpha 1-, beta 1-, and nonselective beta-adrenoceptor blockade in man.
Topics: Adult; Atenolol; Blood Glucose; Catecholamines; Fatty Acids, Nonesterified; Hemodynamics; Humans; Lactates; Male; Physical Exertion; Prazosin; Propranolol; Quinazolines | 1984 |
[Polycardiographic and ergometric studies after administration of atenolol and propranolol].
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Depression, Chemical; Heart Function Tests; Humans; Male; Myocardial Contraction; Physical Exertion; Propanolamines; Propranolol | 1982 |
Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal man.
Topics: Adult; Atenolol; Carbon Dioxide; Female; Heart Rate; Humans; Hypercapnia; Male; Metoprolol; Propanolamines; Propranolol; Respiratory Function Tests | 1980 |
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Monitoring, Physiologic; Physical Exertion; Pindolol; Propanolamines; Propranolol; Random Allocation; Time Factors | 1982 |
Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
Topics: Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Tachycardia | 1983 |
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Propanolamines; Propranolol; Random Allocation | 1980 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Propanolamines; Propranolol | 1980 |
A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.
Topics: Adult; Atenolol; Blood Pressure; Creatinine; Female; Heart Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Propanolamines; Propranolol; Renin | 1980 |
Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Topics: Adult; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Propanolamines; Propranolol; Random Allocation | 1980 |
[Atenolol (Tenormin) in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol | 1980 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Propanolamines; Propranolol; Random Allocation | 1980 |
Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
Topics: Administration, Oral; Adolescent; Adult; Atenolol; Blood Glucose; Blood Pressure Determination; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Propanolamines; Propranolol; Respiratory Function Tests | 1981 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Myocardial Infarction; Patient Compliance; Placebos; Propranolol; Random Allocation; Sulfinpyrazone | 1981 |
Cardioselectivity of atenolol in asthmatic patients.
Topics: Airway Resistance; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Forced Expiratory Volume; Heart; Heart Rate; Humans; Hypertension; Isoproterenol; Propanolamines; Propranolol; Random Allocation | 1981 |
The effect of beta-blockers on ventilatory function in chronic bronchitis.
Topics: Adult; Atenolol; Bronchitis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Propanolamines; Propranolol; Pulmonary Ventilation | 1982 |
Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metoprolol; Penbutolol; Propanolamines; Propranolol; Pulse | 1982 |
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
Topics: Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Propranolol | 1982 |
[Long term comparison between atenolol and a depot form of propranolol hydrochloride on the heart rate and blood pressure at rest and during physical work in normal subjects].
Topics: Adult; Atenolol; Blood Pressure; Delayed-Action Preparations; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Propanolamines; Propranolol; Rest; Time Factors | 1980 |
Selective and non-selective beta-adrenoreceptor blockade in the human forearm.
Topics: Adult; Atenolol; Blood Glucose; Fatty Acids, Nonesterified; Forearm; Hemodynamics; Humans; Lactates; Male; Oxygen Consumption; Physical Exertion; Propanolamines; Propranolol; Regional Blood Flow | 1980 |
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human unstimulated whole saliva flow rate and protein composition.
Topics: Adult; Amylases; Atenolol; Double-Blind Method; Hexosamines; Humans; Male; N-Acetylneuraminic Acid; Placebos; Propranolol; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sialic Acids; Time Factors | 1994 |
Stereoselective vascular effects of the (R)- and (S)-enantiomers of propranolol and atenolol.
Topics: Adult; Analysis of Variance; Atenolol; Blood Pressure; Forearm; Humans; Male; Plethysmography; Propranolol; Regional Blood Flow; Stereoisomerism; Structure-Activity Relationship; Vascular Resistance; Vasoconstriction; Vasodilation | 1995 |
Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Epinephrine; Exercise; Heart Rate; Humans; Male; Norepinephrine; Propranolol; Stereoisomerism | 1995 |
Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Analysis of Variance; Atenolol; Cognition; Female; Humans; Lorazepam; Male; Mental Processes; Mental Recall; Propranolol; Reference Values | 1993 |
Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.
Topics: Adrenergic alpha-Antagonists; Adult; Animals; Atenolol; Central Nervous System; Female; Humans; In Vitro Techniques; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Rabbits; Rats; Receptors, Adrenergic, alpha | 1993 |
Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion.
Topics: Adult; Atenolol; Double-Blind Method; Humans; Male; Parotid Gland; Propranolol; Saliva; Salivary Glands; Salivary Proteins and Peptides; Salivation; Secretory Rate; Stimulation, Chemical; Sublingual Gland; Submandibular Gland | 1994 |
Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
Topics: Administration, Oral; Adult; Aged; Atenolol; Circadian Rhythm; Female; Humans; Hypertension; Intestinal Absorption; Male; Middle Aged; Propranolol; Time Factors | 1993 |
Effect of increased plasma non-esterified fatty acid concentrations on endurance performance during beta-adrenoceptor blockade.
Topics: Adult; Atenolol; Double-Blind Method; Energy Metabolism; Exercise; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Hemodynamics; Humans; Male; Physical Endurance; Propranolol | 1993 |
beta-blockade, atrial natriuretic peptide and exercise.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Atrial Natriuretic Factor; Cross-Over Studies; Double-Blind Method; Epinephrine; Exercise Test; Humans; Male; Norepinephrine; Pindolol; Propranolol; Vasopressins | 1996 |
Cardiovascular responses to beta-blockade and 5 degrees C cold air stress.
Topics: Adult; Atenolol; Blood Pressure; Heart Rate; Hemodynamics; Humans; Male; Propranolol | 1996 |
The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Quality of Life; Sodium Chloride Symporter Inhibitors; Surveys and Questionnaires | 1996 |
Beta 1-adrenoreceptors regulate resting metabolic rate.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Exercise; Exercise Test; Female; Humans; Male; Oxygen Consumption; Propranolol; Receptors, Adrenergic, beta-1; Sympathetic Nervous System | 1997 |
Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Celiprolol; Double-Blind Method; Heart Rate; Humans; Male; Propranolol | 1997 |
Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Tolerance; Humans; Mibefradil; Propranolol; Safety; Tetrahydronaphthalenes; Treatment Outcome | 1998 |
Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Catecholamines; Energy Metabolism; Exercise; Fatty Acids; Heart Rate; Humans; Hydrocortisone; Insulin; Male; Oxidation-Reduction; Oxygen Consumption; Propranolol; Reference Values; Triglycerides | 1998 |
Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Heart Rate; Humans; Lipid Metabolism; Lipid Peroxidation; Lipids; Male; Metoprolol; Middle Aged; Propranolol; Prospective Studies; Triglycerides | 1998 |
Micellar liquid chromatography: a worthy technique for the determination of beta-antagonists in urine samples.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Chromatography, Liquid; Ethylamines; Humans; Hydrogen-Ion Concentration; Metoprolol; Micelles; Propranolol; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Surface-Active Agents | 1999 |
Baroreflex sensitivity and the blood pressure response to beta-blockade.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Baroreflex; Blood Pressure; Exercise; Exercise Test; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol | 1999 |
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Celiprolol; Double-Blind Method; Humans; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Propranolol | 1999 |
Influence of beta-blockers on melatonin release.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Carbazoles; Carvedilol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Male; Melatonin; Propanolamines; Propranolol; Stereoisomerism; Verapamil | 1999 |
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Female; Humans; Infant; Long QT Syndrome; Male; Metoprolol; Nadolol; Propranolol; Survival Analysis | 2000 |
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Cachexia; Calorimetry, Indirect; Carbohydrate Metabolism; Energy Metabolism; Female; Heart Rate; Humans; Male; Neoplasms; Propranolol; Receptors, Adrenergic, beta; Statistics, Nonparametric; Weight Loss | 2000 |
Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anastomosis, Surgical; Atenolol; Cross-Over Studies; Female; Gastrectomy; Gastric Mucosa; Humans; Male; Middle Aged; Propranolol; Statistics, Nonparametric; Stomach | 2000 |
Both atenolol and propranolol blunt the fibrinolytic response to exercise but not resting fibrinolytic potential.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Antifibrinolytic Agents; Atenolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Fibrinolytic Agents; Heart Rate; Humans; Male; Physical Exertion; Placebos; Plasminogen Activator Inhibitor 1; Propranolol; Rest; Serine Proteinase Inhibitors; Tissue Plasminogen Activator | 2000 |
Role of alpha1-blockade in congenital long QT syndrome: investigation by exercise stress test.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Doxazosin; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Propranolol | 2001 |
Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Antipsychotic Agents; Atenolol; Blood Glucose; Clozapine; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Lipids; Male; Propranolol; Psychotic Disorders; Schizophrenia; Statistics, Nonparametric; Weight Gain | 2003 |
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Area Under Curve; Atenolol; Blood Pressure; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Half-Life; Heart Rate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Propranolol | 2003 |
[Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Female; Humans; Hyperlipidemias; Male; Middle Aged; Propranolol | 2002 |
Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Female; Humans; Hyperthyroidism; Male; Metoprolol; Middle Aged; Propranolol; Radioimmunoassay; Thyroid Hormones; Weight Gain | 2003 |
[Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Area Under Curve; Atenolol; Blood Pressure; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Half-Life; Heart Rate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Propranolol; Time Factors; Treatment Outcome | 2004 |
Noradrenergic blockade and numeric working memory in humans.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Atenolol; Blood-Brain Barrier; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Male; Memory, Short-Term; Norepinephrine; Prefrontal Cortex; Propranolol; Psychomotor Performance; Reaction Time; Sympathetic Nervous System | 2005 |
Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Atenolol; Child; Dilatation, Pathologic; Enalapril; Female; Humans; Male; Marfan Syndrome; Propranolol; Prospective Studies; Treatment Outcome | 2005 |
Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Female; Humans; Hypertension; Male; Platelet Aggregation; Propranolol; Prospective Studies | 2005 |
Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.
Topics: Adrenergic beta-Antagonists; Adult; Amines; Amitriptyline; Analgesics, Non-Narcotic; Anticonvulsants; Atenolol; Cyclohexanecarboxylic Acids; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Pizotyline; Propranolol; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil; Weight Gain | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studies; Digoxin; Female; Humans; Male; Middle Aged; Nociceptors; Pindolol; Propranolol; Young Adult | 2010 |
Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Aortic Diseases; Atenolol; Child; Dilatation, Pathologic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Losartan; Male; Marfan Syndrome; Pilot Projects; Propranolol; Treatment Outcome; Young Adult | 2013 |
Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Topics: Adrenergic beta-Antagonists; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Male; Propranolol; Risk Assessment; Skin Neoplasms; Time Factors; Treatment Outcome | 2014 |
Cardio-protection afforded by β-blockade is maintained during resistance exercise.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiac Output; Double-Blind Method; Exercise; Heart Rate; Humans; Male; Oxygen Consumption; Propranolol; Resistance Training; Young Adult | 2017 |
A STUDY ON THE HAEMODYNAMIC INTERACTIONS BETWEEN ACTIVATED CHARCOAL AND PROPRANOLOL/ATENOLOL IN NORMAL HUMAN SUBJECTS.
Topics: Adult; Atenolol; Charcoal; Cross-Over Studies; Hemodynamics; Humans; Male; Propranolol | 1999 |
Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
Topics: Adrenergic beta-Antagonists; Atenolol; Case-Control Studies; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Propranolol; Retrospective Studies; Treatment Outcome | 2017 |
Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Atenolol; China; Female; Hemangioma, Capillary; Humans; Infant; Male; Propranolol; Prospective Studies | 2021 |
669 other study(ies) available for propranolol and atenolol
Article | Year |
---|---|
2-Methoxyphenylethanolamines, potential beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Ethanolamines; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Structure-Activity Relationship; Trachea | 1978 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
Topics: Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; Heart Rate; Hydrogen Bonding; Imidazoles; In Vitro Techniques; Receptors, Adrenergic, beta; Solubility; Structure-Activity Relationship | 1986 |
(Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Topics: Adrenergic beta-Antagonists; Amines; Carbamates; Cell Membrane Permeability; Pharmaceutical Preparations; Prodrugs | 1988 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class.
Topics: Adrenergic alpha-Agonists; Animals; Female; Guinea Pigs; Heart; Imidazoles; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Receptors, Adrenergic; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1983 |
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea | 1999 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.
Topics: Administration, Oral; Animals; Anti-Obesity Agents; Biological Availability; Brain; Cell Line; Humans; Injections, Intravenous; Intestinal Absorption; Ligands; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Mimicry; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Structure-Activity Relationship; Tissue Distribution | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
Topics: Administration, Oral; Animals; Antiviral Agents; Combinatorial Chemistry Techniques; Drug Design; Haplorhini; Hepacivirus; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Pyridazines; Structure-Activity Relationship; Viral Nonstructural Proteins | 2008 |
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessme
Topics: Administration, Oral; Animals; Antiviral Agents; Combinatorial Chemistry Techniques; Drug Design; Hepacivirus; Humans; Microsomes, Liver; Molecular Structure; Pyridazines; Rats; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Viral Nonstructural Proteins | 2008 |
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
Topics: Animals; Antiviral Agents; Binding Sites; Cell Line; Crystallography, X-Ray; Humans; Hydrogen Bonding; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyridazines; Pyrroles; Structure-Activity Relationship; Viral Nonstructural Proteins | 2008 |
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Genotype; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; RNA, Viral; Structure-Activity Relationship; Thiazoles; Thiophenes; Viral Nonstructural Proteins | 2008 |
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.
Topics: Caco-2 Cells; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Hepacivirus; Humans; Inhibitory Concentration 50; Microsomes, Liver; Models, Chemical; Molecular Conformation; Pyridazines; Structure-Activity Relationship; Thiazines; Time Factors; Viral Nonstructural Proteins | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
Topics: Antiviral Agents; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Drug Design; Hepacivirus; Humans; Microsomes, Liver; Molecular Structure; Pyridazines; Structure-Activity Relationship; Viral Nonstructural Proteins | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
Topics: Antiviral Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cyclic S-Oxides; DNA-Directed RNA Polymerases; Drug Design; Genotype; Humans; Inhibitory Concentration 50; Microsomes; Models, Chemical; Molecular Conformation; Pyridazines; Structure-Activity Relationship; Thiadiazines; Viral Nonstructural Proteins | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.
Topics: Animals; Biological Availability; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Nitric Oxide; Oxadiazoles; Protein Conformation; Rats; Schistosoma; Schistosomiasis; Schistosomicides; Solubility; Structure-Activity Relationship; Substrate Specificity | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties.
Topics: Animals; Cytoprotection; Insecticides; Male; Microsomes, Liver; Parkinson Disease; Rats; Rotenone; Structure-Activity Relationship; Triazines | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450 Enzyme System; Disease Models, Animal; Emulsions; Fats; Fatty Liver; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport.
Topics: Antineoplastic Agents; Biological Transport; Bridged-Ring Compounds; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Microtubules; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Taxoids | 2011 |
Exploring the interplay of physicochemical properties, membrane permeability and giardicidal activity of some benzimidazole derivatives.
Topics: Antiprotozoal Agents; Benzimidazoles; Caco-2 Cells; Cell Membrane Permeability; Chemical Phenomena; Duodenum; Giardia lamblia; Humans; Hydrophobic and Hydrophilic Interactions; Jejunum; Solubility; Trophozoites; Water | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventi
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Discovery; Drug Stability; Female; Humans; Indenes; Isoquinolines; Ligands; Microsomes, Liver; Rats; Response Elements; Retinoid X Receptors; Transcription, Genetic | 2012 |
Triazolopyridazine LRRK2 kinase inhibitors.
Topics: Dose-Response Relationship, Drug; HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridazines; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Re-exploring the N-phenylpicolinamide derivatives to develop mGlu4 ligands with improved affinity and in vitro microsomal stability.
Topics: Animals; Humans; Ligands; Microsomes; Molecular Structure; Picolines; Positron-Emission Tomography; Rats; Receptors, Metabotropic Glutamate; Structure-Activity Relationship | 2015 |
Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Topics: Animals; Binding Sites; Cell Line; Chagas Disease; Disease Models, Animal; Leishmania donovani; Mice; Mice, Inbred BALB C; Nitroreductases; Parasitic Sensitivity Tests; Prodrugs; Protein Structure, Tertiary; Protozoan Proteins; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2015 |
3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Topics: Animals; Cell Line; Chagas Disease; Dose-Response Relationship, Drug; Humans; Leishmania donovani; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; Piperazines; Rats; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2015 |
Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.
Topics: Anilides; Antineoplastic Agents; Benzamides; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Drug Resistance, Neoplasm; Humans; Male; Microsomes, Liver; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitriles; Permeability; Phenylthiohydantoin; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Tosyl Compounds | 2016 |
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase.
Topics: Animals; Caco-2 Cells; Humans; Imidazoles; Microsomes, Liver; Molecular Docking Simulation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyrazines; Rats; Structure-Activity Relationship | 2016 |
Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Piperidines; Receptors, G-Protein-Coupled; Spiro Compounds; Structure-Activity Relationship | 2016 |
Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors.
Topics: Binding Sites; Catalytic Domain; Drug Design; Enzyme Inhibitors; Esters; Inhibitory Concentration 50; Lipid Bilayers; Permeability; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship; Sulfonic Acids | 2017 |
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Discovery; Humans; Imidazoles; Inflammation; Mitogen-Activated Protein Kinase 14; Phosphodiesterase 4 Inhibitors; Protein Kinase Inhibitors; Tumor Necrosis Factor-alpha | 2017 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy.
Topics: Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Glaucoma; Humans; Intraocular Pressure; Male; Molecular Targeted Therapy; Rabbits; Receptors, Adrenergic, beta; Structure-Activity Relationship | 2018 |
Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Topics: Antiviral Agents; Cell Line; Humans; Intracellular Signaling Peptides and Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Structure-Activity Relationship; Thiazoles | 2018 |
Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Guanidine; Hedgehog Proteins; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; NIH 3T3 Cells; Structure-Activity Relationship; Thiourea | 2018 |
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.
Topics: Alkylation; Anti-Bacterial Agents; Caco-2 Cells; Guanidine; Humans; Microbial Sensitivity Tests; Permeability; Structure-Activity Relationship | 2018 |
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface-Active Agents; Virus Internalization; Zebrafish | 2019 |
Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.
Topics: Animals; Antigens, CD; Cell Membrane Permeability; Diabetes Mellitus, Type 2; Esters; Glucose; Humans; Obesity; Protein Binding; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Receptor, Insulin; Stereoisomerism; Sulfonic Acids | 2019 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.
Topics: Animals; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Cyclophilin A; Cyclosporine; Cyclosporins; Drug Design; Humans; Hydrogen Bonding; Male; Mice, Inbred ICR; Molecular Conformation; Protein Binding | 2021 |
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioblastoma; HEK293 Cells; Humans; Molecular Structure; Orphan Nuclear Receptors; Propranolol; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship | 2021 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; CREB-Binding Protein; Drug Design; Humans; Indolizidines; Male; Mice; Mice, SCID; Microsomes, Liver; Models, Molecular; Molecular Docking Simulation; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2022 |
Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carrier Proteins; Cell Line, Tumor; DNA-Binding Proteins; Humans; Male; Prostatic Neoplasms; Protein Domains | 2022 |
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.
Topics: Imidazoles; Ligands; Pyridines; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2022 |
Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Circadian Rhythm; Female; Humans; Intraocular Pressure; Male; Middle Aged; Practolol; Propranolol | 1975 |
Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Pindolol; Practolol; Propranolol; Rats; Sympathomimetics | 1976 |
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Propranolol; Raynaud Disease; Skin Temperature | 1976 |
Letter: Raynaud's phenomenon as side effect of beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Oxprenolol; Propranolol; Raynaud Disease | 1976 |
[Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Platelets; Blood Pressure; Catecholamines; Dopamine beta-Hydroxylase; Humans; Physical Exertion; Practolol; Propranolol; Serotonin; Tyramine | 1976 |
The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Heart Rate; Humans; Middle Aged; Propanolamines; Propranolol; Renin | 1976 |
Once-daily treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Hypertension; Metoprolol; Pindolol; Propranolol; Timolol | 1976 |
A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Vessels; Dogs; Female; Heart; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Vasomotor System | 1975 |
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Humans; Male; Oxprenolol; Physical Exertion; Practolol; Propranolol; Sotalol; Sympathomimetics; Time Factors | 1977 |
beta-adrenoceptor antagonism and intraocular pressure. A clinical study on propranolol, practolol and atenolol.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Pilocarpine; Practolol; Propranolol; Time Factors; Tonometry, Ocular | 1977 |
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Insulin; Isoproterenol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Renin | 1978 |
A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.
Topics: Absorption; Atenolol; Cheek; Chemical Phenomena; Chemistry, Physical; Humans; Hydrogen-Ion Concentration; Models, Biological; Mouth Mucosa; Propanolamines; Propranolol; Solubility; Time Factors | 1978 |
[Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Binding, Competitive; Heart; Lung; Metoprolol; Oxprenolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1977 |
Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arteriosclerosis; Atenolol; Blood Pressure; Depression, Chemical; Heart Rate; Isoproterenol; Male; Oxprenolol; Pindolol; Propanolamines; Propranolol; Rabbits; Timolol | 1978 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Male; Oxprenolol; Physical Exertion; Pindolol; Posture; Practolol; Propranolol; Renin; Timolol | 1975 |
[Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Endocardium; Microspheres; Pericardium; Pindolol; Practolol; Propranolol; Radioactivity | 1978 |
[beta-blockers in hypertension with renal failure].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Propranolol; Renal Dialysis; Renin; Sodium; Vasodilator Agents | 1978 |
Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Male; Pindolol; Propanolamines; Propranolol; Rats; Vascular Resistance | 1978 |
Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Hypertension; Male; Metoprolol; Propranolol; Rats; Social Isolation; Time Factors | 1979 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
[Effects of beta blockaders on ventilatory function in chronic bronchitis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bronchitis; Chronic Disease; Coronary Disease; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Middle Aged; Practolol; Propranolol; Respiration; Vital Capacity | 1979 |
Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Cats; Female; Heart Rate; Hemodynamics; Hindlimb; Isoproterenol; Male; Metoprolol; Muscle Relaxation; Propanolamines; Propranolol; Regional Blood Flow; Vasodilation | 1979 |
Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Amines; Animals; Atenolol; Blood Pressure; Cardiac Surgical Procedures; Desoxycorticosterone; Female; Guanethidine; Heart; Hypertension; Male; Propranolol; Rats; Sodium Chloride; Sympathectomy; Sympathetic Nervous System | 1979 |
The treatment of glaucoma: role of beta-blocking agents.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Glaucoma; Humans; Intraocular Pressure; Propranolol; Timolol | 1979 |
Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Male; Pindolol; Practolol; Propanolamines; Propranolol | 1979 |
Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Catecholamines; Heart Rate; Humans; Male; Norepinephrine; Propranolol; Time Factors | 1979 |
Beta-blocker withdrawal syndrome?
Topics: Atenolol; Humans; Male; Metoprolol; Propanolamines; Propranolol; Substance Withdrawal Syndrome | 1979 |
Peripheral skin necrosis complicating beta-blockage.
Topics: Aged; Atenolol; Drug Eruptions; Female; Foot; Foot Dermatoses; Humans; Ischemia; Male; Middle Aged; Necrosis; Propanolamines; Propranolol | 1979 |
The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.
Topics: Albuterol; Animals; Atenolol; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Hepatic Artery; Isoproterenol; Liver Circulation; Norepinephrine; Phenylephrine; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Vascular Resistance | 1977 |
The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.
Topics: Atenolol; Candida albicans; Cell Movement; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic GMP; Female; Humans; In Vitro Techniques; Male; Neutrophils; Phagocytosis; Propanolamines; Propranolol | 1979 |
A comparative study of the activity of beta-adrenoceptor antagonists in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Oxprenolol; Phenyl Ethers; Physical Exertion; Practolol; Propanolamines; Propranolol | 1975 |
Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Topics: Adult; Angiotensin II; Atenolol; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Plasma Volume; Propanolamines; Propranolol; Renin; Saralasin; Sodium | 1979 |
The effect of beta-adrenergic blocking drugs on the intrinsic beating rate of cultured rat myocytes.
Topics: Atenolol; Cells, Cultured; Dose-Response Relationship, Drug; Isomerism; Myocardial Contraction; Myocardium; Propanolamines; Propranolol | 1979 |
Nylidrin: a potent anti-hypertensive agent in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypertension; Male; Nylidrin; Propranolol; Rats; Time Factors | 1979 |
Reduction of beta-blocking drugs in hypertensive patients treated with minoxidil.
Topics: Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Minoxidil; Propanolamines; Propranolol; Pyrimidines | 1979 |
[Comparative studies with propranolol, verapamil and atenolol in hypertensive dialysis patients].
Topics: Atenolol; Humans; Hypertension, Renal; Kidney Failure, Chronic; Propanolamines; Propranolol; Renal Dialysis; Verapamil | 1977 |
Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing.
Topics: Adult; Atenolol; Cardiac Pacing, Artificial; Coronary Disease; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Propanolamines; Propranolol | 1978 |
Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings].
Topics: Adolescent; Adult; Aged; Atenolol; Humans; Middle Aged; Propanolamines; Propranolol; Protein Binding; Serum Albumin | 1978 |
Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans.
Topics: Antihypertensive Agents; Atenolol; Clonidine; Humans; Kinetics; Propranolol; Renal Dialysis | 1978 |
The buccal absorption of atenolol and propranolol, and their physicochemical characteristics [proceedings].
Topics: Absorption; Atenolol; Cheek; Chemical Phenomena; Chemistry; Humans; Mouth Mucosa; Propanolamines; Propranolol | 1977 |
Atenolol and plasma renin concentration in hypertensive patients.
Topics: Atenolol; Hemodynamics; Humans; Hypertension; Physical Exertion; Propanolamines; Propranolol; Renin | 1977 |
Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension.
Topics: Adult; Animals; Atenolol; Dopamine beta-Hydroxylase; Epinephrine; Humans; Hypertension; Norepinephrine; Physical Exertion; Propranolol; Rats; Rats, Inbred Strains | 1977 |
The pharmacology of atenolol.
Topics: Animals; Anura; Atenolol; Cats; Dogs; Guinea Pigs; Heart Conduction System; Heart Rate; Practolol; Propanolamines; Propranolol; Rats | 1977 |
Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
Topics: Adult; Atenolol; Dose-Response Relationship, Drug; Drug Evaluation; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol | 1976 |
Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
Topics: Atenolol; Blood Pressure; Dopamine beta-Hydroxylase; Humans; Hypertension; Male; Propanolamines; Propranolol | 1975 |
[Use of a new beta-blocking agent, ICI-66082].
Topics: Adjuvants, Anesthesia; Anesthesia, General; Animals; Anura; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Heart Rate; Humans; Practolol; Propanolamines; Propranolol | 1975 |
Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects.
Topics: Aged; Airway Resistance; Asthma; Atenolol; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol | 1975 |
Effects of adrenergic drugs administered during ovum transport and chemical sympathectomy of the oviduct on fertility in rabbits.
Topics: Animals; Ascorbic Acid; Atenolol; Autonomic Agents; Embryo Implantation; Fallopian Tubes; Female; Fertility; Guanethidine; Hydroxydopamines; Ovum Transport; Phenoxybenzamine; Phenylephrine; Pregnancy; Propranolol; Rabbits; Receptors, Adrenergic; Reserpine; Ritodrine; Sympathetic Nervous System | 1975 |
[The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Practolol; Propanolamines; Propranolol; Vascular Resistance | 1975 |
Proceedings: Effect of selective and non-selective beta-blockade on coronary circulation in man.
Topics: Atenolol; Coronary Circulation; Humans; Propanolamines; Propranolol | 1976 |
Preoptic norepinephrine-induced hypothermia is mediated by alpha 2-adrenoceptors.
Topics: Animals; Atenolol; Body Temperature; Body Temperature Regulation; Clonidine; Dialysis; Dobutamine; Dose-Response Relationship, Drug; Guinea Pigs; Male; Norepinephrine; Practolol; Preoptic Area; Propranolol; Receptors, Adrenergic, alpha; Reference Values; Skin Temperature; Yohimbine | 1992 |
Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism.
Topics: Animals; Atenolol; Deoxyglucose; Escherichia coli Infections; Glucose; Glucose Clamp Technique; Insulin Resistance; Male; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tissue Distribution | 1992 |
Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cocaine; Heart Rate; Labetalol; Male; Phentolamine; Prazosin; Propanolamines; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saimiri; Yohimbine | 1992 |
Beta-blocker effects on 24-h activity in normotensive and renovascular hypertensive baboons.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renovascular; Male; Motor Activity; Papio; Propranolol | 1992 |
Study of the glycogenolytic action of platelet activating factor in Tetrahymena pyriformis.
Topics: Animals; Atenolol; Calcium; Cyclic AMP; Glucose; Glycogen; Labetalol; Platelet Activating Factor; Propranolol; Tetrahymena pyriformis | 1992 |
Non-beta-adrenergic-mediated peripheral circulatory hyperkinesia in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Extremities; Female; Heart Rate; Humans; Hyperthyroidism; Male; Middle Aged; Propranolol; Sympathetic Nervous System; Thyroid Hormones; Vascular Resistance | 1992 |
On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arachidonic Acid; Atenolol; Blood Platelets; Male; Membrane Fluidity; Metipranolol; Oxprenolol; Platelet Aggregation Inhibitors; Practolol; Propranolol; Rats; Rats, Wistar; Thrombin; Thromboxane A2 | 1992 |
Performance of baboons under a repeated acquisition procedure during chronic oral exposure to atenolol and propranolol.
Topics: Animals; Atenolol; Blood Pressure; Conditioning, Operant; Hypertension, Renovascular; Male; Papio; Propranolol | 1992 |
Fundamental studies in reversed-phase liquid-solid extraction of basic drugs; III: Sample matrix effects.
Topics: Atenolol; Blood Chemical Analysis; Blood Proteins; Chromatography, High Pressure Liquid; Humans; Paraquat; Propranolol; Protein Binding | 1992 |
Glucose turnover in type I diabetic subjects during exercise. Effect of selective and nonselective beta-blockade and insulin withdrawal.
Topics: Adult; Atenolol; Betaxolol; Blood Glucose; Diabetes Mellitus, Type 1; Exercise; Glucose; Glycated Hemoglobin; Humans; Insulin; Kinetics; Male; Physical Exertion; Propranolol; Tritium | 1992 |
Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
Topics: Adult; Atenolol; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Propranolol; Verapamil | 1992 |
Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.
Topics: Adult; Analysis of Variance; Atenolol; Cardiography, Impedance; Cardiovascular System; Hemodynamics; Humans; Male; Pindolol; Propranolol; Reference Values | 1992 |
Amphetamine actions on pre- and postpubertal rat hippocampal dentate granule neurons.
Topics: Aging; Animals; Atenolol; Calcium Channels; Cocaine; Dextroamphetamine; Evoked Potentials; Haloperidol; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Neurons; Propranolol; Rats; Rats, Inbred Strains; Reserpine; Sexual Maturation; Synapses | 1991 |
Norepinephrine inhibits human natural killer cell activity in vitro.
Topics: Atenolol; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Killer Cells, Natural; Norepinephrine; Propranolol; Receptors, Adrenergic, beta | 1991 |
Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease.
Topics: Aerosols; Animals; Atenolol; Butoxamine; Histamine; Horse Diseases; Horses; Isoproterenol; Lung Diseases, Obstructive; Propranolol; Receptors, Adrenergic, beta; Recurrence; Respiratory Function Tests | 1991 |
The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity.
Topics: Adolescent; Adrenergic beta-Antagonists; Atenolol; Autonomic Nervous System; Child; Epinephrine; Female; Follow-Up Studies; Humans; Isoproterenol; Male; Norepinephrine; Posture; Propranolol; Receptors, Adrenergic, beta; Recurrence; Syncope | 1991 |
Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; DNA; DNA Damage; DNA Repair; Humans; Liver; Male; Metoprolol; Nadolol; Nitrosamines; Nitrosation; Oxprenolol; Propranolol; Rats; Rats, Inbred Strains; Sodium Nitrite; Sotalol | 1991 |
Response to beta-blockers in maternal and fetal rat hearts in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Female; Heart; Heart Rate; Isoproterenol; Labetalol; Metoprolol; Pregnancy; Pregnancy, Animal; Propranolol; Rats; Rats, Inbred Strains | 1991 |
[The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Atenolol; Blood Platelets; Drug Synergism; Malondialdehyde; Platelet Aggregation; Platelet Aggregation Inhibitors; Propranolol; Rats; Rats, Inbred Strains; Thromboxane B2 | 1991 |
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Avoidance Learning; Birth Weight; Body Weight; Brain; Female; Gestational Age; Heart Rate; Male; Motor Activity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sotalol | 1991 |
Mechanism of neurotransmitter release elicited by the preferential alpha 1-adrenergic receptor agonist phenylephrine in superfused superior cervical ganglion cells in culture.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Atenolol; Cells, Cultured; Cocaine; Cyclic AMP; Dioxanes; Dose-Response Relationship, Drug; Electric Stimulation; Ethanolamines; Ganglia, Sympathetic; Kidney; Methoxamine; Neurotransmitter Agents; Norepinephrine; Phenylephrine; Potassium Chloride; Prazosin; Propranolol; Rats; Tritium | 1991 |
Noradrenaline receptors participate in the regulation of GABAergic inhibition in area CA1 of the rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Atenolol; Bicuculline; Clonidine; Dose-Response Relationship, Drug; Evoked Potentials; Female; gamma-Aminobutyric Acid; Hippocampus; Male; Membrane Potentials; Norepinephrine; Propranolol; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, GABA-A; Synapses | 1991 |
Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Bretylium Compounds; Dose-Response Relationship, Drug; Epinephrine; Male; Norepinephrine; Propranolol; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 1991 |
The effect of adrenergic agonists and antagonists on cysteine-proteinase inhibitor (cystatin) in rat saliva.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Blotting, Western; Cysteine Proteinase Inhibitors; Dobutamine; Electrophoresis, Polyacrylamide Gel; Female; Isoproterenol; Methamphetamine; Methoxamine; Metoprolol; Norepinephrine; Propanolamines; Propranolol; Radioimmunoassay; Rats; Rats, Inbred Strains; Salivary Proteins and Peptides; Terbutaline | 1991 |
Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Survival; Cells, Cultured; Dogs; Electron Spin Resonance Spectroscopy; Free Radicals; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Oxygen; Propranolol; Superoxide Dismutase | 1991 |
Propranolol inhibits cyclic AMP accumulation and amylase secretion in parotid acinar cells stimulated by isobutylmethylxanthine and forskolin.
Topics: 1-Methyl-3-isobutylxanthine; Alprenolol; Amylases; Animals; Atenolol; Butoxamine; Colforsin; Cyclic AMP; Male; Membrane Proteins; Parotid Gland; Poly(ADP-ribose) Polymerases; Propranolol; Rats; Rats, Inbred Strains; Saponins; Theophylline | 1990 |
Fast efflux of Ca2+ mediated by the sarcoplasmic reticulum Ca2(+)-ATPase.
Topics: Animals; Atenolol; Biological Transport; Calcium; Calcium-Transporting ATPases; Catalysis; Kinetics; Magnesium; Phosphorylation; Potassium; Propranolol; Rats; Ruthenium Red; Sarcoplasmic Reticulum; Spermidine; Trifluoperazine | 1991 |
Transport of beta-blockers and calcium antagonists by diffusion in cat myocardium.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Biological Transport; Calcium Channel Blockers; Cats; Diffusion; In Vitro Techniques; Metoprolol; Myocardium; Propranolol; Sucrose; Verapamil | 1991 |
Attenuation of insulin-induced drinking by beta-adrenoceptor antagonists.
Topics: Animals; Atenolol; Blood Glucose; Butoxamine; Drinking; Insulin; Insulin Antagonists; Male; Phenoxybenzamine; Propranolol; Rats; Rats, Inbred Strains; Sympathetic Nervous System | 1991 |
Interleukin-8 as a mediator of sympathetic pain.
Topics: Animals; Atenolol; Benzazepines; Carrageenan; Dinoprostone; Edema; Foot; Guanethidine; Interleukin-1; Interleukin-8; Male; Monocytes; Nociceptors; Pain; Propranolol; Rats; Rats, Inbred Strains; Recombinant Proteins; Sympathetic Nervous System | 1991 |
Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Drug Hypersensitivity; Echocardiography; Echocardiography, Doppler; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrome | 1991 |
The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Lipids; Lipoproteins; Male; Pindolol; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
[Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in renal hypertensive dogs].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension, Renal; Male; Propranolol | 1990 |
Reversal of alpha-adrenoceptor blockade by propranolol in isolated rat pulmonary artery.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Pulmonary Artery; Rats; Rats, Inbred Strains | 1990 |
Effects of beta-adrenoceptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Coronary Circulation; Coronary Disease; Ethanolamines; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Mitochondria, Heart; Myocardial Reperfusion Injury; Nebivolol; Oxidative Phosphorylation; Propranolol; Rabbits; Reserpine; Stereoisomerism | 1990 |
Effects of four beta-adrenergic receptor antagonists on male rat sexual behavior.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Labetalol; Male; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1990 |
Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.
Topics: Adrenal Glands; Adrenalectomy; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Epinephrine; Infusions, Intravenous; Male; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1990 |
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Binding Sites; Butylamines; Chromatography; Metoprolol; Molecular Structure; Orosomucoid; Oxprenolol; Pindolol; Propranolol; Protein Conformation; Spectrometry, Fluorescence; Stereoisomerism | 1990 |
T3 plus high doses of beta-blockers: effects on energy intake, body composition, bat and heart in rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Atenolol; Body Composition; Body Weight; Energy Intake; Heart; Heart Rate; Male; Obesity; Organ Size; Propranolol; Rats; Rats, Inbred Strains; Thyroxine; Triiodothyronine | 1990 |
Tilt test for diagnosis of unexplained syncope in pediatric patients.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Child; Electrocardiography; Female; Heart Rate; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Posture; Propranolol; Syncope | 1991 |
Assessment of gain of tachycardia and bradycardia responses of cardiac baroreflex.
Topics: Adult; Animals; Aorta, Thoracic; Atenolol; Blood Pressure; Constriction; Heart; Heart Rate; Humans; Models, Biological; Nitroprusside; Phenylephrine; Pressoreceptors; Propranolol; Rabbits; Sympathetic Nervous System; Vagus Nerve; Vena Cava, Inferior | 1991 |
Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: comparison with atenolol and propranolol.
Topics: Animals; Atenolol; Betaxolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Female; Heart; Heart Rate; Hemodynamics; Male; Propranolol | 1990 |
Cognitive impairment associated with beta-blockade in the elderly.
Topics: Aged; Atenolol; Cognition Disorders; Humans; Male; Propranolol | 1990 |
The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
Topics: Animals; Atenolol; Cholesterol, Dietary; Cholesterol, HDL; Cricetinae; Doxazosin; Humans; Lipoprotein Lipase; Mesocricetus; Prazosin; Propranolol; Time Factors; Triglycerides | 1990 |
Beta-adrenoceptor mediated secretion of active and inactive renin in conscious sheep.
Topics: Animals; Atenolol; Blood Pressure; Female; Isoproterenol; Male; Propranolol; Receptors, Adrenergic, beta; Renin; Sheep | 1990 |
Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal.
Topics: Animals; Atenolol; Behavior, Animal; Corticotropin-Releasing Hormone; Injections, Intraperitoneal; Injections, Intraventricular; Male; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
A pressor effect of noncardioselective beta-blockers in mildly hypertensive patients during acute hospitalization.
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Blood Pressure; Echocardiography; Female; Heart Rate; Hospitalization; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propranolol; Stress, Psychological | 1990 |
Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Topics: Aging; Animals; Antipyrine; Atenolol; Male; Metabolic Clearance Rate; Metoprolol; Orosomucoid; Propranolol; Rats; Rats, Inbred Strains | 1990 |
Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion.
Topics: Adult; Atenolol; Circadian Rhythm; Female; Humans; Hypothalamo-Hypophyseal System; Male; Melatonin; Pineal Gland; Pituitary-Adrenal System; Propranolol | 1990 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
Topics: Acidosis; Animals; Atenolol; Betaxolol; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Propranolol | 1990 |
Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Binding, Competitive; Cells, Cultured; Cyclic AMP; Epinephrine; Isoproterenol; Kinetics; Liver Neoplasms, Experimental; Norepinephrine; Precancerous Conditions; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta | 1985 |
Inhibition of DNA and RNA synthesis in rat liver nuclei by oncogenic and non-oncogenic beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carcinogens; Cell Nucleus; DNA; DNA-Directed RNA Polymerases; Female; In Vitro Techniques; Liver; Male; Nucleic Acid Synthesis Inhibitors; Propanolamines; Propranolol; Rats; RNA; Sex Factors | 1985 |
Ventricular hypertrophy--physiological mechanisms.
Topics: Action Potentials; Animals; Atenolol; Cardiomegaly; Eating; Growth; Hypoxia; Membrane Potentials; Organ Size; Propranolol; Rabbits | 1986 |
Adrenergic activity on rat pleural and peritoneal mast cells. Loss of beta-receptors during the purification procedure.
Topics: Animals; Atenolol; Cell Separation; Epinephrine; Female; Histamine Release; Isoproterenol; Male; Mast Cells; Norepinephrine; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Pleura; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1987 |
Affinity and selectivity of beta-adrenoceptor antagonists in vitro.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding, Competitive; Bisoprolol; Propanolamines; Propranolol; Rats; Salivary Glands; Tritium | 1986 |
Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Bisoprolol; Chemistry, Physical; Humans; Kinetics; Male; Osmolar Concentration; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta | 1986 |
Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Topics: Animals; Atenolol; Differential Threshold; Dogs; Drug Combinations; Isoproterenol; Lidocaine; Metoprolol; Myocardial Contraction; Pindolol; Propranolol; Time Factors; Ventricular Fibrillation | 1987 |
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anesthesia; Animals; Atenolol; Benzopyrans; Cats; Ethanolamines; Exercise Test; Guinea Pigs; Hemodynamics; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Nebivolol; Pindolol; Propranolol; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1988 |
Pharmacological evaluation of central adrenergic involvement in chlordecone-induced hypothermia.
Topics: Animals; Atenolol; Chlordecone; Cisterna Magna; Colon; Dopamine; Drug Interactions; Hydroxydopamines; Hypothermia, Induced; Injections; Insecticides; Male; Norepinephrine; Oxidopamine; Phenoxybenzamine; Phentolamine; Propranolol; Rats; Rats, Inbred F344; Receptors, Adrenergic | 1988 |
Adrenergic effects on secretion of amylase from the rat salivary glands.
Topics: Amylases; Animals; Atenolol; Epinephrine; Isoenzymes; Isoproterenol; Male; Norepinephrine; Phenoxybenzamine; Propranolol; Rats; Rats, Inbred Strains; Salivary Glands; Sympathomimetics | 1988 |
Inhibitors of prostaglandin synthesis reverse the effects of chronic beta-receptor blockade to attenuate adrenergic neurovascular transmission in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cyclooxygenase Inhibitors; Dogs; Female; Indomethacin; Male; Membranes; Norepinephrine; Phenylephrine; Propranolol; Prostaglandin Antagonists; Stereoisomerism; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1988 |
Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Cholesterol; Cholesterol, Dietary; Cricetinae; Doxazosin; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Mesocricetus; Norepinephrine; Prazosin; Propranolol; Thyroid Hormones; Triglycerides | 1989 |
Depression associated with enalapril.
Topics: Atenolol; Depressive Disorder; Enalapril; Female; Humans; Middle Aged; Propranolol | 1989 |
Distribution and subtype determination of beta-receptors in the spinal cord of the adult rat.
Topics: Adenylyl Cyclases; Animals; Atenolol; Binding, Competitive; Dihydroalprenolol; Isoproterenol; Male; Practolol; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Spinal Cord | 1989 |
High-performance liquid chromatographic determination of the enantiomers of beta-adrenoceptor blocking agents in biological fluids. II. Studies with atenolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Cyanates; Humans; Isocyanates; Propranolol; Spectrometry, Fluorescence; Stereoisomerism | 1989 |
A study of beta-adrenoceptors in rat lung parenchymal strip.
Topics: Albuterol; Animals; Atenolol; Butoxamine; In Vitro Techniques; Isoproterenol; Lung; Male; Norepinephrine; Propranolol; Rats; Receptors, Adrenergic, beta | 1989 |
Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arachidonic Acid; Arachidonic Acids; Atenolol; Hydrolysis; Metipranolol; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Platelet Aggregation Inhibitors; Propranolol; Solubility; Thrombin | 1989 |
Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Coronary Vessels; Electrocardiography; Male; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1989 |
Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atenolol; Benzopyrans; Blood Glucose; Blood Pressure; Dogs; Ethanolamines; Fatty Acids, Nonesterified; Female; Heart Rate; Insulin; Isoproterenol; Nebivolol; Propranolol | 1989 |
Liquid chromatographic analysis of atenolol enantiomers in human plasma and urine.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chemistry, Pharmaceutical; Chromatography, Gas; Chromatography, High Pressure Liquid; Humans; Male; Propranolol; Spectrophotometry, Ultraviolet; Stereoisomerism | 1989 |
Heterogeneity of beta-adrenoceptor in canine veins: comparison among the facial, portal and saphenous veins.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bucladesine; Catecholamines; Colforsin; Dogs; Ethanolamines; Face; Isoproterenol; Male; Portal Vein; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Saphenous Vein; Veins | 1989 |
Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Heart Rate; Humans; Metoprolol; Middle Aged; Nadolol; Ophthalmic Solutions; Potassium; Propranolol; Succinylcholine; Time Factors; Timolol | 1989 |
Design of polyvinyl alcohol hydrogel as a controlled-release vehicle for rectal administration of dl-propranolol-HCl and atenolol.
Topics: Animals; Atenolol; Delayed-Action Preparations; Dogs; Excipients; Gels; Male; Polyvinyl Alcohol; Propranolol; Rats; Rats, Inbred Strains | 1989 |
Effects of beta-adrenoceptor blocking agents on isolated atrial and papillary muscles from experimentally diabetic rats.
Topics: Animals; Atenolol; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glycosylation; Heart Atria; Heart Rate; Hemoglobins; In Vitro Techniques; Isoproterenol; Male; Organ Size; Papillary Muscles; Propranolol; Rats; Rats, Inbred Strains | 1989 |
Modulation of the effects of salbutamol by propranolol and atenolol.
Topics: Adult; Albuterol; Atenolol; Blood Glucose; Blood Pressure; Drug Interactions; Heart Rate; Humans; Male; Potassium; Propranolol | 1989 |
Beta-adrenergic blockade does not influence the thermogenic response to a mixed meal in man.
Topics: Adult; Atenolol; Blood Chemical Analysis; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Metabolism; Humans; Male; Oxygen Consumption; Propranolol | 1989 |
Beta adrenergic blockade with propranolol and atenolol in the exercising dog: evidence for beta 2 adrenoceptors in the sinoatrial node.
Topics: Animals; Atenolol; Cardiac Output; Dogs; Heart Rate; Hemodynamics; Myocardial Contraction; Oxygen Consumption; Physical Exertion; Propranolol; Receptors, Adrenergic, beta; Sinoatrial Node | 1987 |
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms.
Topics: Animals; Antigen-Presenting Cells; Astrocytes; Atenolol; Brain; Bucladesine; Cells, Cultured; Dipyridamole; Gene Expression Regulation; Histocompatibility Antigens Class II; Interferon-gamma; Isoproterenol; Norepinephrine; Phentolamine; Propranolol; Rats; Rats, Inbred Lew; Receptors, Adrenergic, beta | 1988 |
Chronopharmacological study of furosemide in rats: (II). Influence of beta-adrenoceptor blockade.
Topics: Animals; Atenolol; Circadian Rhythm; Diuresis; Furosemide; Male; Natriuresis; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1988 |
Beta blocker overdose with propranolol and with atenolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Female; Glucagon; Humans; Poisoning; Propranolol; Substance-Related Disorders | 1985 |
Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Hypertension, Portal; Male; Portal System; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1985 |
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Drug Tolerance; Female; Heart; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Verapamil | 1985 |
Beta-adrenoreceptors in rat brown adipose tissue: proportions of beta 1- and beta 2-subtypes.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Age Factors; Animals; Atenolol; Binding Sites; Body Temperature Regulation; Dihydroalprenolol; Intracellular Membranes; Lung; Microsomes; Myocardium; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sex Factors; Time Factors | 1985 |
Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Biotransformation; Half-Life; Humans; In Vitro Techniques; Kinetics; Male; Propranolol; Rats; Receptors, Adrenergic, beta; Reticulocytes; Time Factors | 1985 |
Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Metoprolol; Oxprenolol; Propranolol; Surveys and Questionnaires | 1985 |
Effect of beta-adrenergic antagonists on experimentally induced drinking in female rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Butoxamine; Drinking; Female; Hypertonic Solutions; Propranolol; Rats; Rats, Inbred Strains; Sodium Chloride; Stereoisomerism; Water Deprivation | 1985 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol | 1985 |
Exercise training during chronic beta blockade in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Artery Bypass; Female; Heart Rate; Humans; Male; Metoprolol; Myocardial Infarction; Nadolol; Physical Exertion; Propanolamines; Propranolol; Timolol | 1985 |
Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Carteolol; Dogs; In Vitro Techniques; Oxprenolol; Propranolol; Sinoatrial Node; Sotalol | 1985 |
The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Circulation; Blood Pressure; Celiprolol; Dogs; Female; Heart Rate; Male; Mecamylamine; Myocardial Contraction; Propanolamines; Propranolol; Verapamil | 1985 |
Autoregulation of endogenous epinephrine release via presynaptic adrenoceptors in the rat hypothalamic slice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Benzylamines; Butoxamine; Chromatography, High Pressure Liquid; Clonidine; Electric Stimulation; Epinephrine; Homeostasis; Hypothalamus; Isoproterenol; Male; Potassium Chloride; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Sulpiride; Yohimbine | 1985 |
Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Half-Life; Heart Rate; Kinetics; Male; Metoprolol; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Structure-Activity Relationship; Time Factors; Tissue Distribution | 1985 |
Beta-blocker brain concentrations in man.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Brain Chemistry; Cats; Humans; Lipid Metabolism; Metoprolol; Oxprenolol; Propranolol; Rats; Solubility; Species Specificity; Subarachnoid Hemorrhage; Tissue Distribution | 1985 |
Effect of beta-blockers on psychomotor performance in normal volunteers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anxiety; Arousal; Atenolol; Diazepam; Drug Interactions; Electroencephalography; Emotions; Evoked Potentials; False Positive Reactions; Female; Health Planning; Humans; Kinetics; Male; Methyldopa; Metoprolol; Propranolol; Psychometrics; Psychomotor Performance; Reaction Time; Reference Values; Reserpine; Time Factors; Visual Acuity | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1985 |
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Epoprostenol; Humans; Labetalol; Pindolol; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Male; Mathematics; Membrane Fluidity; Metipranolol; Microscopy, Electron; Platelet Aggregation; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Temperature | 1985 |
Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Half-Life; Humans; Kinetics; Lipids; Male; Metoprolol; Propranolol; Solubility; Sotalol | 1985 |
A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Blood Proteins; Female; Half-Life; Humans; Hypertension; Kinetics; Male; Metoprolol; Oxprenolol; Propranolol; Protein Binding | 1985 |
Cardiac beta-adrenoceptor blockade: the quest for selectivity.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cats; Coronary Circulation; Dogs; Drug Evaluation, Preclinical; Heart; Humans; Practolol; Propranolol | 1985 |
Beta-2 adrenergic receptors are not only for circulating catecholamines in ventricular muscles of carp heart (Cyprinus carpio).
Topics: Animals; Atenolol; Carps; Catecholamines; Cyprinidae; Epinephrine; Female; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; Time Factors | 1986 |
[Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol; Time Factors | 1986 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Metaproterenol; Middle Aged; Pindolol; Propranolol | 1986 |
Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Debrisoquin; Genetic Variation; Humans; Hypertension; Isoquinolines; Kinetics; Male; Metoprolol; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Propranolol; Structure-Activity Relationship; Timolol | 1986 |
Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Inflammation; Injections, Intravenous; Male; Metoprolol; Orosomucoid; Oxprenolol; Portal Vein; Propranolol; Protein Binding; Rats; Rats, Inbred Strains | 1986 |
Enzymatic adaptation to physical training under beta-blockade in the rat. Evidence of a beta 2-adrenergic mechanism in skeletal muscle.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Adaptation, Physiological; Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Atenolol; Carnitine O-Palmitoyltransferase; Citrate (si)-Synthase; Electron Transport Complex IV; Fructose-Bisphosphatase; Malate Dehydrogenase; Male; Muscles; Physical Conditioning, Animal; Propranolol; Rats; Rats, Inbred Strains | 1986 |
Regulation of coronary blood flow by counteraction of coronary vascular alpha and beta adrenergic activation during experimental pliable coronary stenosis.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Hemodynamics; Norepinephrine; Phentolamine; Propranolol | 1986 |
The antianxiety effect of beta-blockers on punished responding.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Atenolol; Columbidae; Conditioning, Operant; Electroshock; Propranolol; Punishment; Reinforcement Schedule | 1986 |
Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Butoxamine; Epinephrine; Immunity, Cellular; Isomerism; Isoproterenol; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Norepinephrine; Phentolamine; Propranolol; Receptors, Adrenergic, beta; T-Lymphocytes, Cytotoxic; Terbutaline | 1986 |
Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Metoprolol; Propanolamines; Propranolol | 1986 |
The effect of beta-adrenoreceptor antagonists on the inhibition of pendular movements of rabbit ileum produced by periarterial sympathetic nerve stimulation and some sympathomimetic amines.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Gastrointestinal Motility; Isoproterenol; Muscle, Smooth; Neural Inhibition; Norepinephrine; Propranolol; Rabbits; Sympathetic Nervous System; Synaptic Transmission | 1986 |
Selective beta 1-adrenergic receptor-blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Propranolol; Time Factors | 1987 |
Selective beta-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus.
Topics: 5-Methoxytryptamine; 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Ethanolamines; Hippocampus; In Vitro Techniques; Male; Membranes; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin | 1987 |
Selective manipulation of neurohumoral control of the cardiac pacemaker by drugs given intrapericardially.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; N-Methylscopolamine; Parasympatholytics; Pericardium; Pressoreceptors; Propranolol; Rabbits; Reflex; Scopolamine Derivatives | 1987 |
Beta-blockers: a new therapeutic approach to Raynaud's disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Cold Temperature; Humans; Propranolol; Raynaud Disease; Vasoconstriction | 1987 |
Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Atenolol; Dreams; Female; Hallucinations; Humans; Male; Melatonin; Metoprolol; Middle Aged; Propranolol | 1987 |
Comparison of hemodynamic responses to isoproterenol infusion and surgical stress in patients given cardioselective and noncardioselective beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Atenolol; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Evaluation; Heart; Heart Rate; Hemodynamics; Humans; Isoproterenol; Metoprolol; Propranolol; Receptors, Adrenergic, beta; Stimulation, Chemical; Stress, Physiological; Time Factors | 1987 |
The effect of beta-adrenoceptor blockers on the absorption and excretion of chlorothiazide in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chlorothiazide; Half-Life; Humans; Male; Pindolol; Propranolol | 1987 |
Synergistic action of postsynaptic alpha-adrenergic receptor stimulation on vasoactive intestinal polypeptide-induced increases in pineal N-acetyltransferase activity.
Topics: Acetyltransferases; Adrenergic alpha-Agonists; Animals; Arylamine N-Acetyltransferase; Atenolol; Clonidine; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Male; Methoxamine; Phenoxybenzamine; Phentolamine; Phenylephrine; Pineal Gland; Prazosin; Propranolol; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha; Vasoactive Intestinal Peptide; Yohimbine | 1987 |
[Lipoprotein metabolism and beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol, HDL; Humans; Hyperlipoproteinemias; Lipoproteins; Metoprolol; Propranolol; Risk; Triglycerides | 1987 |
Comparison of the effect of beta adrenergic antagonists with different ancillary properties on isolated canine and human coronary arteries.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzeneacetamides; Child; Child, Preschool; Coronary Vessels; Dogs; Humans; Infant; Isoproterenol; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1987 |
Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Apolipoproteins; Atenolol; Humans; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Male; Nadolol; Pindolol; Propranolol | 1987 |
Myocardial flow and function after regional beta-blockade in exercising dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Flow Velocity; Coronary Circulation; Dogs; Heart; Myocardial Contraction; Physical Exertion; Propanolamines; Propranolol | 1987 |
A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol | 1987 |
Analysis of the tachycardiac response to 5-hydroxytryptamine in the spinal guinea-pig.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Decerebrate State; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Piperidines; Propranolol; Reserpine; Serotonin; Serotonin Antagonists; Tyramine | 1988 |
[Correlations between beta blockers and the induction of psoriasis].
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Humans; Male; Metoprolol; Middle Aged; Propranolol; Psoriasis | 1987 |
Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Aged; Aorta, Abdominal; Aortic Aneurysm; Atenolol; Female; Humans; Male; Metoprolol; Propranolol; Retrospective Studies; Ultrasonography | 1988 |
Effects of cardioselective beta blockade on the peripheral lung in guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bronchi; Dose-Response Relationship, Drug; Drug Synergism; Guinea Pigs; Heart Rate; Histamine; Isoproterenol; Lung; Lung Compliance; Propanolamines; Propranolol | 1988 |
Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.
Topics: Adrenergic beta-Antagonists; Atenolol; Celiprolol; Female; Humans; In Vitro Techniques; Labetalol; Maternal-Fetal Exchange; Placenta; Pregnancy; Propanolamines; Propranolol; Timolol | 1988 |
Effects of beta-adrenergic agents in lungs of normal and air-embolized awake sheep.
Topics: Adrenergic beta-Agonists; Animals; Atenolol; Blood Pressure; Blood Proteins; Cardiac Output; Embolism, Air; Female; Lung; Lymph; Nadolol; Propranolol; Proteins; Pulmonary Circulation; Reference Values; Sheep | 1988 |
Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys.
Topics: Adrenergic beta-Antagonists; Angiotensins; Atenolol; Humans; Hypertension, Renal; Kidney; Kidney Transplantation; Metoprolol; Nephrectomy; Propranolol; Renin; Retrospective Studies | 1988 |
Beta-adrenergic receptor stimulation induces inositol trisphosphate production and Ca2+ mobilization in rat parotid acinar cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Antagonists; Animals; Atenolol; Calcium; Carbachol; Cyclic AMP; Cytosol; Egtazic Acid; Enkephalins; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Isoproterenol; Male; Parotid Gland; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Propanolamines; Propranolol; Protein Precursors; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sugar Phosphates | 1988 |
Beta-adrenoceptor stimulation enhances transmitter output from the rat phrenic nerve.
Topics: Animals; Atenolol; In Vitro Techniques; Isoproterenol; Neurotransmitter Agents; Norepinephrine; Phrenic Nerve; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1988 |
Effects of atenolol and some other beta-adrenoceptor blocking agents on norepinephrine-induced responses in isolated and perfused rat hearts.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Heart Rate; In Vitro Techniques; Male; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Timolol | 1988 |
Demonstration of beta 1-adrenoceptor mediating relaxation of porcine coronary artery by radioligand binding and pharmacological methods.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Coronary Vessels; Dihydroalprenolol; In Vitro Techniques; Kinetics; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Practolol; Propanolamines; Propranolol; Prostaglandin Endoperoxides, Synthetic; Receptors, Adrenergic, beta; Swine | 1988 |
Beta blockers inhibit fetal thromboxane A2 production in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Labetalol; Metoprolol; Pregnancy; Propranolol; Thromboxane A2 | 1988 |
Hypothalamic alpha-adrenergic blockade modifies drinking and blood pressure responses to central angiotensin II in conscious rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Atenolol; Blood Pressure; Cerebral Ventricles; Drinking Behavior; Hippocampus; Injections, Intraventricular; Male; Phentolamine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Reference Values; Yohimbine | 1988 |
Pressor response to beta 1- and beta 2-blockers in conscious rats treated with phentolamine.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Catecholamines; Dose-Response Relationship, Drug; Heart Rate; Male; Phentolamine; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1988 |
Comparative study of the effects of acebutolol, atenolol, d-propranolol and dl,-propranolol on the alterations in energy metabolism caused by ischemia and reperfusion: a 31P NMR study on the isolated rat heart.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Disease; Energy Metabolism; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Reperfusion; Myocardium; Propranolol; Rats | 1988 |
Amelioration by beta-adrenergic blockade of regional myocardial dysfunction induced by coronary artery occlusion after, but not before collateral development in conscious dogs.
Topics: Animals; Atenolol; Collateral Circulation; Coronary Disease; Dogs; Hemodynamics; Myocardial Contraction; Propranolol; Time Factors | 1989 |
A skeletal muscle ventricle made from rectus abdominis muscle in the dog.
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Dogs; Heart Ventricles; Muscles; Propranolol | 1989 |
The mechanisms of action of noradrenaline on ouabain-sensitive rubidium uptake in guinea-pig myocardium.
Topics: Animals; Atenolol; Dose-Response Relationship, Drug; Guinea Pigs; Heart; In Vitro Techniques; Myocardium; Norepinephrine; Ouabain; Phentolamine; Potassium; Propranolol; Rubidium; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical | 1985 |
The role of presynaptic beta-receptors in Raynaud's disease.
Topics: Adult; Atenolol; Feedback; Female; Humans; Isoproterenol; Male; Middle Aged; Propranolol; Raynaud Disease; Receptors, Adrenergic, beta; Synaptic Membranes | 1985 |
Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats.
Topics: Anesthesia; Animals; Atenolol; Bisoprolol; Blood Pressure; Bronchi; Cardiovascular Physiological Phenomena; Cardiovascular System; Cats; Female; Heart Rate; Isoproterenol; Male; Muscle Contraction; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Respiration | 1986 |
Reflex vagal withdrawal and the hemodynamic response to intravenous isoproterenol in the presence of beta-antagonists.
Topics: Atenolol; Blood Pressure; Drug Interactions; Female; Heart Rate; Humans; Infusions, Parenteral; Injections, Intravenous; Isoproterenol; Male; Physical Exertion; Propranolol; Random Allocation; Receptors, Adrenergic, beta | 1986 |
Evidence of beta-adrenergic involvement in forced swimming-induced behavioural despair of mice.
Topics: Animals; Atenolol; Behavior, Animal; Female; Imipramine; Immobilization; Isoproterenol; Male; Metoprolol; Mice; Physical Exertion; Propranolol; Receptors, Adrenergic, beta; Reserpine; Stress, Psychological; Swimming | 1987 |
Beta-adrenoceptors in human tracheal smooth muscle: characteristics of binding and relaxation.
Topics: Atenolol; Binding, Competitive; Humans; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Pindolol; Propranolol; Receptors, Adrenergic, beta; Sarcolemma; Stereoisomerism; Trachea | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolol; Propranolol; Renin; Time Factors; Vasodilation | 1988 |
Beta-blockers, mood and behaviour.
Topics: Adult; Affect; Atenolol; Humans; Male; Memory, Short-Term; Oxazepam; Propranolol; Psychomotor Performance | 1988 |
More commonly prescribed medications.
Topics: Alprazolam; Atenolol; Dental Care; Drug Therapy; Furosemide; Humans; Ibuprofen; Propranolol | 1988 |
The effect of beta adrenergic blockade on the carotid body response to hyperkalaemia in the cat.
Topics: Animals; Atenolol; Carotid Body; Cats; Dose-Response Relationship, Drug; Hyperkalemia; Hypoxia; Potassium; Propranolol; Time Factors | 1988 |
Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.
Topics: Animals; Atenolol; Coronary Circulation; Dogs; Drug Interactions; Female; Heart; Heart Rate; Isomerism; Isoproterenol; Lidocaine; Male; Propranolol | 1987 |
Beta-blockade after myocardial infarction: is prolonged treatment feasible?
Topics: Adult; Aged; Atenolol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Time Factors | 1987 |
Hypersomnolence with beta-adrenergic blockers.
Topics: Aged; Atenolol; Disorders of Excessive Somnolence; Humans; Hypertension; Male; Propranolol; Sleep Wake Disorders | 1987 |
[Medical therapy of portal hypertension].
Topics: Atenolol; Cardiac Output; Humans; Hypertension, Portal; Metoprolol; Propranolol | 1986 |
Effects of antiglaucoma drugs on [32P]orthophosphate incorporation into phospholipids of cat iris and ciliary process.
Topics: Animals; Atenolol; Carbachol; Cats; Ciliary Body; Intraocular Pressure; Iris; Phosphates; Phospholipids; Pilocarpine; Propranolol; Timolol | 1985 |
Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes.
Topics: Animals; Atenolol; Calcium; Cerebral Cortex; Cesium; Hydroxydopamines; In Vitro Techniques; Lithium; Male; Membrane Potentials; Neuromuscular Depolarizing Agents; Norepinephrine; Oxidopamine; Potassium; Propranolol; Rats; Rubidium; Synaptosomes; Tetrodotoxin; Time Factors; Veratridine | 1985 |
Role of catecholamines in calcitonin-induced analgesia.
Topics: Analgesics; Animals; Atenolol; Calcitonin; Catecholamines; Hydroxydopamines; Injections, Intraventricular; Male; Norepinephrine; Oxidopamine; Pain; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Sensory Thresholds; Time Factors | 1985 |
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Atenolol; Collagen; Drug Synergism; Epoprostenol; Humans; Labetalol; Pindolol; Platelet Aggregation; Propranolol; Solubility; Sympatholytics | 1985 |
Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
Topics: Adult; Atenolol; Cardiac Output; Depression, Chemical; Female; Half-Life; Hemodynamics; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Propranolol; Venous Pressure | 1985 |
Platelet adhesion in hyperlipidemic and hypertensive patients.
Topics: Adult; Arteriosclerosis; Atenolol; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hypertension; Middle Aged; Platelet Adhesiveness; Propranolol; Time Factors | 1985 |
beta-Adrenoceptor blockade spares chemoreceptor responsiveness to hypoxia.
Topics: Animals; Atenolol; Carotid Body; Cats; Female; Hypoxia; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1984 |
Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cyclic AMP; Epinephrine; In Vitro Techniques; Isoproterenol; Kidney Tubules; Propranolol; Rats; Sotalol; Thyroxine; Triiodothyronine | 1980 |
Cardioselective beta-adrenoceptor blocking actions of some 2-methoxyphenylethanolamines in guinea pig tissues.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Isoproterenol; Phenethylamines; Propranolol; Trachea | 1980 |
Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Blood Chemical Analysis; Blood Gas Analysis; Blood Pressure; Double-Blind Method; Heart; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physical Endurance; Physical Exertion; Potassium; Propranolol; Renin | 1980 |
Failure of isoprenaline and beta-receptor blocking drugs to modify depressor response and bradycardia induced by electrical stimulation of the anterior hypothalamus of cats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Butoxamine; Cats; Electric Stimulation; Female; Heart Rate; Hypothalamus; Hypothalamus, Anterior; Isoproterenol; Male; Propranolol; Time Factors | 1980 |
Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Aqueous Humor; Atenolol; Carbon Radioisotopes; Ciliary Body; Cornea; Eye; Female; Iris; Male; Metoprolol; Nictitating Membrane; Propranolol; Rabbits; Timolol; Tritium | 1980 |
Protective effects of beta-adrenergic blockade in isolated ischemic hearts.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium; Cats; Coronary Disease; Heart; In Vitro Techniques; Microscopy, Electron; Myocardium; Propranolol; Receptors, Adrenergic, beta | 1980 |
[Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Female; Guinea Pigs; Heart; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Propanolamines; Propranolol; Stimulation, Chemical; Trachea | 1980 |
Interaction of cimetidine with metoprolol, propranolol, or atenolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Interactions; Humans; Metoprolol; Propanolamines; Propranolol | 1981 |
Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Female; Half-Life; Male; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Time Factors | 1981 |
Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Central Nervous System; Central Nervous System Diseases; Female; Humans; Male; Middle Aged; Pindolol; Propanolamines; Propranolol | 1981 |
A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiovascular System; Female; Heart Rate; Isoproterenol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Sotalol | 1981 |
Perverse T waves and chronic beta-blocker treatment.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Electrocardiography; Humans; Male; Middle Aged; Propranolol | 1982 |
Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dogs; Female; Heart; Heart Rate; Male; Membranes; Myocardial Infarction; Nadolol; Propanolamines; Propranolol | 1981 |
Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Fluorenes; Heart Rate; Isoproterenol; Male; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1981 |
Atenolol: a long-acting beta 1- adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Hypertension; Kinetics; Propanolamines; Propranolol | 1982 |
Inhibition in vitro of yeast DNA polymerase I activity by beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Carcinogens; Cell-Free System; DNA Polymerase I; Nucleic Acid Synthesis Inhibitors; Propanolamines; Propranolol; Saccharomyces cerevisiae; Structure-Activity Relationship | 1982 |
Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.
Topics: Adrenergic beta-Antagonists; Atenolol; Cell Membrane; Cells, Cultured; DNA; Humans; In Vitro Techniques; Lymphocytes; Phytohemagglutinins; Pokeweed Mitogens; Propranolol; Thymidine | 1982 |
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroidism; Oxprenolol; Propranolol; Substance Withdrawal Syndrome; Valsalva Maneuver | 1981 |
Withdrawal of beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Physical Exertion; Pindolol; Propranolol; Substance Withdrawal Syndrome; Sympathomimetics | 1982 |
Can ISA compensate for bradycardia due to beta-adrenoceptor blockade?
Topics: Adrenergic beta-Antagonists; Atenolol; Heart Rate; Humans; Pindolol; Propranolol; Sympathomimetics | 1982 |
Managing angina with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propanolamines; Propranolol; Timolol | 1982 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Treatment of hypertension with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Male; Propranolol | 1982 |
The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Atenolol; Coronary Circulation; Coronary Disease; Isoproterenol; Metoprolol; Perfusion; Phentolamine; Prazosin; Propranolol; Rats; Time Factors; Ventricular Fibrillation; Yohimbine | 1983 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Metoprolol; Oxprenolol; Propranolol | 1983 |
Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Humans; Hyperthyroidism; Metoprolol; Middle Aged; Propranolol; Sotalol; Triiodothyronine; Triiodothyronine, Reverse | 1983 |
Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzeneacetamides; Blood Glucose; Blood Pressure; Dogs; Fatty Acids, Nonesterified; Heart Rate; Hemodynamics; Insulin; Isoproterenol; Lactates; Lactic Acid; Male; Propanolamines; Propranolol | 1983 |
Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; In Vitro Techniques; Male; Pindolol; Platelet Aggregation; Procaine; Propranolol; Verapamil | 1983 |
A comparative study of the acute effects of cetamolol (AI-27,303), atenolol, propranolol, and dexpropranolol on blood pressure, sympathetic nerve and ganglion activity of cats.
Topics: Acetamides; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cats; Female; Ganglia, Sympathetic; Male; Propranolol; Sympathetic Nervous System | 1983 |
[Effect of beta-adrenoblockers on prostaglandin-induced ocular hypertension in rabbits].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dinoprostone; Male; Ocular Hypertension; Oxprenolol; Propanolamines; Propranolol; Prostaglandins E; Rabbits; Timolol | 1983 |
[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Echocardiography; Exercise Test; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1983 |
In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity.
Topics: Acetamides; Adrenergic beta-Antagonists; Animals; Atenolol; Guinea Pigs; Male; Myocardial Contraction; Propranolol; Rats; Receptors, Adrenergic, beta | 1983 |
Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Diuretics; Female; Furosemide; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Systole | 1983 |
Facilitation of calcium blocking and membrane effects by intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Agonists; Animals; Atenolol; Calcium; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; In Vitro Techniques; Myocardial Contraction; Propanolamines; Propranolol; Verapamil; Xamoterol | 1984 |
Effects of acute and chronic treatments with atenolol and propranolol on cardiovascular responses to handling stress in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Handling, Psychological; Hemodynamics; Hypertension; Male; Propranolol; Rats; Rats, Inbred Strains; Stress, Physiological; Time Factors | 1983 |
Which beta-blocker for the restless leg?
Topics: Adult; Atenolol; Humans; Male; Propranolol; Restless Legs Syndrome; Vomiting | 1984 |
Beta-blockers in isoproterenol-enhanced essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Humans; Isoproterenol; Metoprolol; Middle Aged; Propranolol; Timolol; Tremor | 1984 |
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Male; Nadolol; Propanolamines; Propranolol; Sotalol; Ventricular Fibrillation | 1984 |
Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Cardiac Output; Coronary Circulation; Male; Myocardium; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Tritium | 1984 |
Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Alprenolol; Animals; Atenolol; Dihydroalprenolol; Dose-Response Relationship, Drug; Female; Myometrium; Pregnancy; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Sheep; Uterine Contraction | 1984 |
Vagus- and post-acetylcholine-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockade.
Topics: Acetylcholine; Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Conduction System; Heart Rate; Heart Ventricles; Male; Propranolol; Vagus Nerve; Ventricular Function | 1984 |
The use of Doppler ultrasound techniques to study the effects of isoprenaline and beta-adrenoceptor blocking drugs on peripheral blood vessels in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Flow Velocity; Double-Blind Method; Femoral Artery; Heart Rate; Humans; Isoproterenol; Male; Propranolol; Random Allocation; Regional Blood Flow; Ultrasonography | 1984 |
Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions.
Topics: 7-Alkoxycoumarin O-Dealkylase; Adrenergic beta-Antagonists; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Cytochrome P-450 CYP1A1; Disopyramide; In Vitro Techniques; Microsomes, Liver; Oxidoreductases; Oxygenases; Pharmaceutical Preparations; Propranolol; Rats; Solubility | 1984 |
Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Drug Interactions; Humans; Kinetics; Male; Metoprolol; Nifedipine; Propranolol | 1984 |
Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Drug Interactions; Female; Half-Life; Heart Diseases; Heart Rate; Humans; Kinetics; Male; Metoprolol; Propranolol; Verapamil | 1984 |
The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Cimetidine; Drug Interactions; Histamine H2 Antagonists; Humans; Kinetics; Metoprolol; Penbutolol; Pindolol; Propranolol; Ranitidine | 1984 |
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.
Topics: Adrenergic beta-Antagonists; Atenolol; Biological Availability; Drug Interactions; Humans; Kinetics; Male; Metoprolol; Propranolol; Warfarin | 1984 |
The interaction of cigarette smoking and beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Atenolol; Double-Blind Method; Heart Rate; Humans; Physical Exertion; Propranolol; Smoking | 1984 |
[Role of transmembrane ion currents in the mechanism of action of beta-adrenoblockers].
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart; Ion Channels; Labetalol; Oxprenolol; Pindolol; Propranolol; Rana ridibunda | 1984 |
Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Topics: Acetamides; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Cats; Coronary Circulation; Dogs; Hemodynamics; Isoproterenol; Macaca mulatta; Membranes; Myocardium; Nadolol; Organ Specificity; Oxygen Consumption; Pindolol; Propanolamines; Propranolol; Stroke Volume; Vascular Resistance | 1984 |
Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dithiothreitol; Liver; Male; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Timolol; Triiodothyronine | 1984 |
Effect of beta-adrenergic blockade on nucleoside release from the hypoperfused isolated heart.
Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Guinea Pigs; Heart; Inosine; Male; Myocardium; Norepinephrine; Nucleosides; Oxygen Consumption; Perfusion; Propranolol; Regional Blood Flow; Time Factors | 1984 |
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cholesterol, HDL; Ether; Lipase; Liver; Male; Metoprolol; Norepinephrine; Prazosin; Propranolol; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1984 |
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Female; Fingers; Heart Rate; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Isoproterenol; Male; Practolol; Propranolol; Sotalol; Tremor | 1984 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Proteins; Drug Interactions; Female; Humans; Lidocaine; Male; Metoprolol; Oxidation-Reduction; Propranolol; Protein Binding; Tolbutamide | 1984 |
Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Male; Nadolol; Propanolamines; Propranolol; Renin | 1984 |
Beta-blockers in thyrotoxicosis.
Topics: Antithyroid Agents; Atenolol; Humans; Hyperthyroidism; Metabolic Clearance Rate; Practolol; Propanolamines; Propranolol; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse | 1980 |
Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats.
Topics: Animals; Aorta; Atenolol; Heart Ventricles; Hydralazine; Hypertension; Male; Norepinephrine; Organ Size; Phentolamine; Propanolamines; Propranolol; Protein Biosynthesis; Rats; RNA | 1980 |
Lanthanum staining of coronary microvascular endothelium: effects of ischemia reperfusion, propranolol, and atenolol.
Topics: Animals; Atenolol; Capillaries; Cats; Coronary Vessels; Endothelium; Ischemia; Lanthanum; Microcirculation; Perfusion; Propanolamines; Propranolol; Staining and Labeling | 1981 |
Degeneration secretion of amylase from the parotid gland of the rat.
Topics: Amylases; Animals; Atenolol; Dihydroergotamine; Male; Nerve Degeneration; Parotid Gland; Propranolol; Rats; Rats, Inbred Strains; Saliva | 1982 |
Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Butoxamine; Ethanolamines; Fenoterol; Histamine Release; Humans; In Vitro Techniques; Leukotriene E4; Lung; Propranolol; SRS-A | 1983 |
Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists.
Topics: Animals; Atenolol; Body Water; Cardiomegaly; Female; Heart Atria; Heart Ventricles; Hypoxia; Male; Myocardium; Organ Size; Propanolamines; Propranolol; Rabbits | 1982 |
Pharmacological evidence for differences in the beta-adrenoceptor populations influencing atrial rate in guinea pig and cat.
Topics: Animals; Atenolol; Cats; Fenoterol; Guinea Pigs; Heart Atria; Heart Rate; Norepinephrine; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1980 |
Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
Topics: Adult; Aged; Atenolol; Cyclic AMP; Female; Humans; Hyperthyroidism; Male; Middle Aged; Posture; Propanolamines; Propranolol; Thyroxine; Triiodothyronine | 1980 |
Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation.
Topics: Animals; Atenolol; Blood Pressure; Butoxamine; Dogs; Electric Stimulation; Female; Glomerular Filtration Rate; Kidney; Male; Natriuresis; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin | 1981 |
Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission.
Topics: Animals; Atenolol; Bretylium Compounds; Bretylium Tosylate; Guanethidine; Guinea Pigs; Ileum; Male; Propanolamines; Propranolol; Pulmonary Artery; Rabbits; Stereoisomerism; Sympathetic Nervous System; Synaptic Transmission; Tetracaine; Vas Deferens | 1981 |
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.
Topics: Adenosine Triphosphate; Animals; Atenolol; Coronary Disease; Cyclic AMP; Heart; Male; Myocardium; Phosphates; Phosphocreatine; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Stereoisomerism; Ventricular Fibrillation | 1981 |
[Use of a simplified exercise test in the study of a beta-blocker].
Topics: Adult; Atenolol; Exercise Test; Heart Rate; Humans; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1982 |
A comparative study of beta-adrenoceptors in human and porcine lung parenchyma strip.
Topics: Animals; Atenolol; Epinephrine; Humans; In Vitro Techniques; Isoproterenol; Lung; Norepinephrine; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Species Specificity; Swine | 1982 |
Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Cyclic AMP; Female; Heart Rate; Humans; Hypertension; Male; Propanolamines; Propranolol; Stress, Psychological | 1982 |
The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo.
Topics: Animals; Atenolol; Blood Vessels; Female; Heart; Hemodynamics; Hypertension; Isoproterenol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1982 |
Evidence for cardiac beta 2-adrenoceptors in man.
Topics: Adult; Atenolol; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Isoproterenol; Male; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1983 |
Classification of beta-adrenoceptors in isolated bronchus of the pig.
Topics: Animals; Atenolol; Bronchi; Catechols; Drug Interactions; Epinephrine; In Vitro Techniques; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Swine | 1983 |
The role of beta- and alpha-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat.
Topics: Albuterol; Animals; Atenolol; Cats; Clonidine; Male; Metoprolol; Phentolamine; Practolol; Prazosin; Prenalterol; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sleep Stages | 1983 |
Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
Topics: Adult; Aged; Aldosterone; Atenolol; Female; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Propranolol; Receptors, Adrenergic, beta; Renal Dialysis | 1983 |
Adrenaline involvement in the presynaptic beta-adrenoceptor-mediated mechanism of dopamine release from slices of the rat hypothalamus.
Topics: Action Potentials; Albuterol; Animals; Atenolol; Butoxamine; Chromatography, High Pressure Liquid; Dopamine; Epinephrine; Hypothalamus; Isoproterenol; Male; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta; Tetrodotoxin | 1984 |
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
Topics: Adult; Atenolol; Drug Interactions; Factor VII; Heart Rate; Humans; Kinetics; Male; Metoprolol; Propranolol; Prothrombin Time; Receptors, Adrenergic, beta; Warfarin | 1984 |
Effects of nonselective and beta-1-selective blockade on glucose metabolism and hormone responses during insulin-induced hypoglycemia in normal man.
Topics: Adult; Atenolol; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin; Kinetics; Male; Norepinephrine; Prolactin; Propanolamines; Propranolol | 1983 |
Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog.
Topics: Animals; Atenolol; Dogs; Electric Stimulation; Female; Kidney; Male; Natriuresis; Phentolamine; Prazosin; Propranolol; Receptors, Adrenergic; Renin | 1983 |
[Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina].
Topics: Adult; Angina Pectoris; Atenolol; Drug Evaluation; Echocardiography; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Propranolol | 1984 |
Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.
Topics: Adult; Atenolol; Drug Interactions; Female; Glipizide; Humans; Isoindoles; Kinetics; Male; Phenylbutyrates; Propranolol; Sulfonylurea Compounds | 1984 |
[Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
Topics: Adult; Atenolol; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Propranolol; Renin-Angiotensin System | 1984 |
Flurbiprofen interaction with single doses of atenolol and propranolol.
Topics: Adult; Aldosterone; Atenolol; Blood Pressure; Body Weight; Female; Flurbiprofen; Heart Rate; Humans; Hypertension; Kinetics; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Propionates; Propranolol | 1984 |
Inhibition by propranolol of the contractile response of the rat diaphragm to tetanic field stimulation in vitro.
Topics: Animals; Atenolol; Diaphragm; Electric Stimulation; In Vitro Techniques; Isoproterenol; Lidocaine; Male; Muscle Contraction; Propranolol; Rats; Rats, Inbred Strains; Stereoisomerism; Tubocurarine | 1983 |
Propranolol-induced depression: mechanism and management.
Topics: Adult; Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1983 |
Effect of propranolol, practolol and atenolol on human platelet thromboxane formation and plasma levels of prostaglandins 6-keto-F1 alpha and E2.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Atenolol; Blood Platelets; Blood Pressure; Dinoprostone; Female; Heart Rate; Humans; Male; Middle Aged; Practolol; Propranolol; Prostaglandins E; Thromboxane B2; Thromboxanes | 1984 |
Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Lactates; Lactic Acid; Lipolysis; Male; Physical Exertion; Practolol; Propranolol | 1983 |
[Effects of propranolol and atenolol on the rat kidney].
Topics: Animals; Atenolol; Chlorine; Diuretics; Dose-Response Relationship, Drug; Kidney; Male; Natriuresis; Potassium; Propranolol; Rats; Rats, Inbred Strains | 1983 |
[Behavior of the arterial pressure in patients taking atenolol and propranolol under the influence of alcohol].
Topics: Alcohol Drinking; Atenolol; Blood Pressure; Female; Humans; Hypertension; Male; Propranolol | 1983 |
The action of beta-adrenoceptor antagonists on rat heart mitochondrial function in vitro: a comparison of propranolol, timolol, and atenolol.
Topics: Animals; Atenolol; Depression, Chemical; Electron Transport; Male; Mitochondria, Heart; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Oxygen Consumption; Propranolol; Rats; Rats, Inbred Strains; Submitochondrial Particles; Timolol | 1984 |
Lack of pharmacokinetic interaction between isosorbide dinitrate and the beta-adrenergic receptor blockers atenolol and propranolol.
Topics: Adult; Atenolol; Drug Interactions; Female; Humans; Isosorbide Dinitrate; Kinetics; Male; Middle Aged; Propranolol | 1984 |
Propranolol, atenolol, and trifluoperazine reduce the spontaneous occurrence of meiotic diploid products in Saccharomyces cerevisiae.
Topics: Atenolol; Caffeine; Diploidy; Propanolamines; Propranolol; Saccharomyces cerevisiae; Spores, Fungal; Trifluoperazine | 1982 |
[Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Catecholamines; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Hypoglycemia; Insulin; Male; Premedication; Propanolamines; Propranolol | 1982 |
Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Depression, Chemical; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Myocardial Contraction; Propanolamines; Propranolol; Renin; Systole | 1982 |
The interaction of cimetidine with metoprolol, atenolol, propranolol, pindolol and penbutolol.
Topics: Atenolol; Biological Availability; Cimetidine; Drug Interactions; Guanidines; Humans; Metoprolol; Penbutolol; Pindolol; Propanolamines; Propranolol | 1983 |
[Effect of atenolol and propranolol on systemic and regional hemodynamics].
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Coronary Circulation; Hemodynamics; Male; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Vascular Resistance | 1983 |
Mechanism of constriction of large coronary arteries by beta-adrenergic receptor blockade.
Topics: Animals; Arteries; Atenolol; Coronary Circulation; Coronary Vessels; Dogs; Female; Hemodynamics; Male; Phentolamine; Prazosin; Propanolamines; Propranolol; Vascular Resistance; Vasoconstriction | 1983 |
Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Topics: Adult; Aged; Atenolol; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Pindolol; Propanolamines; Propranolol | 1980 |
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hypertension; Male; Propanolamines; Propranolol; Rats; Renin | 1980 |
Cardiac dynamics during hemorrhage. Relative unimportance of adrenergic inotropic responses.
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Cardiac Volume; Dogs; Epinephrine; Female; Heart Rate; Hemorrhage; Isoproterenol; Male; Myocardial Contraction; Norepinephrine; Propranolol; Sympathetic Nervous System | 1982 |
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Topics: Administration, Oral; Atenolol; Female; Humans; Hyperthyroidism; Kinetics; Male; Metabolic Clearance Rate; Methimazole; Metoprolol; Middle Aged; Propanolamines; Propranolol | 1982 |
High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.
Topics: Animals; Atenolol; Brain Chemistry; Chromatography, High Pressure Liquid; Male; Metoprolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Tissue Distribution | 1982 |
The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.
Topics: Adult; Antipyrine; Atenolol; Drug Interactions; Female; Half-Life; Humans; Kinetics; Labetalol; Male; Propranolol; Sympatholytics | 1982 |
A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Desoxycorticosterone; Hypertension; Hypertension, Renal; Propanolamines; Propranolol; Rats; Sodium Chloride | 1982 |
Substitution of atenolol for propranolol in a case of propranolol-related depression.
Topics: Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Imipramine; Middle Aged; Myocardial Infarction; Propanolamines; Propranolol | 1982 |
Atenolol vs. propranolol in essential tremor. A controlled, quantitative study.
Topics: Adult; Aged; Atenolol; Double-Blind Method; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol; Random Allocation; Tremor | 1982 |
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
Topics: Adult; Atenolol; Cimetidine; Drug Interactions; Guanidines; Humans; Kinetics; Male; Metoprolol; Propanolamines; Propranolol | 1982 |
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremia.
Topics: Adult; Aged; Atenolol; Bicarbonates; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Propanolamines; Propranolol; Uremia | 1982 |
Relaxation of isolated dog coronary artery induced by propranolol.
Topics: Animals; Atenolol; Coronary Vessels; Dogs; Female; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium; Propranolol | 1981 |
Chronic dog intestinal loop model for studying drug absorption as exemplified by beta-adrenoreceptor blocking agents, atenolol and propranolol.
Topics: Animals; Atenolol; Dogs; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Models, Biological; Propanolamines; Propranolol | 1981 |
A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
Topics: Adult; Atenolol; Blood Pressure; Catecholamines; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Propanolamines; Propranolol; Substance Withdrawal Syndrome | 1981 |
[Effect of propranolol and atenolol on peripheral tissue blood flow and effective plasma flow through the kidneys].
Topics: Adult; Atenolol; Blood Circulation; Humans; Hypertension; Leg; Male; Neurocirculatory Asthenia; Plasma; Propanolamines; Propranolol; Renal Circulation | 1981 |
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Topics: Adolescent; Adult; Aged; Atenolol; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Plasma; Propanolamines; Propranolol | 1981 |
Evaluation of effect of drugs on the exercise ECG.
Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil | 1981 |
Blockers of beta and H2 receptors and secondary hyperparathyroidism in uraemia.
Topics: Adult; Aged; Atenolol; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Hormone; Propanolamines; Propranolol; Uremia | 1981 |
Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.
Topics: Animals; Atenolol; Chlorisondamine; Circadian Rhythm; Half-Life; In Vitro Techniques; Male; Myocardium; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Rats | 1980 |
beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
Topics: Atenolol; Blood-Brain Barrier; Brain; Humans; Kinetics; Metoprolol; Propanolamines; Propranolol | 1980 |
Pharmacology of histamine liberation. Cationic amphiphilic drugs and mast cells.
Topics: Animals; Atenolol; Histamine Release; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Propranolol; Rats; Rats, Wistar; Temperature; Time Factors | 1994 |
Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Atenolol; Atropine; Autonomic Nervous System; Bronchoconstriction; Electric Stimulation; Ethanolamines; Formoterol Fumarate; Guinea Pigs; In Vitro Techniques; Isometric Contraction; Male; Muscle Contraction; Phentolamine; Propanolamines; Propranolol; Substance P | 1993 |
Beta-adrenergic stimulation and cAMP mobilize Ca2+ from an IP3-insensitive pool in rat submandibular granular ducts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Alkaloids; Animals; Atenolol; Atropine; Calcium; Carbachol; Cyclic AMP; Epinephrine; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Isoproterenol; Isoquinolines; Kinetics; Male; Phentolamine; Piperazines; Propanolamines; Propranolol; Protein Kinase C; Protein Kinase Inhibitors; Putrescine; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Staurosporine; Submandibular Gland | 1993 |
Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cerebral Cortex; Dihydroalprenolol; Down-Regulation; Drinking; Hypertension; Immobilization; Male; Prazosin; Propranolol; Rats; Rats, Wistar; Stress, Psychological; Weight Gain | 1995 |
Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity.
Topics: Animals; Aorta, Thoracic; Aortic Aneurysm; Atenolol; Blood Pressure; Heart Rate; Male; Mice; Mice, Mutant Strains; Nadolol; Propranolol; Protein-Lysine 6-Oxidase | 1995 |
Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Animals; Atenolol; Body Temperature; Deoxyglucose; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Insulin; Male; Muscle, Skeletal; Phenethylamines; Propanolamines; Propranolol; Rats; Rats, Wistar | 1995 |
Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Atenolol; Cocaine; Injections, Intraperitoneal; Male; Morphine Dependence; Propranolol; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Hemodynamic responses to selective blockade of beta 2- and beta 1-adrenoceptors in conscious rats with cirrhosis.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Combinations; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Biliary; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley | 1994 |
Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Benzopyrans; Blood Pressure; Cardiovascular Physiological Phenomena; Diltiazem; Ethanolamines; Exercise; Exercise Test; Fatigue; Glycolysis; Humans; Male; Muscle Contraction; Muscles; Myocardial Contraction; Nebivolol; Propranolol; Time Factors | 1993 |
Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Avoidance Learning; Male; Naloxone; Narcotics; Propranolol; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1993 |
Beta 1 adrenoceptor mediated decrease in pHi in quiescent ventricular myocardium.
Topics: Adrenergic beta-Antagonists; Amiloride; Animals; Atenolol; Colforsin; Culture Techniques; Female; Guinea Pigs; Heart Ventricles; Hydrogen-Ion Concentration; Isoproterenol; Male; Membrane Potentials; Myocardium; Phenylephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Stimulation, Chemical | 1994 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.
Topics: Animals; Atenolol; Body Weight; Carcinogens; Diethylnitrosamine; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Precancerous Conditions; Propranolol; Rats; Rats, Inbred F344; Sex Factors | 1994 |
Studies on the glycemic and lipidemic effect of atenolol and propranolol in normal and diabetic rats.
Topics: Animals; Atenolol; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Glyburide; Insulin; Lipids; Male; Propranolol; Rats; Rats, Sprague-Dawley; Triglycerides | 1994 |
Participation of alpha 1- and beta 1-adrenoceptors in norepinephrine-induced contraction and relaxation of isolated equine coronary artery in vitro.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Butoxamine; Coronary Vessels; Endothelium, Vascular; Female; Horses; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Thromboxane A2; Yohimbine | 1994 |
Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Male; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1993 |
Effects of propranolol, pindolol and atenolol after multiple administration in rats on the duration of hexobarbital sleeping time and on the activity of some drug-metabolizing enzyme systems.
Topics: Animals; Atenolol; Cytochromes; Hexobarbital; Liver; Male; Mixed Function Oxygenases; Pindolol; Propranolol; Rats; Rats, Wistar; Sleep | 1993 |
Involvement of beta-adrenergic systems in the antagonizing effect of paeoniflorin on the scopolamine-induced deficit in radial maze performance in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Benzoates; Bridged-Ring Compounds; Glucosides; Male; Memory; Monoterpenes; Propranolol; Psychomotor Performance; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Scopolamine | 1993 |
The interaction between central cholinergic and peripheral beta-adrenergic systems on radial maze performance in rats.
Topics: Acetylcholine; Animals; Atenolol; Male; Propranolol; Psychomotor Performance; Rats; Rats, Wistar; Scopolamine; Spatial Behavior; Sympathetic Nervous System | 1993 |
Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors.
Topics: Animals; Atenolol; Calcium Channels; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Guinea Pigs; Heart; Humans; In Vitro Techniques; Models, Cardiovascular; Myocardium; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism; Thionucleotides | 1993 |
Postexercise syncope: evidence for increased activity of the sympathetic nervous system.
Topics: Adult; Arousal; Atenolol; Bradycardia; Epinephrine; Exercise Test; Heart Arrest; Humans; Hypertension; Male; Norepinephrine; Propranolol; Sympathetic Nervous System; Syncope; Vagus Nerve | 1993 |
Interaction between beta-blockers and contrast media during intracoronary administration in rabbit heart.
Topics: Animals; Atenolol; Atrioventricular Node; Diatrizoate Meglumine; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Female; Heart; Heart Block; Heart Rate; Injections; Iohexol; Male; Myocardial Contraction; Propranolol; Rabbits | 1994 |
Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Animals; Atenolol; Biphenyl Compounds; Dose-Response Relationship, Drug; Feedback; Imidazoles; Indomethacin; Injections, Intravenous; Losartan; Male; Meclofenamic Acid; Propranolol; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin; Sympathetic Nervous System; Tetrazoles | 1993 |
Reduction by beta-adrenoceptor blockade of hypoxia-induced right heart hypertrophy in the rat.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Female; Hypertrophy, Right Ventricular; Hypoxia; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1 | 1995 |
The effects of extracellular ions on beta-blocker cardiotoxicity.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Circulation; Heart; Heart Diseases; Heart Rate; Male; Potassium; Potassium Channels; Propranolol; Rats; Sodium; Ventricular Pressure | 1996 |
Relative toxicity of beta blockers in overdose.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child, Preschool; Databases, Factual; Drug Overdose; Female; Humans; Infant; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Prospective Studies; Seizures; Sotalol | 1996 |
Effects of acute cardioselective and non-selective beta-adrenergic blockade on plasma ammonia levels in exercising dogs.
Topics: Adrenergic beta-Antagonists; Ammonia; Animals; Anti-Arrhythmia Agents; Atenolol; Dogs; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Heart Rate; Infusions, Intravenous; Male; Physical Conditioning, Animal; Propranolol; Sotalol | 1996 |
Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Amylases; Antihypertensive Agents; Atenolol; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Placebos; Polypharmacy; Prevalence; Propranolol; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sex Factors; Surveys and Questionnaires; Sweden; Xerostomia | 1996 |
The regulation of total creatine content in a myoblast cell line.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Cell Line; Clenbuterol; Creatine; Energy Metabolism; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Labetalol; Methoxamine; Mice; Muscle, Skeletal; Norepinephrine; Phentolamine; Propranolol; Sodium; Triiodothyronine | 1996 |
Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Brain; Copulation; Ejaculation; Injections, Intraventricular; Male; Metoprolol; Pindolol; Propranolol; Rats; Sexual Behavior, Animal | 1996 |
Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hypertension; In Vitro Techniques; Membranes; Myocardium; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 1996 |
Application of capillary electrophoresis of characterizing interactions between drugs and bile salts. Part I.
Topics: Atenolol; Bile Acids and Salts; Chloramphenicol; Diclofenac; Electrophoresis, Capillary; Glycochenodeoxycholic Acid; Glycocholic Acid; Glycodeoxycholic Acid; Hydrogen-Ion Concentration; Micelles; Models, Chemical; Osmolar Concentration; Pharmaceutical Preparations; Propranolol; Quinine; Salicylates; Taurocholic Acid; Tetracycline | 1996 |
beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cell Count; Cocaine; Dopamine; Dose-Response Relationship, Drug; Male; Propranolol; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
Peripheral beta-adrenoreceptors and stress-induced hypercholesterolemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Butoxamine; Electroshock; Fatty Acids, Nonesterified; Hypercholesterolemia; Male; Propranolol; Rats; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Stress, Psychological | 1996 |
Interaction between prolactin and catecholamines on hypothalamic GnRH release in vitro.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Corticotropin-Releasing Hormone; Depression, Chemical; Dose-Response Relationship, Drug; Gonadotropin-Releasing Hormone; Hypothalamus; Male; Organ Culture Techniques; Phentolamine; Prazosin; Prolactin; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Yohimbine | 1996 |
[Chiral separation of seven beta-blockers in the French pharmacopoeia].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Chromatography, High Pressure Liquid; Female; France; Humans; Male; Pharmacopoeias as Topic; Propranolol; Stereoisomerism | 1997 |
Heterogeneity of beta-adrenoceptors in guinea-pig brain: radioligand binding and cyclic nucleotide generation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Cerebellum; Cyclic AMP; Cyclic GMP; Female; Guinea Pigs; Inositol Phosphates; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Pindolol; Population; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Signal Transduction; Vasodilator Agents | 1997 |
Contraction and relaxation responses of femoral artery and aorta to norepinephrine in young rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Butoxamine; Femoral Artery; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Propranolol; Rats; Rats, Wistar | 1996 |
Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amygdala; Animals; Atenolol; Dexamethasone; Ethanolamines; Glucocorticoids; Male; Memory; Norepinephrine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Glucocorticoid | 1997 |
Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Dinoprost; Dose-Response Relationship, Drug; Isoproterenol; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Oxytocics; Propanolamines; Propranolol; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1997 |
Concurrent blockade of beta-adrenergic and muscarinic receptors suppresses synergistically long-term potentiation of population spikes in the rat hippocampal CA1 region.
Topics: Acetylcholine; Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Muscarinic Antagonists; Norepinephrine; Propranolol; Rats; Rats, Wistar; Receptors, Muscarinic; Scopolamine | 1997 |
Enantiomeric separation and sensitive detection of propranolol, metoprolol and atenolol derivatized with a fluorogenic reagent, 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulf onyl-2,1, 3-benzoxadiazole (DBD-COCl), on cellulose chiral colum
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, Gel; Chromatography, High Pressure Liquid; Indicators and Reagents; Metoprolol; Oxadiazoles; Propanolamines; Propranolol; Stereoisomerism | 1997 |
Effects of some beta-adrenergic blockers on male fertility parameters in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Fertility; Genitalia, Male; Male; Metoprolol; Organ Size; Propranolol; Rats; Sperm Head; Sperm Motility; Sperm Tail | 1998 |
Direct injection of large volumes of plasma/serum on a new biocompatible extraction column for the determination of atenolol, propranolol and ibuprofen. Mechanisms for the improvement of chromatographic performance.
Topics: Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Atenolol; Biocompatible Materials; Chromatography, High Pressure Liquid; Humans; Ibuprofen; Indicators and Reagents; Propranolol; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet | 1998 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Pizotyline; Propranolol; Sympatholytics; Treatment Refusal; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Evaluation Studies as Topic; Metoprolol; Propranolol; Reproducibility of Results | 1998 |
[Antioxidant effect of drugs used in cardiovascular therapy].
Topics: Adrenergic beta-Antagonists; Antioxidants; Ascorbic Acid; Atenolol; Calcium Channel Blockers; Copper; Female; Fluorescence; Humans; Lipid Peroxidation; Male; Metoprolol; Nifedipine; Pindolol; Propranolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
Continuous blood withdrawal as a rapid screening method for determining clearance of oral bioavailability in rats.
Topics: Administration, Oral; Animals; Area Under Curve; Atenolol; Biological Availability; Male; Propranolol; Rats; Rats, Sprague-Dawley; Theophylline; Warfarin | 1998 |
Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Atrial Function; Dose-Response Relationship, Drug; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardium; Pindolol; Propranolol; Receptors, Adrenergic, beta; Time Factors | 1998 |
The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propranolol; Rats; Rats, Wistar | 1998 |
Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.
Topics: Actins; Administration, Topical; Animals; Atenolol; Biological Transport; Calcium; Chelating Agents; Conjunctiva; Cornea; Cytochalasin B; Egtazic Acid; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Male; Oligopeptides; Propranolol; Rabbits; Sympatholytics; Tight Junctions | 1998 |
Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
Topics: Angina Pectoris; Animals; Atenolol; Blood Pressure; Diltiazem; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Male; Nicorandil; Propranolol; Vasodilator Agents | 1998 |
Preliminary communication on intralymphocyte ionized magnesium in hypertensive patients under treatment with beta-blockers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Calcium; Female; Humans; Hypertension; Lymphocytes; Magnesium; Male; Norepinephrine; Propranolol | 1999 |
Influence of beta-adrenergic antagonists on cell proliferation rates in the kidney of untreated and diethylnitrosamine-treated male F344 rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carcinogens; Cell Division; Diethylnitrosamine; Eating; Kidney; Male; Organ Size; Propranolol; Rats; Rats, Inbred F344; Retrospective Studies | 1999 |
Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
Topics: Adrenergic beta-Antagonists; Atenolol; Depressive Disorder, Major; Disability Evaluation; Drug Therapy, Combination; Follow-Up Studies; Humans; Long-Term Care; Metoprolol; Pindolol; Propranolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confidence Intervals; Databases as Topic; Diuretics; Drug Compounding; Evaluation Studies as Topic; Female; Humans; Hydrochlorothiazide; Logistic Models; Male; Metolazone; Metoprolol; Myocardial Infarction; Odds Ratio; Ontario; Propranolol; Retrospective Studies; Sex Factors; Sodium Chloride Symporter Inhibitors; Timolol | 1999 |
In vitro effects of calcium channel blockers and beta-adrenergic blocking agents on microsomal lipid perocidation and cytochrome p-450 content.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Cytochrome P-450 Enzyme System; Diltiazem; In Vitro Techniques; Lipid Peroxidation; Male; Microsomes, Liver; Nifedipine; Propranolol; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Verapamil | 1999 |
Adrenaline influences the release of interleukin-6 from murine pituicytes: role of beta2-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cells, Cultured; Drug Interactions; Epinephrine; Interleukin-1; Interleukin-6; Mice; Pituitary Gland, Posterior; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2 | 1999 |
Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Atenolol; Atropine; Blotting, Western; Brain Chemistry; Butoxamine; DNA-Binding Proteins; Encephalitis; I-kappa B Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscarinic Antagonists; Neural Pathways; NF-kappa B; NF-KappaB Inhibitor alpha; Phentolamine; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Corticotropin; Receptors, Melanocortin; Spinal Cord; Tumor Necrosis Factor-alpha | 1999 |
Drug release from a porous ion-exchange membrane in vitro.
Topics: Acrylic Resins; Adsorption; Atenolol; Biocompatible Materials; Cations; Dexmedetomidine; Diazepam; Drug Delivery Systems; Hydrogen-Ion Concentration; Ion Transport; Kinetics; Membranes, Artificial; Polyvinyls; Propranolol; Sotalol; Surface Properties; Timolol | 1999 |
In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Biological Clocks; Drug Interactions; Heart Rate; Hypotension; Isoproterenol; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Tachycardia | 1999 |
Voltammetric determination of N-nitrosoderivatives of atenolol and propranolol in simulated gastric juice.
Topics: Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Nitrosamines; Polarography; Propranolol | 1999 |
Beta1- and beta3-adrenoceptors mediate relaxation in ovine trachealis smooth muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Ethanolamines; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3; Sheep; Trachea | 1999 |
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Child, Preschool; Cohort Studies; Death, Sudden; Electric Countershock; Female; Follow-Up Studies; Humans; Incidence; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Middle Aged; Nadolol; Pacemaker, Artificial; Prognosis; Propranolol; Risk Assessment; Survival Analysis; Treatment Outcome | 1999 |
Two reproducible and sensitive liquid chromatographic methods to quantify atenolol and propranolol in human plasma and determination of their associated analytical error functions.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, Liquid; Humans; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2000 |
Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Carbazoles; Carvedilol; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Guanidines; Heart; Interleukin-1; Isoproterenol; Muscle Proteins; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nucleic Acid Synthesis Inhibitors; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 2000 |
Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blotting, Northern; Blotting, Western; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Gene Expression; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; RNA; Sarcoplasmic Reticulum | 2000 |
The role of beta-adrenergic receptors in the cutaneous water evaporation mechanism in the heat-acclimated pigeon (Columba livia).
Topics: Acclimatization; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Body Water; Columbidae; Hot Temperature; Metoprolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Skin | 2000 |
Hydrogen/deuterium exchange using a coaxial sheath-flow interface for capillary electrophoresis/mass spectrometry.
Topics: Atenolol; Cimetidine; Deuterium; Electrophoresis, Capillary; Hydrogen; Mass Spectrometry; Molecular Structure; Propranolol | 2000 |
Effect of beta-antagonists on isoprenaline-induced secretion of fluid, amylase and protein by the parotid gland of the red kangaroo, Macropus rufus.
Topics: Acetylcholine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amylases; Animals; Atenolol; Dose-Response Relationship, Drug; Female; Isoproterenol; Macropodidae; Male; Parotid Gland; Propanolamines; Propranolol; Proteins; Saliva | 2000 |
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium | 2000 |
Blockade of isoprenaline-induced fluid and protein secretion by the mandibular glands of the red kangaroo, Macropus rufus, with selective antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atenolol; Female; Isoproterenol; Macropodidae; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Saliva; Salivary Glands; Salivary Proteins and Peptides; Sympatholytics; Sympathomimetics | 2000 |
Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Aorta; Atenolol; Constriction, Pathologic; Hypertension, Portal; In Vitro Techniques; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Portal Vein; Propranolol; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Vasodilation; Vasodilator Agents | 2000 |
Beta-adrenoceptor modulation and heart rate variability--the value of scatterplot measures of compactness.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Analysis of Variance; Atenolol; Double-Blind Method; Heart Rate; Humans; Male; Pindolol; Propranolol; Randomized Controlled Trials as Topic | 2000 |
Biotransformations with Rhizopus arrhizus and Geotrichum candidum for the preparation of (S)-atenolol and (S)-propranolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Biodegradation, Environmental; Biotransformation; Geotrichum; Hydrogen-Ion Concentration; Molecular Conformation; Molecular Structure; Propranolol; Rhizopus; Stereoisomerism; Time Factors | 2000 |
Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression.
Topics: Animals; Atenolol; Biological Transport; Cell Line; Cell Membrane Permeability; Cimetidine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Erythromycin; Glucose; Humans; Mammals; Mannitol; Mixed Function Oxygenases; Pharmaceutical Preparations; Phenylalanine; Propranolol; Recombinant Proteins; Testosterone; Tumor Cells, Cultured; Verapamil | 2000 |
Divergent effects of different beta-blocking agents on endothelium-dependent vasodilatation in the human forearm.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Blood Pressure; Diclofenac; Endothelium, Vascular; Female; Forearm; Heart Rate; Humans; Injections, Intra-Arterial; Labetalol; Male; Methacholine Chloride; Nitroprusside; Plethysmography; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Muscarinic; Vasodilation; Vasodilator Agents | 2000 |
Comparison of skin permeability of drugs in mice and human cadaver skin.
Topics: Administration, Cutaneous; Adult; Animals; Atenolol; Cadaver; Epidermis; Humans; Male; Mice; Minoxidil; Permeability; Prazosin; Propranolol; Skin Absorption; Species Specificity | 2000 |
[In vitro permeability studies as a substitute for in vivo studies--which requirements have to be met?].
Topics: Animal Testing Alternatives; Atenolol; Cell Culture Techniques; Cell Line; Cell Membrane Permeability; Humans; Intestinal Mucosa; Metoprolol; Propranolol; Quality Control; Reproducibility of Results; Tumor Cells, Cultured | 2001 |
Characterization of [3H]CGP 12177 binding to beta-adrenergic receptors in intact eel hepatocytes.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Alprenolol; Anguilla; Animals; Atenolol; Binding Sites; Binding, Competitive; Butoxamine; Cell Count; Colforsin; Cyclic AMP; Epinephrine; Glucose; Guanosine 5'-O-(3-Thiotriphosphate); Hepatocytes; Kinetics; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tritium | 2001 |
Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Baltimore; Female; Humans; Male; Medical Records; Metoprolol; Myocardial Infarction; Outcome Assessment, Health Care; Patient Discharge; Proportional Hazards Models; Propranolol; Retrospective Studies; Survival Analysis | 2001 |
Nebivolol and airway responsiveness in the rabbit.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Animals; Atenolol; Benzopyrans; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Female; Histamine; Lung Compliance; Male; Nebivolol; Pindolol; Propranolol; Rabbits | 2001 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Drug Costs; Evidence-Based Medicine; Female; Humans; Male; Metoprolol; Myocardial Infarction; Propranolol; Research Design; Survival Analysis; Treatment Outcome | 2001 |
Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Angiotensin II; Animals; Animals, Genetically Modified; Atenolol; Cells, Cultured; Dose-Response Relationship, Drug; Isoproterenol; Male; Melatonin; Norepinephrine; Pineal Gland; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System | 2001 |
Beta2-adrenoceptor-mediated inhibition of field stimulation induced contractile responses of the smooth muscle of the rat prostate gland.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Albuterol; Animals; Atenolol; Catechols; Colforsin; Electric Stimulation; Electrophysiology; Ethanolamines; Male; Muscle Contraction; Nitroprusside; Norepinephrine; Propanolamines; Propranolol; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2 | 2001 |
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Weight; Enzyme Inhibitors; Fibrosis; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Propranolol; Rats; Rats, Wistar; Time Factors | 2002 |
Familial association of autonomic and gastrointestinal symptoms.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Autonomic Nervous System Diseases; Child; Fatigue; Female; Gastrointestinal Diseases; Humans; Hypnotics and Sedatives; Male; Phenobarbital; Propranolol; Retreatment; Sleep Initiation and Maintenance Disorders | 2001 |
Isoproterenol amplifies 17 beta-estradiol-mediated vasorelaxation: role of endothelium/nitric oxide and cyclic AMP.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Cyclic AMP; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; In Vitro Techniques; Isoproterenol; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Vasodilation | 2002 |
Methylcellulose-immobilized reversed-phase precolumn for direct analysis of drugs in plasma by HPLC.
Topics: Animals; Atenolol; Caffeine; Chromatography, Gel; Chromatography, High Pressure Liquid; Humans; Ketoprofen; Male; Methylcellulose; Pharmaceutical Preparations; Propranolol; Proteins; Rats; Silicon Dioxide; Time Factors | 2001 |
Effect of physicochemical parameters on skin permeability of antihypertensive.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Atenolol; Chemical Phenomena; Chemistry, Physical; Diltiazem; Female; In Vitro Techniques; Mice; Permeability; Prazosin; Propranolol; Reserpine; Skin | 2001 |
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Topics: Acoustic Stimulation; Adrenergic beta-Antagonists; Animals; Anticonvulsants; Atenolol; Body Temperature; Carbamazepine; Epilepsy, Reflex; Female; Lamotrigine; Male; Metoprolol; Mice; Mice, Inbred DBA; Motor Activity; Phenobarbital; Propanolamines; Propranolol; Stereoisomerism; Triazines; Valproic Acid | 2002 |
Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Atenolol; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Dermatitis, Atopic; Dexamethasone; Enzyme Activation; Epinephrine; Humans; Kinetics; Monocytes; Phentolamine; Propranolol; Receptors, Adrenergic, beta-2; Stress, Physiological; U937 Cells | 2002 |
[A case of familial restrictive cardiomyopathy].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Atenolol; Atrial Fibrillation; Cardiomyopathy, Restrictive; Cardiotonic Agents; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Niacin; Platelet Aggregation Inhibitors; Potassium Magnesium Aspartate; Propranolol; Time Factors; Vasodilator Agents | 2002 |
[The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Depressive Disorder; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Middle Aged; Perindopril; Propranolol; Thiazepines; Time Factors; Treatment Outcome | 2002 |
Trypanosoma cruzi antigen that interacts with the beta1-adrenergic receptor and modifies myocardial contractile activity.
Topics: Animals; Antibodies, Monoclonal; Antigens, Protozoan; Atenolol; CHO Cells; Cricetinae; Cyclic AMP; Isoproterenol; Muscle Proteins; Myocardial Contraction; Myocardium; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Recombinant Proteins; Trypanosoma cruzi | 2003 |
Direct enantiomeric resolution of (+/-)-atenolol, (+/-)-metoprolol, and (+/-)-propranolol by impregnated TLC using L-aspartic acid as chiral selector.
Topics: Adrenergic beta-Antagonists; Aspartic Acid; Atenolol; Chromatography, Thin Layer; Hydrogen-Ion Concentration; Metoprolol; Propranolol; Solvents; Stereoisomerism | 2003 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Proportional Hazards Models; Propranolol; Recurrence; Syncope, Vasovagal; Treatment Failure | 2003 |
Polymeric matrix membrane sensors for sensitive potentiometric determination of some beta-blockers in pharmaceutical preparations.
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Indicators and Reagents; Ions; Metoprolol; Phosphates; Polyvinyl Chloride; Potentiometry; Propranolol; Sensitivity and Specificity; Timolol; Tungsten Compounds | 2003 |
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.
Topics: Animals; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Cells, Cultured; Dimethyl Fumarate; Enzyme Inhibitors; Fumarates; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Liver Extracts; Microvilli; Pancreatic Extracts; Propranolol; Psoriasis; Swine | 2003 |
Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
Topics: Animals; Antipyrine; Atenolol; Hydrogen-Ion Concentration; Liver; Male; Microsomes, Liver; Models, Biological; Propranolol; Rats; Rats, Wistar | 2004 |
The beta3-adrenoceptor-mediated relaxation induced by dopamine in guinea pig taenia caecum.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Butoxamine; Cecum; Dopamine; Dopamine Antagonists; Guinea Pigs; Haloperidol; Male; Muscle Relaxation; Phentolamine; Prazosin; Propranolol; Receptors, Adrenergic, beta-3; Yohimbine | 2003 |
Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anterior Hypothalamic Nucleus; Aortic Coarctation; Atenolol; Blood Pressure; Clenbuterol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Hypertension; Hypotension; Isoproterenol; Male; Metoprolol; Microinjections; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta | 2004 |
Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Apoptosis; Atenolol; Blotting, Western; Caspase 2; Caspase 3; Caspase 6; Caspase 9; Caspase Inhibitors; Caspases; Cells, Cultured; Cytochromes c; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Genes, bcl-2; Myocardium; Norepinephrine; Oligopeptides; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley | 2004 |
Determination of enantiomeric compositions of pharmaceutical products by near-infrared spectrometry.
Topics: alpha-Cyclodextrins; Atenolol; Ibuprofen; Isomerism; Pharmaceutical Preparations; Propranolol; Spectroscopy, Near-Infrared; Water | 2004 |
Effect of Larrea divaricata Cav. extract and nordihydroguaiaretic acid upon peroxidase secretion in rat submandibulary glands.
Topics: 3,3'-Diaminobenzidine; Animals; Argentina; Aspirin; Atenolol; Butoxamine; Dinoprostone; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Forecasting; Larrea; Masoprocol; Peroxidase; Plant Extracts; Plant Leaves; Prazosin; Propranolol; Rats; Rats, Wistar; Submandibular Gland; Water | 2004 |
The use of multi-frequency EPR techniques to identify the radicals produced in irradiated beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Electron Spin Resonance Spectroscopy; Free Radicals; Nadolol; Propanolamines; Propranolol; Temperature | 2004 |
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
Topics: Administration, Oral; Atenolol; Biopharmaceutics; Dosage Forms; Humans; Intestinal Absorption; Propranolol; Solubility; Therapeutic Equivalency; Verapamil | 2004 |
Influence of beta-adrenoceptor agonists and antagonists on baclofen-induced memory impairment in mice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Animals, Outbred Strains; Atenolol; Avoidance Learning; Baclofen; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; GABA Agonists; Injections, Intraperitoneal; Male; Memory Disorders; Mice; Propranolol | 2004 |
Enantioseparation using sulfated cyclosophoraoses as a novel chiral additive in capillary electrophoresis.
Topics: Atenolol; Electrolytes; Electrophoresis, Capillary; Isoproterenol; Metoprolol; Molecular Structure; Norepinephrine; Oligosaccharides; Propranolol; Rhizobium leguminosarum; Stereoisomerism | 2004 |
Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
Topics: Amoxicillin; Animals; Antipyrine; Area Under Curve; Atenolol; Biological Availability; Gastrointestinal Tract; Intestinal Absorption; Liver; Male; Models, Animal; Propranolol; Rats; Rats, Sprague-Dawley; Testosterone | 2004 |
Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala.
Topics: Adrenergic beta-Antagonists; Amygdala; Androstanols; Animals; Atenolol; Corticosterone; Emotions; Escape Reaction; Hippocampus; Hormone Antagonists; Male; Maze Learning; Mental Recall; Propranolol; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Glucocorticoid; Stress, Psychological; Xamoterol | 2004 |
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glutamic Acid; Iontophoresis; Isoproterenol; Male; Migraine Disorders; Neural Inhibition; Piperazines; Procaterol; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Somatosensory Cortex; Synaptic Transmission; Trigeminal Nerve; Ventral Thalamic Nuclei | 2005 |
Initial risk assessment for three beta-blockers found in the aquatic environment.
Topics: Adrenergic beta-Antagonists; Animals; Araceae; Atenolol; Biomarkers; Chlorophyta; Daphnia; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Metoprolol; Propranolol; Risk Assessment; Toxicity Tests, Acute; Water Pollutants, Chemical | 2005 |
Modeling the electrophoretic mobility of beta-blockers in capillary electrophoresis using artificial neural networks.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrolytes; Electrophoresis, Capillary; Electrophoretic Mobility Shift Assay; Labetalol; Models, Chemical; Neural Networks, Computer; Pharmaceutical Preparations; Practolol; Predictive Value of Tests; Propranolol; Solvents; Technology, Pharmaceutical; Timolol | 2005 |
Selective beta(1)-adrenoreceptor blocking activity of newly synthesized acyl amino-substituted aryloxypropanolamine derivatives, DPJ 955 and DPJ 890, in rats.
Topics: Acetamides; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Atrial Function, Right; Benzamides; Blood Pressure; Colon; Female; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Oxalates; Propranolol; Rats; Rats, Wistar; Uterus | 2005 |
Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
Topics: Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Thromboxane B2 | 2005 |
Insights into cyclodextrin interactions during sample stacking using capillary isotachophoresis with on-line microcoil NMR detection.
Topics: Albuterol; Alprenolol; Atenolol; Cyclodextrins; Diffusion; Electrolytes; Electrophoresis; Magnetic Resonance Spectroscopy; Propranolol; Protons; Sensitivity and Specificity; Terbutaline | 2005 |
Effects of beta-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum.
Topics: Aconitine; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding Sites; Electric Stimulation; In Vitro Techniques; Insect Proteins; Male; Metoprolol; Muscle Relaxation; Neurotoxins; Nitric Oxide; Penis; Propanolamines; Propranolol; Rabbits; Saxitoxin; Scorpion Venoms; Sodium Channel Agonists; Tetrodotoxin; Veratridine | 2005 |
[Spectrofluorometric analysis of propranolol and atenolol].
Topics: Adrenergic beta-Antagonists; Atenolol; Chemistry, Pharmaceutical; Propranolol; Spectrometry, Fluorescence; Spectrophotometry | 1992 |
Enantioselective binding to the human organic cation transporter-1 (hOCT1) determined using an immobilized hOCT1 liquid chromatographic stationary phase.
Topics: Animals; Atenolol; Binding Sites; Cell Line; Chromatography, Affinity; Chromatography, Liquid; Dogs; Ephedrine; Humans; Hydrogen Bonding; Organic Cation Transporter 1; Phenethylamines; Propranolol; Stereoisomerism | 2005 |
Effects of atenolol and propanolol on platelet aggregation in moderate essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Humans; Hypertension; Platelet Aggregation; Propranolol | 2005 |
Gas chromatographic-mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Gas Chromatography-Mass Spectrometry; Humans; Metoprolol; Propranolol; Reference Standards; Sensitivity and Specificity | 2005 |
Enantiomeric impurity determination in capillary electrophoresis using a highly-sulfated cyclodextrins-based method.
Topics: Atenolol; Chlorpheniramine; Computer Simulation; Cyclodextrins; Electrophoresis, Capillary; Propranolol; Reproducibility of Results; Stereoisomerism; Tryptophan | 2006 |
Post-mortem redistribution of three beta-blockers in the rabbit.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Infusions, Intravenous; Male; Metoprolol; Models, Animal; Postmortem Changes; Propranolol; Rabbits; Tissue Distribution | 2006 |
Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS.
Topics: Adrenergic beta-Antagonists; Aerospace Medicine; Atenolol; Atmospheric Pressure; Chromatography, High Pressure Liquid; Forensic Medicine; Humans; Metoprolol; Molecular Structure; Postmortem Changes; Propranolol; Spectrometry, Mass, Electrospray Ionization | 2006 |
Neurotensin-induced myocardial noradrenergic effects in spontaneously hypertensive rats.
Topics: Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Male; Myocardial Contraction; Neurotensin; Norepinephrine; Perfusion; Propranolol; Pyrazoles; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Receptors, Neurotensin; Sympathetic Nervous System; Ventricular Function, Left | 2006 |
Norepinephrine stimulates calprotectin expression in human monocytic cells.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Atenolol; Calgranulin A; Calgranulin B; CCAAT-Enhancer-Binding Proteins; DNA; Humans; Hydrocortisone; Leukocyte L1 Antigen Complex; Monocytes; Norepinephrine; Phentolamine; Propranolol; Protein Binding; RNA, Messenger; Stress, Psychological; U937 Cells | 2006 |
Role of sympathetic and parasympathetic nervous systems in heart rate regulation in cats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Atropine; Cats; Electrocardiography; Female; Heart; Heart Rate; Male; Nervous System; Oscillometry; Parasympathetic Nervous System; Propranolol; Sympathetic Nervous System | 2005 |
Swellable drug-polyelectrolyte matrices (SDPM) of alginic acid characterization and delivery properties.
Topics: Alginates; Atenolol; Calorimetry, Differential Scanning; Drug Delivery Systems; Glucuronic Acid; Hardness; Hexuronic Acids; Hydrogels; Metoclopramide; Propranolol; Spectroscopy, Fourier Transform Infrared; Water; X-Ray Diffraction | 2006 |
Stereoisomer quantification of the beta-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry.
Topics: Adrenergic beta-Antagonists; Atenolol; Canada; Chromatography, High Pressure Liquid; Mass Spectrometry; Metoprolol; Molecular Structure; Propranolol; Reproducibility of Results; Sewage; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2006 |
Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
Topics: Ampicillin; Atenolol; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Griseofulvin; Permeability; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Stability of atenolol, acebutolol and propranolol in acidic environment depending on its diversified polarity.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Propranolol; Static Electricity; Temperature; Thermodynamics | 2006 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
Topics: Animals; Antiprotozoal Agents; Atenolol; Buffers; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Molecular Structure; Naphthoquinones; Perfusion; Permeability; Propranolol; Quinidine; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Verapamil | 2007 |
Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach.
Topics: Adrenergic beta-Antagonists; Atenolol; Chlorophyta; Endpoint Determination; Humans; Liposomes; Metoprolol; Photosynthesis; Propranolol; Quantitative Structure-Activity Relationship; Risk Assessment; Toxicity Tests; Water Pollutants, Chemical | 2006 |
Pharmacological characterization of the beta-adrenoceptor that mediates the relaxant response to noradrenaline in guinea-pig tracheal smooth muscle.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Albuterol; Animals; Atenolol; Bupranolol; Butoxamine; Desipramine; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Trachea | 2007 |
Effects of some beta-adrenoceptor antagonists on orthostatic hypotension in repeatedly cold- (SART-) stressed rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cold Temperature; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypotension, Orthostatic; Isoproterenol; Male; Posture; Propranolol; Rats; Rats, Wistar; Stress, Physiological | 2007 |
Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatography/UV detection.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Chromatography, High Pressure Liquid; Dimethyl Sulfoxide; Intestinal Mucosa; Male; Perfusion; Permeability; Propranolol; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2007 |
Elimination of beta-blockers in sewage treatment plants.
Topics: Adrenergic beta-Antagonists; Adsorption; Atenolol; Chromatography, High Pressure Liquid; Kinetics; Metoprolol; Molecular Structure; Propranolol; Sotalol; Tandem Mass Spectrometry; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2007 |
Kinetics and degradation products for direct photolysis of beta-blockers in water.
Topics: Adrenergic beta-Antagonists; Atenolol; Biodegradation, Environmental; Chromatography, High Pressure Liquid; Free Radical Scavengers; Fresh Water; Industrial Waste; Kinetics; Magnetic Resonance Spectroscopy; Metoprolol; Oxidation-Reduction; Photolysis; Propranolol; Seasons; Water Pollutants, Chemical | 2007 |
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Benzylamines; Female; Guinea Pigs; Male; Myocardial Ischemia; Necrosis; Propanolamines; Propranolol; Rats; Rats, Wistar; Reperfusion Injury | 2007 |
Peculiarities of regulation of heart rate and stroke volume in rats during ontogeny.
Topics: Adrenergic Antagonists; Age Factors; Animals; Atenolol; Atropine; Cardiac Output; Heart Rate; Muscarinic Antagonists; Phentolamine; Plethysmography, Impedance; Prazosin; Propranolol; Rats; Stroke Volume | 2006 |
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Topics: Aspirin; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cetirizine; Cimetidine; Diffusion; Dose-Response Relationship, Drug; Drug Interactions; Flunarizine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Oxazolidinones; Permeability; Propranolol; Serotonin Receptor Agonists; Sodium-Hydrogen Exchangers; Tryptamines | 2007 |
beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Calcium; Cells, Cultured; Cyclic AMP; Ethanolamines; Humans; Isoproterenol; Male; Phenylephrine; Potassium Channel Blockers; Propanolamines; Propranolol; Prostate; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Stromal Cells; Xamoterol | 2007 |
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Male; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies.
Topics: Antipyrine; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Chromatography, High Pressure Liquid; Drug Stability; Furosemide; Humans; Intestinal Absorption; Permeability; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Topotecan | 2007 |
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Buffers; Celiprolol; Clenbuterol; Electroosmosis; Electrophoresis, Capillary; Fenoterol; Hydrogen-Ion Concentration; Isoproterenol; Metal Nanoparticles; Metoprolol; Propranolol; Reproducibility of Results; Terbutaline; Titanium; Uncertainty | 2008 |
Direct TLC resolution of atenolol and propranolol into their enantiomers using three different chiral selectors as impregnating reagents.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, Thin Layer; Propranolol; Stereoisomerism | 2008 |
beta-Adrenoceptor blockers protect against staurosporine-induced apoptosis in SH-SY5Y neuroblastoma cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Atenolol; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Cytochromes c; Cytoprotection; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Humans; In Situ Nick-End Labeling; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroblastoma; Neurons; Poly(ADP-ribose) Polymerases; Propanolamines; Propranolol; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine; Time Factors | 2008 |
Effect of beta-adrenoblockers on heart rate variability in awake and narcotized rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Electrocardiography; Heart Rate; Male; Parasympathetic Nervous System; Propranolol; Rats; Sympathetic Nervous System; Wakefulness | 2007 |
beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Benzylamines; Blood Pressure; Colon; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Atria; Hypertension, Renal; Isoproterenol; Male; Propanolamines; Propranolol; Rats; Rats, Wistar; Uterus | 2008 |
Effects of a strongly adsorbed additive on process performance in chiral preparative chromatography.
Topics: Acetic Acid; Adsorption; Alprenolol; Atenolol; Chromatography; Ethylamines; Models, Chemical; Propranolol; Solvents; Stereoisomerism; Thermodynamics; Time Factors | 2008 |
HO-1-u-1 model for screening sublingual drug delivery--influence of pH, osmolarity and permeation enhancer.
Topics: Adjuvants, Pharmaceutic; Administration, Sublingual; Adrenergic beta-Antagonists; Animals; Atenolol; Biological Transport; Cell Line, Tumor; Chromatography, High Pressure Liquid; Diffusion; Drug Evaluation, Preclinical; Glycodeoxycholic Acid; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Metoprolol; Models, Biological; Mouth Mucosa; Osmolar Concentration; Permeability; Propranolol; Sus scrofa | 2009 |
Preparation and evaluation of propranolol molecularly imprinted solid-phase microextraction fiber for trace analysis of beta-blockers in urine and plasma samples.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Chromatography, High Pressure Liquid; Humans; Molecular Imprinting; Pindolol; Polymers; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction | 2009 |
Effect of atropine, propranolol, and atenolol on wave structure of heart rate oscillations in rats.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Atropine; Autonomic Nervous System; Drug Evaluation, Preclinical; Electrocardiography; Female; Heart Rate; Male; Propranolol; Rats; Rats, Inbred Strains; Respiration; Spectrum Analysis | 2008 |
Direct detection of analyte binding to single molecularly imprinted polymer particles by confocal Raman spectroscopy.
Topics: Adrenergic beta-Antagonists; Atenolol; Binding Sites; Biosensing Techniques; Microscopy, Electron, Scanning; Microspheres; Molecular Imprinting; Nanospheres; Particle Size; Polymers; Propranolol; Radioligand Assay; Spectrum Analysis, Raman | 2009 |
Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiopulmonary Bypass; Chromatography, High Pressure Liquid; Coronary Artery Bypass; Coronary Disease; Female; Humans; Male; Middle Aged; Postoperative Period; Preoperative Period; Propranolol | 2009 |
Photo-induced environmental depletion processes of beta-blockers in river waters.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Hydrogen-Ion Concentration; Kinetics; Metoprolol; Photochemical Processes; Propranolol; Rivers; Sterilization; Sunlight | 2009 |
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failure; Heart Rate; Male; Metoprolol; Nebivolol; Pindolol; Propranolol; Rats | 2009 |
Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of beta-blockade therapy and interest of unilateral adrenalectomy.
Topics: Adrenal Glands; Adrenalectomy; Adrenergic beta-Antagonists; Atenolol; Cushing Syndrome; Female; Humans; Hydrocortisone; Hyperplasia; Middle Aged; Posture; Propranolol; Treatment Outcome; Vasopressins | 2009 |
An improved primary human nasal cell culture for the simultaneous determination of transepithelial transport and ciliary beat frequency.
Topics: Administration, Intranasal; Antihypertensive Agents; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Membrane Permeability; Cells, Cultured; Cilia; Cresols; Epithelial Cells; Humans; Mucociliary Clearance; Nasal Mucosa; Propanolamines; Propranolol | 2009 |
Influence of perfusate composition on drug disposition in the in-situ perfused rat lung.
Topics: Animals; Antipyrine; Atenolol; Buffers; Carbon Radioisotopes; Deuterium Oxide; Dextrans; Evans Blue; Hydrogen-Ion Concentration; Indicator Dilution Techniques; Lung; Male; Models, Biological; Morpholines; Perfusion; Permeability; Pressure; Propranolol; Rats; Rats, Wistar; Serum Albumin, Bovine; Sucrose | 2009 |
Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor.
Topics: Atenolol; Benzoquinones; Biodegradation, Environmental; Carbamazepine; Clofibric Acid; Hydrogen Peroxide; Iron; Oxalates; Oxidation-Reduction; Pharmaceutical Preparations; Propranolol; Trametes; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Depression, Chemical; Electrocardiography; Epinephrine; Heart Failure; Heart Rate; Male; Norepinephrine; Organ Size; Propranolol; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Ultrasonography; Ventricular Remodeling | 2010 |
Different approaches of impregnation for resolution of enantiomers of atenolol, propranolol and salbutamol using Cu(II)-L-amino acid complexes for ligand exchange on commercial thin layer chromatographic plates.
Topics: Adrenergic beta-Antagonists; Albuterol; Amino Acids; Atenolol; Chromatography, Thin Layer; Copper; Ligands; Limit of Detection; Propranolol; Stereoisomerism; Temperature | 2010 |
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blotting, Northern; Ca(2+) Mg(2+)-ATPase; Dose-Response Relationship, Drug; Echocardiography; Gene Expression; Heart; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Phosphorylation; Propranolol; Rats; Rats, Sprague-Dawley; Troponin I; Ventricular Remodeling | 2011 |
Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting.
Topics: Antimetabolites; Atenolol; Chromatography, High Pressure Liquid; Metabolome; Micrococcus luteus; Propranolol; Pseudomonas; Spectroscopy, Fourier Transform Infrared; Sphingomonadaceae | 2010 |
Norepinephrine antagonists and cancer risk.
Topics: Atenolol; Breast Neoplasms; Clonidine; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Metoprolol; Neoplasms; Norepinephrine; Odds Ratio; Prazosin; Propranolol; Prostatic Neoplasms; Risk Assessment | 2011 |
Electrochemical degradation of beta-blockers. Studies on single and multicomponent synthetic aqueous solutions.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Electrochemistry; Metoprolol; Propranolol | 2010 |
The intestinal permeability of neolignans from the seeds of Myristica fragrans in the Caco-2 cell monolayer model.
Topics: Atenolol; Biological Transport; Caco-2 Cells; Chromatography, High Pressure Liquid; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Lignans; Myristica; Permeability; Propranolol; Seeds | 2010 |
Square-wave voltammetric determination of propranolol and atenolol in pharmaceuticals using a boron-doped diamond electrode.
Topics: Adrenergic beta-Antagonists; Atenolol; Boron; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Diamond; Electrochemistry; Electrodes; Limit of Detection; Models, Chemical; Pharmaceutical Preparations; Potentiometry; Propranolol; Tablets | 2010 |
The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation.
Topics: Amoxicillin; Atenolol; Cell Membrane Permeability; Cimetidine; Computer Simulation; Gastric Emptying; Gastrointestinal Tract; Humans; Metoprolol; Pharmaceutical Preparations; Propranolol; Software | 2010 |
The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia; Anesthetics; Atenolol; Biomimetics; Lipid Bilayers; Lipids; Liposomes; Membranes, Artificial; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2010 |
Possible involvement of β₁ receptors in various emetogen-induced increases in salivary amylase activity in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Amylases; Animals; Antiemetics; Apomorphine; Atenolol; Butoxamine; Cisplatin; Depression, Chemical; Emetics; Isoproterenol; Lithium Chloride; Male; Metoclopramide; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Saliva | 2011 |
Maternal defense is modulated by beta adrenergic receptors in lateral septum in mice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aggression; Animals; Atenolol; Choice Behavior; Female; Isoproterenol; Male; Maternal Behavior; Mice; Mice, Inbred ICR; Microinjections; Norepinephrine; Propranolol; Receptors, Adrenergic, beta; Septum of Brain | 2011 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |
Expanding our therapeutic options: Beta blockers for breast cancer?
Topics: Adrenergic beta-Antagonists; Atenolol; Breast Neoplasms; Diabetes Complications; Disease-Free Survival; Female; Humans; Hypertension; Medical Oncology; Models, Biological; Neoplasm Metastasis; Propranolol; Receptors, Estrogen; Recurrence; Treatment Outcome | 2011 |
Beta blockers and breast cancer mortality: a population- based study.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Breast Neoplasms; Disease Progression; Female; Humans; Hypertension; Incidence; Middle Aged; Neoplasm Metastasis; Odds Ratio; Probability; Propranolol; Regression Analysis; Signal Transduction | 2011 |
Degradation of pharmaceutical beta-blockers by electrochemical advanced oxidation processes using a flow plant with a solar compound parabolic collector.
Topics: Adrenergic beta-Antagonists; Atenolol; Boron; Carbon; Diamond; Electrochemistry; Ferric Compounds; Hydrogen Peroxide; Iron; Kinetics; Metoprolol; Nitrates; Nitrogen Compounds; Oxidation-Reduction; Photochemistry; Platinum; Propranolol; Quaternary Ammonium Compounds; Sunlight; Water Pollutants, Chemical; Water Purification | 2011 |
Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
Topics: Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Male; Propranolol; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2011 |
Chronic β-adrenoceptor antagonists upregulate the rat alveolar macrophage adrenergic system through the β1-subtype.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Dopamine beta-Hydroxylase; Fluorescent Dyes; Interleukin-6; Lipopolysaccharides; Macrophages, Alveolar; Norepinephrine; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |
Induced nanoelectrospray ionization for matrix-tolerant and high-throughput mass spectrometry.
Topics: Atenolol; Chlorobenzoates; Cocaine; Propranolol; Spectrometry, Mass, Electrospray Ionization | 2011 |
Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Allosteric Regulation; Atenolol; Cell Line; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Immunoprecipitation; Isoproterenol; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myometrium; Oxytocin; Phosphorylation; Propranolol; Protein Binding; Protein Multimerization; Receptors, Adrenergic, beta-2; Receptors, Oxytocin; Recombinant Fusion Proteins; Signal Transduction; Timolol; Vasotocin | 2012 |
Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus.
Topics: Animals; Atenolol; Intestinal Absorption; Intestinal Mucosa; Male; Metoprolol; Models, Biological; Permeability; Phenolsulfonphthalein; Propranolol; Rats; Rats, Wistar | 2012 |
A pharmacokinetic study of a combination of beta adrenoreceptor antagonists - in the isolated perfused ovine eye.
Topics: Adrenergic beta-Antagonists; Animals; Anterior Eye Segment; Atenolol; Choroid; Intravitreal Injections; Posterior Eye Segment; Propranolol; Retina; Sheep; Timolol; Tissue Distribution | 2012 |
Pharmacophore modeling for hERG channel facilitation.
Topics: Animals; Atenolol; Chlorpheniramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoxetine; Haloperidol; Humans; Hydrophobic and Hydrophilic Interactions; Imipramine; Metoprolol; Nortriptyline; Potassium Channel Blockers; Promethazine; Propranolol; Quantitative Structure-Activity Relationship; Sotalol; Terfenadine; Verapamil; Xenopus laevis | 2012 |
Reaction of β-blockers and β-agonist pharmaceuticals with aqueous chlorine. Investigation of kinetics and by-products by liquid chromatography quadrupole time-of-flight mass spectrometry.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Atenolol; Chlorine; Chromatography, Liquid; Halogenation; Kinetics; Mass Spectrometry; Propranolol; Water; Water Pollutants, Chemical; Water Purification | 2012 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Atenolol; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Failure; Labetalol; Linear Models; Liver; Liver Cirrhosis; Liver Diseases; Male; Metabolic Clearance Rate; Metoprolol; Microsomes, Liver; Models, Biological; Necrosis; Nonlinear Dynamics; Perfusion; Propranolol; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Fate of β-blockers in aquifer material under nitrate reducing conditions: batch experiments.
Topics: Adrenergic beta-Antagonists; Atenolol; Environmental Monitoring; Groundwater; Kinetics; Metoprolol; Models, Chemical; Nitrates; Oxidation-Reduction; Propranolol; Water Pollutants, Chemical | 2012 |
Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease.
Topics: Acute Disease; Animals; Atenolol; Chagas Disease; Electrocardiography; Heart Rate; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Parasitemia; Parasympathetic Nervous System; Propranolol; Pyridostigmine Bromide; Receptors, Adrenergic, beta-2; Sympathetic Nervous System | 2012 |
Sleep disturbance among spontaneously hypertensive rats is mediated by an α1-adrenergic mechanism.
Topics: Animals; Atenolol; Blood Pressure; Male; Prazosin; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Sleep; Sleep Wake Disorders | 2012 |
Simultaneous enantiomeric determination of propranolol, metoprolol, pindolol, and atenolol in natural waters by HPLC on new polysaccharide-based stationary phase using a highly selective molecularly imprinted polymer extraction.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Environmental Monitoring; Metoprolol; Molecular Imprinting; Molecular Structure; Pindolol; Polysaccharides; Propranolol; Rivers; Solid Phase Extraction; Stereoisomerism; Water | 2012 |
A prospective, 1-year follow-up study of postural tachycardia syndrome.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents; Atenolol; Cholinesterase Inhibitors; Female; Fludrocortisone; Follow-Up Studies; Heart Rate; Humans; Male; Metoprolol; Midodrine; Nadolol; Norepinephrine; Postural Orthostatic Tachycardia Syndrome; Propranolol; Prospective Studies; Pyridostigmine Bromide; Severity of Illness Index; Sodium; Tilt-Table Test; Virus Diseases | 2012 |
Potentiometric propranolol-selective sensor based on molecularly imprinted polymer.
Topics: Adrenergic Antagonists; Atenolol; Calibration; Electrodes; Metoprolol; Microscopy, Electron, Scanning; Models, Chemical; Molecular Imprinting; Nanoparticles; Nanotechnology; Pharmaceutical Preparations; Polymers; Potentiometry; Propranolol; Solvents; Water | 2013 |
Evaluation of skin permeation of β-blockers for topical drug delivery.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Epidermis; Humans; Middle Aged; Propranolol; Skin; Skin Absorption; Timolol; Young Adult | 2013 |
Phototransformation of wastewater-derived trace organic contaminants in open-water unit process treatment wetlands.
Topics: Atenolol; Carbamazepine; Carbonates; Cimetidine; Dimethylnitrosamine; Diuron; Estradiol; Hydroxyl Radical; Models, Chemical; Photolysis; Propranolol; Sulfamethoxazole; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Wetlands | 2013 |
Oxidation-coagulation of β-blockers by K2FeVIO4 in hospital wastewater: assessment of degradation products and biodegradability.
Topics: Adrenergic beta-Antagonists; Atenolol; Biodegradation, Environmental; Chromatography, Liquid; Data Interpretation, Statistical; Hospitals; Iron; Mass Spectrometry; Medical Waste; Medical Waste Disposal; Metoprolol; Models, Theoretical; Oxidation-Reduction; Propranolol; Water Pollutants, Chemical | 2013 |
Multi-residue enantiomeric analysis of pharmaceuticals and their active metabolites in the Guadalquivir River basin (South Spain) by chiral liquid chromatography coupled with tandem mass spectrometry.
Topics: Atenolol; Chromatography, Liquid; Environmental Monitoring; Fluoxetine; Metoprolol; Pharmaceutical Preparations; Propanolamines; Propranolol; Reproducibility of Results; Rivers; Sensitivity and Specificity; Spain; Stereoisomerism; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2013 |
Effect of chronic restraint stress on human colorectal carcinoma growth in mice.
Topics: Adrenergic Antagonists; Animals; Atenolol; Cell Proliferation; Colorectal Neoplasms; Epinephrine; Gene Expression; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Transplantation; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Restraint, Physical; Stress, Physiological; Tumor Burden; Tumor Cells, Cultured | 2013 |
Equilibrium and release properties of hyaluronic acid-drug complexes.
Topics: Atenolol; Drug Carriers; Hyaluronic Acid; Lidocaine; Propranolol; Viscosity | 2013 |
In vitro evaluation of the ciliary beat frequency of the rat nasal epithelium using a high-speed digital imaging system.
Topics: Acetylcholine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Atropine; Cefazolin; Cholinergic Agonists; Cilia; Image Processing, Computer-Assisted; In Vitro Techniques; Male; Mucociliary Clearance; Muscarinic Antagonists; Nasal Mucosa; Propranolol; Rats; Rats, Wistar; Terbutaline; Video Recording | 2013 |
Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Atenolol; Facial Neoplasms; Female; Hemangioma; Humans; Leg; Male; Pain Measurement; Propranolol; Treatment Outcome | 2013 |
β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Case-Control Studies; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Propranolol; Prospective Studies; Registries; United Kingdom | 2013 |
Determination of excipient based solubility increases using the CheqSol method.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Atenolol; Automation, Laboratory; beta-Cyclodextrins; Chemistry, Pharmaceutical; Excipients; Gliclazide; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Pharmaceutical Preparations; Poloxamer; Potentiometry; Propranolol; Solubility; Technology, Pharmaceutical | 2014 |
Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Atenolol; Barium Compounds; Chlorides; Epinephrine; Guinea Pigs; Heart; Lipid Peroxidation; Male; Mice; Propranolol; Protein Binding; Rats; Receptors, Adrenergic, beta-1; Reperfusion Injury; Trachea; Vasoconstriction; Vasodilation; Xanthones | 2014 |
An endogenous sensitizer of β adrenergic receptors and its analogs attenuate the inhibition of β adrenergic receptors by propranolol and atenolol in the rat myocardium.
Topics: Adrenergic beta-Antagonists; Amino Acids; Animals; Atenolol; Female; Heart; Humans; Myocardial Contraction; Pregnancy; Propranolol; Rats; Serum | 2014 |
Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability.
Topics: Animals; Atenolol; Body Fluids; Carbazoles; Carvedilol; Humans; Intestinal Secretions; Male; Metoprolol; Permeability; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Solubility; Solvents | 2014 |
Effect of adrenoblockers on slow (LF) waves in rabbit heart rate.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Outbred Strains; Atenolol; Female; Heart Rate; Male; Myocardial Contraction; Propranolol; Rabbits | 2014 |
β-Adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Biomarkers; Down-Regulation; Embryoid Bodies; Embryonic Stem Cells; Mice; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Propanolamines; Propranolol; Receptors, Adrenergic, beta; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A | 2014 |
[My hypertensive patient wants beta blockers. Are they not obsolete?].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Substitution; Germany; Guideline Adherence; Humans; Hypertension; Patient Participation; Propranolol; Treatment Outcome | 2014 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Genotype; Heart Arrest; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Metoprolol; Multivariate Analysis; Nadolol; Proportional Hazards Models; Propranolol; Registries; Regression Analysis; Risk Factors; Syncope; Time Factors; Treatment Outcome; Young Adult | 2014 |
Development of a MSFIA sample treatment system as front end of GC-MS for atenolol and propranolol determination in human plasma.
Topics: Acetamides; Atenolol; Factor Analysis, Statistical; Flow Injection Analysis; Fluoroacetates; Gas Chromatography-Mass Spectrometry; Humans; Microwaves; Propranolol; Sensitivity and Specificity; Solid Phase Extraction; Trimethylsilyl Compounds | 2015 |
Functional effects of β3-adrenoceptor on pacemaker activity in interstitial cells of Cajal from the mouse colon.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aminophenols; Animals; Atenolol; Benzophenanthridines; Biological Clocks; Butoxamine; Calcium; Colon; Dose-Response Relationship, Drug; Ethanolamines; Female; Interstitial Cells of Cajal; Intestine, Small; Male; Membrane Potentials; Mice; NG-Nitroarginine Methyl Ester; Norepinephrine; Potassium Channel Blockers; Propanolamines; Propranolol; Receptors, Adrenergic, beta-3; Sulfonamides | 2015 |
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Epinephrine; HT29 Cells; Humans; Isoproterenol; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Signal Transduction | 2015 |
Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
Topics: Acridines; Animals; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzopyrans; Biological Transport; Blood Proteins; Brain; Caco-2 Cells; Catecholamines; Cell Membrane Permeability; Dogs; Dopamine beta-Hydroxylase; Humans; Imidazoles; Liver; Madin Darby Canine Kidney Cells; Male; Mice; Propranolol; Protein Binding; Tetrahydroisoquinolines; Thiones; Tissue Distribution | 2015 |
Reactivity of β-blockers/agonists with aqueous permanganate. Kinetics and transformation products of salbutamol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Atenolol; Hydrogen-Ion Concentration; Kinetics; Oxidation-Reduction; Potassium Permanganate; Propranolol; Water; Water Pollutants, Chemical | 2015 |
Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Apoptosis; Atenolol; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cytochromes c; ErbB Receptors; G1 Phase Cell Cycle Checkpoints; Gene Expression; HCT116 Cells; HT29 Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Propanolamines; Propranolol; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |
Rapid chiral separation of atenolol, metoprolol, propranolol and the zwitterionic metoprolol acid using supercritical fluid chromatography-tandem mass spectrometry - Application to wetland microcosms.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, Supercritical Fluid; Metoprolol; Propranolol; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Tandem Mass Spectrometry; Water Pollutants, Chemical; Wetlands | 2015 |
Aqueous chlorination of acebutolol: kinetics, transformation by-products, and mechanism.
Topics: Acebutolol; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Chlorine; Chromatography, Liquid; Halogenation; Kinetics; Mass Spectrometry; Oxidation-Reduction; Propranolol; Water; Water Pollutants, Chemical; Water Purification | 2016 |
Study of the Biotransformation of Tongmai Formula by Human Intestinal Flora and Its Intestinal Permeability across the Caco-2 Cell Monolayer.
Topics: Atenolol; Bacteria; Biological Transport; Biotransformation; Caco-2 Cells; Cardiovascular Diseases; Drugs, Chinese Herbal; Feces; Gastrointestinal Microbiome; Humans; Isoflavones; Medicine, Chinese Traditional; Microbial Consortia; Permeability; Propranolol | 2015 |
Double-wavelength overlapping resonance Rayleigh scattering technique for the simultaneous quantitative analysis of three β-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Atenolol; Erythrosine; Fluorescent Dyes; Humans; Light; Limit of Detection; Metoprolol; Propranolol; Scattering, Radiation; Spectrometry, Fluorescence; Spectrophotometry | 2016 |
Liquid chromatographic enantioseparation of three beta-adrenolytics using new derivatizing reagents synthesized from (S)-ketoprofen and confirmation of configuration of diastereomers.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Ketoprofen; Limit of Detection; Metoprolol; Models, Molecular; Molecular Conformation; Propranolol; Stereoisomerism | 2016 |
The influence of non-ionisable excipients on precipitation parameters measured using the CheqSol method.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Atenolol; beta-Cyclodextrins; Chemistry, Pharmaceutical; Excipients; Gliclazide; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Pharmaceutical Solutions; Poloxamer; Propranolol; Solubility; Solutions | 2016 |
Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.
Topics: Animals; Atenolol; Biotransformation; Carbamazepine; Diazepam; Diclofenac; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Metoprolol; Models, Animal; Oncorhynchus mykiss; Phenylbutazone; Propranolol; Tandem Mass Spectrometry; Water Pollutants, Chemical; Xenobiotics | 2017 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; California; Cohort Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus; Eclampsia; Female; Gestational Age; Heart Defects, Congenital; Heart Failure; Humans; Hyperlipidemias; Hypertension; Labetalol; Logistic Models; Metoprolol; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Propranolol; Retrospective Studies; Risk; Risk Factors | 2017 |
Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Atenolol; Intestinal Absorption; Intestines; Male; Metoprolol; Propranolol; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2017 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolol; Calcium-Binding Proteins; Child; Combined Modality Therapy; Defibrillators, Implantable; Electrocardiography; Extracorporeal Membrane Oxygenation; Heart Arrest; Humans; Male; Membrane Proteins; Muscle Proteins; Mutation; Propanolamines; Propranolol; Sympathectomy; Tachycardia, Ventricular | 2018 |
β-blockers interfere with cell homing receptors and regulatory proteins in a model of spontaneously hypertensive rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atenolol; beta-Arrestin 1; beta-Arrestin 2; Carbazoles; Carvedilol; Cell Movement; Chemokine CXCL12; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; Hypertension; Kidney; Liver; Lung; Metoprolol; Myocardium; NF-kappa B; Propanolamines; Propranolol; Rats, Inbred SHR; Receptors, CXCR; Receptors, CXCR4; Signal Transduction | 2018 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enalapril; Government Programs; Humans; Hydrochlorothiazide; Hypertension; Losartan; Lymphocytes; Macrophages; Male; Mutagenicity Tests; Program Evaluation; Propranolol | 2018 |
Beta-blocker subtypes and risk of low birth weight in newborns.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Metoprolol; Pregnancy; Prevalence; Propranolol; Retrospective Studies | 2018 |
Occurrence and enantiomer profiles of β-blockers in wastewater and a receiving water body and adjacent soil in Tianjin, China.
Topics: Adrenergic beta-Antagonists; Atenolol; China; Environmental Monitoring; Metoprolol; Propranolol; Soil; Stereoisomerism; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2019 |
Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre.
Topics: Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Hospitals, Pediatric; Humans; Infant; Male; Patient Safety; Propranolol; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2019 |
Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
Topics: Administration, Oral; Atenolol; Drug Substitution; Female; Hemangioma, Capillary; Humans; Infant; Patient Safety; Prognosis; Propranolol; Risk Assessment; Sampling Studies; Skin Neoplasms; Sleep Wake Disorders; Treatment Outcome | 2019 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
Equine bronchial fibroblasts enhance proliferation and differentiation of primary equine bronchial epithelial cells co-cultured under air-liquid interface.
Topics: Animals; Atenolol; Biological Transport; Bronchi; Cell Differentiation; Cell Membrane Permeability; Cell Proliferation; Cell Shape; Cells, Cultured; Coculture Techniques; Electricity; Epithelial Cells; Fibroblasts; Horses; Mitomycin; Phenotype; Propranolol; Rats; Tight Junctions; Time Factors | 2019 |
Suppression of tooth movement-induced sclerostin expression using β-adrenergic receptor blockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bone Morphogenetic Proteins; Bone Remodeling; Bone Resorption; Butoxamine; Genetic Markers; Osteoclasts; Osteocytes; Propranolol; RANK Ligand; Rats; Rats, Inbred SHR; Tooth Movement Techniques | 2020 |
Toxicity of Atenolol and Propranolol on Rat Heart Mitochondria.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Atenolol; Cytochromes c; Electron Transport Complex II; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membranes; Mitochondrial Swelling; Oxidative Stress; Propranolol; Rats; Reactive Oxygen Species; Toxicity Tests, Acute | 2020 |
Interaction between Angiotensin Receptor and β-Adrenergic Receptor Regulates the Production of Amyloid β-Protein.
Topics: Adrenergic beta-Antagonists; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Bisoprolol; Cells, Cultured; Mice, Inbred C57BL; Propanolamines; Propranolol; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-2; Telmisartan | 2020 |
Effects of β-adrenoceptor activation on haemodynamics during hypoxic stress in rats.
Topics: Animals; Arterial Pressure; Atenolol; Catecholamines; Heart Rate; Hemodynamics; Hypoxia; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Vascular Resistance | 2020 |
Dispersive solid-phase extraction of racemic drugs using chiral ionic liquid-metal-organic framework composite sorbent.
Topics: Adrenergic beta-Antagonists; Atenolol; Chromatography, High Pressure Liquid; Copper; Ionic Liquids; Metal-Organic Frameworks; Metoprolol; Pharmaceutical Preparations; Propranolol; Solid Phase Extraction; Solvents; Stereoisomerism | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
Gel electro-membrane extraction of propranolol and atenolol from blood serum samples: Effect of graphene-based nanomaterials on extraction efficiency of gel membrane.
Topics: Atenolol; Graphite; Hydrogen-Ion Concentration; Membranes, Artificial; Nanostructures; Propranolol; Reproducibility of Results; Serum | 2021 |
Traumatic brain injury induced temperature dysregulation: What is the role of β blockers?
Topics: Abbreviated Injury Scale; Adrenergic beta-Antagonists; Atenolol; Body Temperature; Brain Injuries, Traumatic; Female; Humans; Hyperthermia; Male; Metoprolol; Middle Aged; Propensity Score; Propranolol; Retrospective Studies; Treatment Outcome | 2021 |
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas.
Topics: Administration, Oral; Antihypertensive Agents; Atenolol; China; Female; Hemangioma; Humans; Infant; Male; Propranolol; Surveys and Questionnaires; Treatment Outcome | 2021 |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Topics: Animals; Antipyrine; Atenolol; Carbamazepine; Cell Membrane; Digoxin; Diltiazem; Diphenhydramine; Drug Elimination Routes; Gabapentin; Lamotrigine; Liver; Memantine; Membrane Transport Proteins; Microdialysis; Muscle, Skeletal; Ofloxacin; Pharmaceutical Preparations; Propranolol; Pyrilamine; Quinidine; Rats; Terfenadine | 2021 |
Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.
Topics: Animals; Atenolol; Hemangioma; Humans; Mice; Neoplastic Stem Cells; Neovascularization, Pathologic; Propranolol; Xenograft Model Antitumor Assays | 2022 |
Atenolol as treatment for hepatic hemangiomas in a premature infant.
Topics: Atenolol; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Propranolol | 2022 |
Zeolitic imidazolate framework-67-modified open-tubular column with cyclodextrin for enantioseparation in capillary electrochromatography.
Topics: Amlodipine; Atenolol; Capillary Electrochromatography; Cyclodextrins; Histidine; Metoprolol; Propranolol; Stereoisomerism; Zeolites | 2022 |
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma.
Topics: Adrenergic beta-Antagonists; Atenolol; Cross-Sectional Studies; Esthetics; Hemangioma; Hemangioma, Capillary; Humans; Infant; Propranolol; Treatment Outcome | 2022 |
Carboxymethyl-β-cyclodextrin and histidine-zeolitic imidazolate framework-8 used for enantioseparation of three basic drugs in open-tubular capillary electrochromatography.
Topics: Amlodipine; Atenolol; beta-Cyclodextrins; Capillary Electrochromatography; Histidine; Propranolol; Stereoisomerism; Zeolites | 2022 |
Adsorption and leaching of β-blockers in fluvo-aquic and black soil: Behavior characteristic and enantiomer selectivity.
Topics: Adsorption; Atenolol; Propranolol; Soil; Soil Pollutants; Sotalol | 2022 |
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.
Topics: Adrenergic beta-Antagonists; Amines; Atenolol; Autophagy; Cell Proliferation; Child; Endothelial Cells; Hemangioma; Humans; Macrolides; Metoprolol; Propranolol; Sirolimus | 2022 |
A Human Stem Cell-Derived Brain-Liver Chip for Assessing Blood-Brain-Barrier Permeation of Pharmaceutical Drugs.
Topics: Atenolol; Blood-Brain Barrier; Brain; Humans; Induced Pluripotent Stem Cells; Liver; Pharmaceutical Preparations; Propranolol | 2022 |
Mechanism of β-blocker biodegradation by wastewater microorganisms.
Topics: Adrenergic beta-Antagonists; Atenolol; Metoprolol; Molecular Docking Simulation; Propranolol; Sewage; Wastewater | 2023 |
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma.
Topics: Adrenergic beta-Antagonists; Atenolol; Child; Cross-Sectional Studies; Female; Hemangioma; Hemangioma, Capillary; Humans; Infant; Male; Propranolol; Treatment Outcome | 2023 |
First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.
Topics: Atenolol; Hemangioendothelioma; Humans; Kasabach-Merritt Syndrome; Propranolol; Sarcoma, Kaposi | 2023 |